"id"	"chemical_id"	"chemical_name"	"protein_id"	"protein_name"	"relation_name"	"relation_id"	"source"	"dikb_id"	"fda_id"	"drugcentral_id"	"reference"	"year"	"measurement_type"	"measurement_value"
2397	CHEBI_28901	busulfan	PR_P11509	CYP2A6	inhibits	RO_0002449	FDA		74		PL	2017		
2398	CHEBI_8426	probenecid	PR_Q9UNQ0	BCRP	molecularly_interacts_with	RO_0002436	FDA		869			2017		
359	CHEBI_7936	paroxetine	PR_P10635	cyp2d6	inhibits	RO_0002449	dikb	607			http://www.ncbi.nlm.nih.gov/pubmed/12173784	2017		
2399	CHEBI_119573	delavirdine	PR_P08684	CYP3A4	inhibits	RO_0002449	FDA		13		PL	2017		
438	CHEBI_135737	lacidipine	PR_P33261	Cytochrome P450 2C19	is_substrate_of	DIDEO_00000041	drug_central			356	DRUG MATRIX	2017	IC50	5.0
439	CHEBI_4877	ethambutol	PR_P20815	Cytochrome P450 3A5	is_substrate_of	DIDEO_00000041	drug_central			664	WOMBAT-PK	2017	IC50	4.0
440	CHEBI_6715	medroxyprogesterone and estrogen	PR_P33261	Cytochrome P450 2C19	is_substrate_of	DIDEO_00000041	drug_central			366	DRUG MATRIX	2017	IC50	5.0
441	CHEBI_35553	perhexiline	PR_P10635	Cytochrome P450 2D6	molecularly_interacts_with	RO_0002436	drug_central			955	DRUG MATRIX	2017	IC50	6.0
442	CHEBI_6402	leflunomide	PR_P05177	Cytochrome P450 1A2	molecularly_interacts_with	RO_0002436	drug_central			723	DRUG MATRIX	2017	IC50	6.0
443	CHEBI_7465	naltrexone	PR_P10635	Cytochrome P450 2D6	molecularly_interacts_with	RO_0002436	drug_central			942	DRUG MATRIX	2017	IC50	6.0
444	CHEBI_6923	miconazole	PR_P33261	Cytochrome P450 2C19	molecularly_interacts_with	RO_0002436	drug_central			783	DRUG MATRIX	2017	IC50	7.0
445	CHEBI_64318	ergotamine, combinations excl. psycholeptics	PR_P08684	Cytochrome P450 3A4	molecularly_interacts_with	RO_0002436	drug_central			1032	DRUG MATRIX	2017	IC50	6.0
446	CHEBI_10100	zafirlukast	PR_P11712	Cytochrome P450 2C9	molecularly_interacts_with	RO_0002436	drug_central			883	DRUG MATRIX	2017	IC50	5.0
447	CHEBI_8461	prednisolone and promethazine	PR_P10635	Cytochrome P450 2D6	molecularly_interacts_with	RO_0002436	drug_central			961	WOMBAT-PK	2017	Ki	5.0
448	CHEBI_5118	fluoxetine and psycholeptics	PR_P10635	Cytochrome P450 2D6	is_substrate_of	DIDEO_00000041	drug_central			499	DRUG MATRIX	2017	IC50	6.0
449	CHEBI_7459	hydromorphone and naloxone	PR_P10635	Cytochrome P450 2D6	molecularly_interacts_with	RO_0002436	drug_central			947	DRUG MATRIX	2017	IC50	5.0
2400	CHEBI_8426	probenecid	PR_Q96FL8	MATE1	molecularly_interacts_with	RO_0002436	FDA		360		PL	2017		
450	CHEBI_6375	lansoprazole, tetracycline and metronidazole	PR_P10635	Cytochrome P450 2D6	is_substrate_of	DIDEO_00000041	drug_central			512	DRUG MATRIX	2017	IC50	5.0
451	CHEBI_4636	diphenhydramine, combinations	PR_P10635	Cytochrome P450 2D6	is_substrate_of	DIDEO_00000041	drug_central			493	WOMBAT-PK	2017	Ki	4.0
452	CHEBI_45409	lopinavir and ritonavir	PR_P08684	Cytochrome P450 3A4	is_substrate_of	DIDEO_00000041	drug_central			646	WOMBAT-PK	2017	IC50	7.0
453	CHEBI_7565	nifedipine, combinations	PR_P05177	Cytochrome P450 1A2	molecularly_interacts_with	RO_0002436	drug_central			729	DRUG MATRIX	2017	IC50	6.0
454	CHEBI_7789	orphenadrine (chloride)	PR_P10635	Cytochrome P450 2D6	is_substrate_of	DIDEO_00000041	drug_central			526	DRUG MATRIX	2017	IC50	6.0
455	CHEBI_8673	pyrimethamine	PR_P11712	Cytochrome P450 2C9	molecularly_interacts_with	RO_0002436	drug_central			865	WOMBAT-PK	2017	Ki	4.0
456	CHEBI_3238	butenafine	PR_P10635	Cytochrome P450 2D6	molecularly_interacts_with	RO_0002436	drug_central			899	DRUG MATRIX	2017	IC50	6.0
457	CHEBI_7582	enalapril and nitrendipine	PR_P33261	Cytochrome P450 2C19	molecularly_interacts_with	RO_0002436	drug_central			786	DRUG MATRIX	2017	IC50	5.0
458	CHEBI_47381	diclofenac	PR_O60656	UDP-glucuronosyltransferase 1-9	molecularly_interacts_with	RO_0002436	drug_central			1124	CHEMBL	2017	Ki	4.0
459	CHEBI_47381	diclofenac, combinations	PR_P19224	UDP-glucuronosyltransferase 1-6	molecularly_interacts_with	RO_0002436	drug_central			1118	CHEMBL	2017	Ki	4.0
460	CHEBI_8461	promethazine	PR_P10635	Cytochrome P450 2D6	is_substrate_of	DIDEO_00000041	drug_central			539	WOMBAT-PK	2017	Ki	5.0
461	CHEBI_7443	nabumetone	PR_P05177	Cytochrome P450 1A2	is_substrate_of	DIDEO_00000041	drug_central			312	DRUG MATRIX	2017	IC50	5.0
462	CHEBI_45980	tacrine	PR_P10635	Cytochrome P450 2D6	molecularly_interacts_with	RO_0002436	drug_central			980	DRUG MATRIX	2017	IC50	6.0
463	CHEBI_135590	ambroxol	PR_P10635	Cytochrome P450 2D6	molecularly_interacts_with	RO_0002436	drug_central			888	DRUG MATRIX	2017	IC50	6.0
464	CHEBI_6343	labetalol and thiazides	PR_P10635	Cytochrome P450 2D6	is_substrate_of	DIDEO_00000041	drug_central			505	DRUG MATRIX	2017	IC50	6.0
465	CHEBI_45285	rifampicin, pyrazinamide, ethambutol and isoniazid	PR_P08684	Cytochrome P450 3A4	molecularly_interacts_with	RO_0002436	drug_central			1071	WOMBAT-PK	2017	IC50	6.0
466	CHEBI_48574	phenylbutazone and corticosteroids	PR_P11712	Cytochrome P450 2C9	molecularly_interacts_with	RO_0002436	drug_central			862	WOMBAT-PK	2017	Ki	4.0
467	CHEBI_6541	losartan and diuretics	PR_P11712	Cytochrome P450 2C9	molecularly_interacts_with	RO_0002436	drug_central			846	DRUG MATRIX	2017	IC50	5.0
468	CHEBI_47519	ketoconazole	PR_Q16850	Cytochrome P450 51	is_substrate_of	DIDEO_00000041	drug_central			678	CHEMBL	2017	Ki	7.0
469	CHEBI_85078	saxagliptin and dapagliflozin	PR_P31639	Sodium/glucose cotransporter 2	molecularly_interacts_with	RO_0002436	drug_central			1137	CHEMBL	2017	EC50	8.0
470	CHEBI_7565	atenolol and nifedipine	PR_P08684	Cytochrome P450 3A4	molecularly_interacts_with	RO_0002436	drug_central			1063	WOMBAT-PK	2017	IC50	5.0
471	CHEBI_3090	bicalutamide	PR_P33261	Cytochrome P450 2C19	is_substrate_of	DIDEO_00000041	drug_central			339	CHEMBL	2017	IC50	6.0
472	CHEBI_47381	diclofenac, combinations	PR_O60656	UDP-glucuronosyltransferase 1-9	molecularly_interacts_with	RO_0002436	drug_central			1126	CHEMBL	2017	Ki	4.0
473	CHEBI_31859	modafinil	PR_P05177	Cytochrome P450 1A2	molecularly_interacts_with	RO_0002436	drug_central			724	WOMBAT-PK	2017	Ki	4.0
474	CHEBI_5693	hexachlorophene	PR_P33261	Cytochrome P450 2C19	is_substrate_of	DIDEO_00000041	drug_central			354	DRUG MATRIX	2017	IC50	5.0
475	CHEBI_5441	glibenclamide	PR_P11712	Cytochrome P450 2C9	is_substrate_of	DIDEO_00000041	drug_central			418	DRUG MATRIX	2017	IC50	5.0
476	CHEBI_24564	altretamine	PR_P05177	Cytochrome P450 1A2	is_substrate_of	DIDEO_00000041	drug_central			301	DRUG MATRIX	2017	IC50	5.0
477	CHEBI_39548	atorvastatin, acetylsalicylic acid and ramipril	PR_P08684	Cytochrome P450 3A4	molecularly_interacts_with	RO_0002436	drug_central			1005	CHEMBL	2017	IC50	5.0
478	CHEBI_6919	mezlocillin	PR_P11712	Cytochrome P450 2C9	molecularly_interacts_with	RO_0002436	drug_central			850	WOMBAT-PK	2017	IC50	4.0
479	CHEBI_9249	stanozolol	PR_P33261	Cytochrome P450 2C19	molecularly_interacts_with	RO_0002436	drug_central			797	DRUG MATRIX	2017	IC50	7.0
480	CHEBI_8081	phentolamine	PR_P10635	Cytochrome P450 2D6	molecularly_interacts_with	RO_0002436	drug_central			957	DRUG MATRIX	2017	IC50	5.0
481	CHEBI_47519	ketoconazole	PR_P05093	Cytochrome P450 17A1	is_substrate_of	DIDEO_00000041	drug_central			297	CHEMBL	2017	IC50	6.0
482	CHEBI_3215	bupivacaine	PR_P10635	Cytochrome P450 2D6	is_substrate_of	DIDEO_00000041	drug_central			476	DRUG MATRIX	2017	IC50	6.0
483	CHEBI_39548	atorvastatin and amlodipine	PR_P08684	Cytochrome P450 3A4	is_substrate_of	DIDEO_00000041	drug_central			584	CHEMBL	2017	IC50	5.0
484	CHEBI_6723	megestrol and estrogen	PR_P11712	Cytochrome P450 2C9	is_substrate_of	DIDEO_00000041	drug_central			427	DRUG MATRIX	2017	IC50	5.0
485	CHEBI_37924	atazanavir	PR_P11712	Cytochrome P450 2C9	molecularly_interacts_with	RO_0002436	drug_central			815	WOMBAT-PK	2017	Ki	4.0
486	CHEBI_6690	maprotiline	PR_P08684	Cytochrome P450 3A4	is_substrate_of	DIDEO_00000041	drug_central			626	DRUG MATRIX	2017	IC50	5.0
487	CHEBI_135737	lacidipine	PR_P08684	Cytochrome P450 3A4	molecularly_interacts_with	RO_0002436	drug_central			1051	DRUG MATRIX	2017	IC50	6.0
488	CHEBI_9948	verapamil	PR_Q9UNQ0	ATP-binding cassette sub-family G member 2	molecularly_interacts_with	RO_0002436	drug_central			1132	CHEMBL	2017	EC50	4.0
489	CHEBI_72291	emtricitabine, tenofovir disoproxil, elvitegravir and cobicistat	PR_P08684	Cytochrome P450 3A	molecularly_interacts_with	RO_0002436	drug_central			996	SCIENTIFIC LITERATURE	2017	Ki	6.0
490	CHEBI_6541	losartan and diuretics	PR_P11712	Cytochrome P450 2C9	is_substrate_of	DIDEO_00000041	drug_central			425	DRUG MATRIX	2017	IC50	5.0
491	CHEBI_47519	ketoconazole	PR_Q07973	Cytochrome P450 24A1	is_substrate_of	DIDEO_00000041	drug_central			333	CHEMBL	2017	IC50	4.0
492	CHEBI_50692	mifepristone, combinations	PR_P08684	Cytochrome P450 3A4	molecularly_interacts_with	RO_0002436	drug_central			1059	WOMBAT-PK	2017	Ki	6.0
493	CHEBI_7575	nimodipine	PR_P08684	Cytochrome P450 3A4	is_substrate_of	DIDEO_00000041	drug_central			640	WOMBAT-PK	2017	Ki	6.0
494	CHEBI_18358	methoxsalen	PR_P05177	Cytochrome P450 1A2	is_substrate_of	DIDEO_00000041	drug_central			299	DRUG MATRIX	2017	IC50	7.0
495	CHEBI_7772	omeprazole, amoxicillin and metronidazole	PR_P11712	Cytochrome P450 2C9	is_substrate_of	DIDEO_00000041	drug_central			438	WOMBAT-PK	2017	Ki	4.0
496	CHEBI_64216	metergoline	PR_P10635	Cytochrome P450 2D6	molecularly_interacts_with	RO_0002436	drug_central			937	DRUG MATRIX	2017	IC50	6.0
497	CHEBI_37924	atazanavir	PR_P22309	UDP-glucuronosyltransferase 1-1	is_substrate_of	DIDEO_00000041	drug_central			680	WOMBAT-PK	2017	Ki	5.0
498	CHEBI_40050	amprenavir	PR_P08684	Cytochrome P450 3A4	is_substrate_of	DIDEO_00000041	drug_central			575	DRUG MATRIX	2017	IC50	6.0
499	CHEBI_3219	bupropion and naltrexone	PR_P33261	Cytochrome P450 2C19	molecularly_interacts_with	RO_0002436	drug_central			757	DRUG MATRIX	2017	IC50	5.0
500	CHEBI_6413	letrozole	PR_P15538	Cytochrome P450 11B1, mitochondrial	is_substrate_of	DIDEO_00000041	drug_central			289	CHEMBL	2017	IC50	5.0
501	CHEBI_9362	suprofen	PR_P11712	Cytochrome P450 2C9	is_substrate_of	DIDEO_00000041	drug_central			456	WOMBAT-PK	2017	Ki	4.0
502	CHEBI_9671	triamterene	PR_P10635	Cytochrome P450 2D6	is_substrate_of	DIDEO_00000041	drug_central			561	DRUG MATRIX	2017	IC50	5.0
503	CHEBI_9325	sulconazole	PR_P11712	Cytochrome P450 2C9	molecularly_interacts_with	RO_0002436	drug_central			874	DRUG MATRIX	2017	IC50	6.0
504	CHEBI_68639	abiraterone	PR_P19099	Cytochrome P450 11B2, mitochondrial	molecularly_interacts_with	RO_0002436	drug_central			709	CHEMBL	2017	IC50	5.0
505	CHEBI_7825	oxiconazole	PR_P10635	Cytochrome P450 2D6	is_substrate_of	DIDEO_00000041	drug_central			563	DRUG MATRIX	2017	IC50	6.0
506	CHEBI_68639	abiraterone	PR_P05093	Cytochrome P450 17A1	is_substrate_of	DIDEO_00000041	drug_central			298	CHEMBL	2017	IC50	7.0
507	CHEBI_2611	alprazolam	PR_P08684	Cytochrome P450 3A4	molecularly_interacts_with	RO_0002436	drug_central			997	WOMBAT-PK	2017	Ki	3.0
508	CHEBI_63619	propafenone	PR_P10635	Cytochrome P450 2D6	molecularly_interacts_with	RO_0002436	drug_central			964	DRUG MATRIX	2017	IC50	5.0
509	CHEBI_45285	pyrazinamide	PR_P20815	Cytochrome P450 3A5	is_substrate_of	DIDEO_00000041	drug_central			675	WOMBAT-PK	2017	IC50	4.0
510	CHEBI_77780	sulfafenazol	PR_P11712	Cytochrome P450 2C9	is_substrate_of	DIDEO_00000041	drug_central			454	DRUG MATRIX	2017	IC50	6.0
511	CHEBI_83305	oritavancin	NCBITaxon_1201292	Enterococcus faecalis ATCC 29212	molecularly_interacts_with	RO_0002436	drug_central			1127	DRUG LABEL	2017	MIC	8.0
512	CHEBI_6030	streptomycin and isoniazid	PR_P20815	Cytochrome P450 3A5	is_substrate_of	DIDEO_00000041	drug_central			673	WOMBAT-PK	2017	IC50	4.0
513	CHEBI_7577	nisoldipine	PR_P05177	Cytochrome P450 1A2	is_substrate_of	DIDEO_00000041	drug_central			316	DRUG MATRIX	2017	IC50	6.0
514	CHEBI_6923	miconazole	PR_P08684	Cytochrome P450 3A4	molecularly_interacts_with	RO_0002436	drug_central			1056	DRUG MATRIX	2017	IC50	7.0
515	CHEBI_6030	rifampicin, pyrazinamide, ethambutol and isoniazid	PR_P08684	Cytochrome P450 3A4	molecularly_interacts_with	RO_0002436	drug_central			1046	WOMBAT-PK	2017	IC50	5.0
516	CHEBI_77069	eperisone	PR_P10635	Cytochrome P450 2D6	molecularly_interacts_with	RO_0002436	drug_central			918	DRUG MATRIX	2017	IC50	5.0
517	CHEBI_47519	ketoconazole	PR_P22680	Cytochrome P450 7A1	is_substrate_of	DIDEO_00000041	drug_central			679	CHEMBL	2017	IC50	6.0
518	CHEBI_9249	stanozolol	PR_P11712	Cytochrome P450 2C9	is_substrate_of	DIDEO_00000041	drug_central			452	DRUG MATRIX	2017	IC50	5.0
519	CHEBI_5818	hydroxyzine, combinations	PR_P10635	Cytochrome P450 2D6	molecularly_interacts_with	RO_0002436	drug_central			922	WOMBAT-PK	2017	Ki	5.0
520	CHEBI_8499	propranolol and thiazides	PR_P10635	Cytochrome P450 2D6	molecularly_interacts_with	RO_0002436	drug_central			967	DRUG MATRIX	2017	IC50	5.0
521	CHEBI_6375	lansoprazole, amoxicillin and clarithromycin	PR_P10635	Cytochrome P450 2D6	is_substrate_of	DIDEO_00000041	drug_central			507	DRUG MATRIX	2017	IC50	5.0
522	CHEBI_9168	sirolimus	PR_P33261	Cytochrome P450 2C19	molecularly_interacts_with	RO_0002436	drug_central			795	DRUG MATRIX	2017	IC50	5.0
523	CHEBI_8426	probenecid	PR_Q9HAW7	UDP-glucuronosyltransferase 1-7	molecularly_interacts_with	RO_0002436	drug_central			1123	CHEMBL	2017	Ki	4.0
524	CHEBI_7582	enalapril and nitrendipine	PR_P11712	Cytochrome P450 2C9	molecularly_interacts_with	RO_0002436	drug_central			855	DRUG MATRIX	2017	IC50	6.0
525	CHEBI_5818	hydroxyzine, combinations	PR_P10635	Cytochrome P450 2D6	is_substrate_of	DIDEO_00000041	drug_central			501	WOMBAT-PK	2017	Ki	5.0
526	CHEBI_6030	isoniazid	PR_P20815	Cytochrome P450 3A5	molecularly_interacts_with	RO_0002436	drug_central			1096	WOMBAT-PK	2017	IC50	4.0
527	CHEBI_4636	diphenhydramine, combinations	PR_P10635	Cytochrome P450 2D6	molecularly_interacts_with	RO_0002436	drug_central			914	WOMBAT-PK	2017	Ki	4.0
528	CHEBI_45409	ombitasvir, paritaprevir and ritonavir	PR_P11712	Cytochrome P450 2C9	is_substrate_of	DIDEO_00000041	drug_central			449	DRUG MATRIX	2017	IC50	7.0
529	CHEBI_6030	ethambutol and isoniazid	PR_P20815	Cytochrome P450 3A5	molecularly_interacts_with	RO_0002436	drug_central			1095	WOMBAT-PK	2017	IC50	4.0
530	CHEBI_31298	bopindolol and other diuretics	PR_P10635	Cytochrome P450 2D6	is_substrate_of	DIDEO_00000041	drug_central			474	DRUG MATRIX	2017	IC50	5.0
531	CHEBI_7936	paroxetine	PR_P05177	Cytochrome P450 1A2	is_substrate_of	DIDEO_00000041	drug_central			320	WOMBAT-PK	2017	IC50	4.0
532	CHEBI_47381	diclofenac, combinations	PR_P19224	UDP-glucuronosyltransferase 1-6	is_substrate_of	DIDEO_00000041	drug_central			690	CHEMBL	2017	Ki	4.0
533	CHEBI_47519	ketoconazole	PR_P05108	Cytochrome P450 11A1	molecularly_interacts_with	RO_0002436	drug_central			699	CHEMBL	2017	IC50	5.0
534	CHEBI_7550	nicardipine	PR_P11712	Cytochrome P450 2C9	molecularly_interacts_with	RO_0002436	drug_central			853	WOMBAT-PK	2017	IC50	6.0
535	CHEBI_6030	rifampicin, pyrazinamide and isoniazid	PR_P20815	Cytochrome P450 3A5	is_substrate_of	DIDEO_00000041	drug_central			671	WOMBAT-PK	2017	IC50	4.0
536	CHEBI_127342	atomoxetine	PR_P10635	Cytochrome P450 2D6	is_substrate_of	DIDEO_00000041	drug_central			470	WOMBAT-PK	2017	Ki	4.0
537	CHEBI_8499	propranolol and thiazides	PR_P05177	Cytochrome P450 1A2	is_substrate_of	DIDEO_00000041	drug_central			327	DRUG MATRIX	2017	IC50	5.0
538	CHEBI_3545	cefapirin	PR_P08684	Cytochrome P450 3A4	is_substrate_of	DIDEO_00000041	drug_central			590	WOMBAT-PK	2017	IC50	5.0
539	CHEBI_2611	alprazolam	PR_P08684	Cytochrome P450 3A4	is_substrate_of	DIDEO_00000041	drug_central			573	WOMBAT-PK	2017	Ki	3.0
540	CHEBI_77780	sulfaphenazole	PR_P11712	Cytochrome P450 2C9	is_substrate_of	DIDEO_00000041	drug_central			455	DRUG MATRIX	2017	IC50	6.0
541	CHEBI_3994	cyclizine	PR_P10635	Cytochrome P450 2D6	is_substrate_of	DIDEO_00000041	drug_central			490	DRUG MATRIX	2017	IC50	5.0
542	CHEBI_6030	thioacetazone and isoniazid	PR_P20815	Cytochrome P450 3A5	molecularly_interacts_with	RO_0002436	drug_central			1102	WOMBAT-PK	2017	IC50	4.0
543	CHEBI_63632	topotecan	PR_P08684	Cytochrome P450 3A4	molecularly_interacts_with	RO_0002436	drug_central			1080	DRUG MATRIX	2017	IC50	5.0
544	CHEBI_6375	lansoprazole, combinations	PR_P33261	Cytochrome P450 2C19	molecularly_interacts_with	RO_0002436	drug_central			777	DRUG MATRIX	2017	IC50	6.0
545	CHEBI_7565	nifedipine and diuretics	PR_P05177	Cytochrome P450 1A2	molecularly_interacts_with	RO_0002436	drug_central			728	DRUG MATRIX	2017	IC50	6.0
546	CHEBI_45285	pyrazinamide	PR_P08684	Cytochrome P450 3A4	is_substrate_of	DIDEO_00000041	drug_central			642	WOMBAT-PK	2017	IC50	6.0
547	CHEBI_31687	idebenone	PR_P10635	Cytochrome P450 2D6	molecularly_interacts_with	RO_0002436	drug_central			923	DRUG MATRIX	2017	IC50	5.0
548	CHEBI_48574	phenylbutazone	PR_P11712	Cytochrome P450 2C9	is_substrate_of	DIDEO_00000041	drug_central			440	WOMBAT-PK	2017	Ki	4.0
549	CHEBI_4659	disulfiram, combinations	PR_P05177	Cytochrome P450 1A2	molecularly_interacts_with	RO_0002436	drug_central			718	DRUG MATRIX	2017	IC50	5.0
550	CHEBI_4562	dihydroergotamine, combinations	PR_P08684	Cytochrome P450 3A4	molecularly_interacts_with	RO_0002436	drug_central			1027	DRUG MATRIX	2017	IC50	5.0
551	CHEBI_32215	thiamphenicol	PR_P33261	Cytochrome P450 2C19	molecularly_interacts_with	RO_0002436	drug_central			799	WOMBAT-PK	2017	IC50	5.0
552	CHEBI_6030	rifampicin, pyrazinamide, ethambutol and isoniazid	PR_P20815	Cytochrome P450 3A5	is_substrate_of	DIDEO_00000041	drug_central			672	WOMBAT-PK	2017	IC50	4.0
553	CHEBI_7772	omeprazole	PR_P33261	Cytochrome P450 2C19	is_substrate_of	DIDEO_00000041	drug_central			374	WOMBAT-PK	2017	Ki	5.0
554	CHEBI_6923	miconazole	PR_P33261	Cytochrome P450 2C19	is_substrate_of	DIDEO_00000041	drug_central			368	DRUG MATRIX	2017	IC50	7.0
555	CHEBI_47381	diclofenac	PR_O60656	UDP-glucuronosyltransferase 1-9	is_substrate_of	DIDEO_00000041	drug_central			696	CHEMBL	2017	Ki	4.0
556	CHEBI_8060	phenelzine	PR_P11712	Cytochrome P450 2C9	is_substrate_of	DIDEO_00000041	drug_central			439	DRUG MATRIX	2017	IC50	5.0
557	CHEBI_46081	azithromycin, fluconazole and secnidazole	PR_P08684	Cytochrome P450 3A4	molecularly_interacts_with	RO_0002436	drug_central			1037	CHEMBL	2017	IC50	5.0
558	CHEBI_8499	propranolol and thiazides	PR_P10635	Cytochrome P450 2D6	is_substrate_of	DIDEO_00000041	drug_central			544	DRUG MATRIX	2017	IC50	5.0
559	CHEBI_6690	maprotiline	PR_P08684	Cytochrome P450 3A4	molecularly_interacts_with	RO_0002436	drug_central			1052	DRUG MATRIX	2017	IC50	5.0
560	CHEBI_4513	dicoumarol	PR_P11712	Cytochrome P450 2C9	molecularly_interacts_with	RO_0002436	drug_central			826	WOMBAT-PK	2017	Ki	5.0
561	CHEBI_47519	ketoconazole	PR_Q07973	Cytochrome P450 24A1	molecularly_interacts_with	RO_0002436	drug_central			748	CHEMBL	2017	IC50	4.0
562	CHEBI_7789	orphenadrine, combinations	PR_P10635	Cytochrome P450 2D6	molecularly_interacts_with	RO_0002436	drug_central			951	DRUG MATRIX	2017	IC50	6.0
563	CHEBI_4910	etomidate	PR_P15538	Cytochrome P450 11B1, mitochondrial	molecularly_interacts_with	RO_0002436	drug_central			700	CHEMBL	2017	IC50	9.0
564	CHEBI_32215	thiamphenicol, combinations	PR_P33261	Cytochrome P450 2C19	molecularly_interacts_with	RO_0002436	drug_central			800	WOMBAT-PK	2017	IC50	5.0
565	CHEBI_9448	terbinafine	PR_P10635	Cytochrome P450 2D6	molecularly_interacts_with	RO_0002436	drug_central			981	DRUG MATRIX	2017	IC50	6.0
566	CHEBI_5062	alfuzosin and finasteride	PR_P11712	Cytochrome P450 2C9	is_substrate_of	DIDEO_00000041	drug_central			412	DRUG MATRIX	2017	IC50	5.0
567	CHEBI_6375	lansoprazole, amoxicillin and metronidazole	PR_P33261	Cytochrome P450 2C19	is_substrate_of	DIDEO_00000041	drug_central			360	DRUG MATRIX	2017	IC50	6.0
568	CHEBI_5062	alfuzosin and finasteride	PR_P33261	Cytochrome P450 2C19	is_substrate_of	DIDEO_00000041	drug_central			348	DRUG MATRIX	2017	IC50	6.0
569	CHEBI_44241	metyrapone	PR_P19099	Cytochrome P450 11B2, mitochondrial	molecularly_interacts_with	RO_0002436	drug_central			708	CHEMBL	2017	IC50	7.0
570	CHEBI_7575	nimodipine	PR_P08684	Cytochrome P450 3A4	molecularly_interacts_with	RO_0002436	drug_central			1067	WOMBAT-PK	2017	Ki	6.0
571	CHEBI_6923	miconazole, combinations	PR_P33261	Cytochrome P450 2C19	is_substrate_of	DIDEO_00000041	drug_central			369	DRUG MATRIX	2017	IC50	7.0
572	CHEBI_31298	bopindolol	PR_P10635	Cytochrome P450 2D6	molecularly_interacts_with	RO_0002436	drug_central			894	DRUG MATRIX	2017	IC50	5.0
573	CHEBI_10023	voriconazole	PR_P08684	Cytochrome P450 3A4	is_substrate_of	DIDEO_00000041	drug_central			658	CHEMBL	2017	IC50	4.0
574	CHEBI_10093	yohimbine	PR_P10635	Cytochrome P450 2D6	molecularly_interacts_with	RO_0002436	drug_central			987	DRUG MATRIX	2017	IC50	5.0
575	CHEBI_64318	ergotamine	PR_P08684	Cytochrome P450 3A4	is_substrate_of	DIDEO_00000041	drug_central			605	DRUG MATRIX	2017	IC50	6.0
576	CHEBI_9325	sulconazole	PR_P05177	Cytochrome P450 1A2	molecularly_interacts_with	RO_0002436	drug_central			742	DRUG MATRIX	2017	IC50	6.0
577	CHEBI_6030	isoniazid, combinations	PR_P08684	Cytochrome P450 3A4	molecularly_interacts_with	RO_0002436	drug_central			1043	WOMBAT-PK	2017	IC50	5.0
578	CHEBI_6375	lansoprazole, amoxicillin and metronidazole	PR_P10635	Cytochrome P450 2D6	molecularly_interacts_with	RO_0002436	drug_central			930	DRUG MATRIX	2017	IC50	5.0
579	CHEBI_5693	hexachlorophene	PR_P33261	Cytochrome P450 2C19	molecularly_interacts_with	RO_0002436	drug_central			769	DRUG MATRIX	2017	IC50	5.0
580	CHEBI_2675	amoxapine	PR_P10635	Cytochrome P450 2D6	is_substrate_of	DIDEO_00000041	drug_central			467	DRUG MATRIX	2017	IC50	5.0
581	CHEBI_45409	lopinavir and ritonavir	PR_P10635	Cytochrome P450 2D6	molecularly_interacts_with	RO_0002436	drug_central			974	DRUG MATRIX	2017	IC50	4.0
582	CHEBI_72291	emtricitabine, tenofovir alafenamide, elvitegravir and cobicistat	PR_P08684	Cytochrome P450 3A	molecularly_interacts_with	RO_0002436	drug_central			995	SCIENTIFIC LITERATURE	2017	Ki	6.0
583	CHEBI_6343	labetalol and other diuretics	PR_P10635	Cytochrome P450 2D6	molecularly_interacts_with	RO_0002436	drug_central			925	DRUG MATRIX	2017	IC50	6.0
584	CHEBI_52717	bortezomib	PR_P33261	Cytochrome P450 2C19	molecularly_interacts_with	RO_0002436	drug_central			755	WOMBAT-PK	2017	Ki	4.0
585	CHEBI_9566	thioridazine	PR_P10635	Cytochrome P450 2D6	is_substrate_of	DIDEO_00000041	drug_central			559	DRUG MATRIX	2017	IC50	5.0
586	CHEBI_37924	atazanavir	PR_P22309	UDP-glucuronosyltransferase 1-1	molecularly_interacts_with	RO_0002436	drug_central			1108	WOMBAT-PK	2017	Ki	5.0
587	CHEBI_3215	bupivacaine, combinations	PR_P10635	Cytochrome P450 2D6	molecularly_interacts_with	RO_0002436	drug_central			898	DRUG MATRIX	2017	IC50	6.0
588	CHEBI_3023	benzbromarone	PR_P11712	Cytochrome P450 2C9	molecularly_interacts_with	RO_0002436	drug_central			817	DRUG MATRIX	2017	IC50	7.0
589	CHEBI_4877	ethambutol	PR_P08684	Cytochrome P450 3A4	is_substrate_of	DIDEO_00000041	drug_central			608	WOMBAT-PK	2017	IC50	6.0
590	CHEBI_6923	miconazole	PR_P08684	Cytochrome P450 3A4	is_substrate_of	DIDEO_00000041	drug_central			630	DRUG MATRIX	2017	IC50	7.0
591	CHEBI_132922	oxycodone and ibuprofen	PR_P11712	Cytochrome P450 2C9	molecularly_interacts_with	RO_0002436	drug_central			841	WOMBAT-PK	2017	Ki	4.0
592	CHEBI_6923	miconazole, combinations	PR_P08684	Cytochrome P450 3A4	is_substrate_of	DIDEO_00000041	drug_central			631	DRUG MATRIX	2017	IC50	7.0
593	CHEBI_45979	tiabendazole	PR_P05177	Cytochrome P450 1A2	is_substrate_of	DIDEO_00000041	drug_central			329	DRUG MATRIX	2017	IC50	6.0
594	CHEBI_5296	gemfibrozil	PR_P11712	Cytochrome P450 2C9	is_substrate_of	DIDEO_00000041	drug_central			417	WOMBAT-PK	2017	Ki	4.0
595	CHEBI_35553	perhexiline	PR_P10635	Cytochrome P450 2D6	is_substrate_of	DIDEO_00000041	drug_central			532	DRUG MATRIX	2017	IC50	6.0
596	CHEBI_9588	ticlopidine	PR_P11509	Cytochrome P450 2A6	molecularly_interacts_with	RO_0002436	drug_central			750	WOMBAT-PK	2017	Ki	6.0
597	CHEBI_3545	cefapirin	PR_P08684	Cytochrome P450 3A4	molecularly_interacts_with	RO_0002436	drug_central			1016	WOMBAT-PK	2017	IC50	5.0
598	CHEBI_3738	clemastine	PR_P10635	Cytochrome P450 2D6	molecularly_interacts_with	RO_0002436	drug_central			907	WOMBAT-PK	2017	Ki	5.0
599	CHEBI_9753	troglitazone	PR_P11712	Cytochrome P450 2C9	molecularly_interacts_with	RO_0002436	drug_central			878	DRUG MATRIX	2017	IC50	5.0
600	CHEBI_45285	rifampicin, pyrazinamide, ethambutol and isoniazid	PR_P20815	Cytochrome P450 3A5	is_substrate_of	DIDEO_00000041	drug_central			677	WOMBAT-PK	2017	IC50	4.0
601	CHEBI_7582	nitrendipine	PR_P11712	Cytochrome P450 2C9	is_substrate_of	DIDEO_00000041	drug_central			435	DRUG MATRIX	2017	IC50	6.0
602	CHEBI_31298	bopindolol and other diuretics	PR_P10635	Cytochrome P450 2D6	molecularly_interacts_with	RO_0002436	drug_central			895	DRUG MATRIX	2017	IC50	5.0
603	CHEBI_8435	prochlorperazine	PR_P05177	Cytochrome P450 1A2	is_substrate_of	DIDEO_00000041	drug_central			323	DRUG MATRIX	2017	IC50	5.0
604	CHEBI_10033	warfarin	PR_P11712	Cytochrome P450 2C9	molecularly_interacts_with	RO_0002436	drug_central			882	WOMBAT-PK	2017	Ki	4.0
605	CHEBI_4315	danazol	PR_P11712	Cytochrome P450 2C9	molecularly_interacts_with	RO_0002436	drug_central			825	DRUG MATRIX	2017	IC50	6.0
606	CHEBI_28593	quinidine	PR_P10635	Cytochrome P450 2D6	is_substrate_of	DIDEO_00000041	drug_central			546	SCIENTIFIC LITERATURE	2017	Ki	7.0
607	CHEBI_6723	megestrol and estrogen	PR_P11712	Cytochrome P450 2C9	molecularly_interacts_with	RO_0002436	drug_central			848	DRUG MATRIX	2017	IC50	5.0
608	CHEBI_6923	miconazole, combinations	PR_P10635	Cytochrome P450 2D6	is_substrate_of	DIDEO_00000041	drug_central			523	DRUG MATRIX	2017	IC50	6.0
609	CHEBI_8499	propranolol	PR_P05177	Cytochrome P450 1A2	is_substrate_of	DIDEO_00000041	drug_central			325	DRUG MATRIX	2017	IC50	5.0
610	CHEBI_45409	lopinavir and ritonavir	PR_P10635	Cytochrome P450 2D6	is_substrate_of	DIDEO_00000041	drug_central			551	DRUG MATRIX	2017	IC50	4.0
611	CHEBI_6919	mezlocillin	PR_P10632	Cytochrome P450 2C8	is_substrate_of	DIDEO_00000041	drug_central			395	WOMBAT-PK	2017	IC50	6.0
612	CHEBI_72291	darunavir and cobicistat	PR_P08684	Cytochrome P450 3A	is_substrate_of	DIDEO_00000041	drug_central			570	SCIENTIFIC LITERATURE	2017	Ki	6.0
613	CHEBI_8499	propranolol and other antihypertensives	PR_P10635	Cytochrome P450 2D6	is_substrate_of	DIDEO_00000041	drug_central			543	DRUG MATRIX	2017	IC50	5.0
614	CHEBI_6532	loperamide, combinations	PR_P10635	Cytochrome P450 2D6	molecularly_interacts_with	RO_0002436	drug_central			936	DRUG MATRIX	2017	IC50	5.0
615	CHEBI_7575	nimodipine	PR_P11712	Cytochrome P450 2C9	is_substrate_of	DIDEO_00000041	drug_central			433	DRUG MATRIX	2017	IC50	6.0
616	CHEBI_7565	nifedipine	PR_P05177	Cytochrome P450 1A2	is_substrate_of	DIDEO_00000041	drug_central			313	DRUG MATRIX	2017	IC50	6.0
617	CHEBI_3223	buspirone	PR_P08684	Cytochrome P450 3A4	molecularly_interacts_with	RO_0002436	drug_central			1012	WOMBAT-PK	2017	Ki	5.0
618	CHEBI_28593	quinidine, combinations with psycholeptics	PR_P10635	Cytochrome P450 2D6	molecularly_interacts_with	RO_0002436	drug_central			971	SCIENTIFIC LITERATURE	2017	Ki	7.0
619	CHEBI_44915	propofol	PR_P11712	Cytochrome P450 2C9	molecularly_interacts_with	RO_0002436	drug_central			863	WOMBAT-PK	2017	IC50	4.0
620	CHEBI_10023	voriconazole	PR_P33261	Cytochrome P450 2C19	is_substrate_of	DIDEO_00000041	drug_central			391	CHEMBL	2017	IC50	4.0
621	CHEBI_52717	bortezomib	PR_P33261	Cytochrome P450 2C19	is_substrate_of	DIDEO_00000041	drug_central			340	WOMBAT-PK	2017	Ki	4.0
622	CHEBI_45409	ritonavir	PR_P08684	Cytochrome P450 3A4	molecularly_interacts_with	RO_0002436	drug_central			1075	WOMBAT-PK	2017	IC50	7.0
623	CHEBI_3125	bisacodyl, combinations	PR_P11712	Cytochrome P450 2C9	is_substrate_of	DIDEO_00000041	drug_central			402	DRUG MATRIX	2017	IC50	5.0
624	CHEBI_39548	atorvastatin and perindopril	PR_P08684	Cytochrome P450 3A4	molecularly_interacts_with	RO_0002436	drug_central			1010	CHEMBL	2017	IC50	5.0
625	CHEBI_9588	ticlopidine	PR_P33261	Cytochrome P450 2C19	is_substrate_of	DIDEO_00000041	drug_central			388	DRUG MATRIX	2017	IC50	6.0
626	CHEBI_50305	podophyllotoxin	PR_P11712	Cytochrome P450 2C9	molecularly_interacts_with	RO_0002436	drug_central			885	DRUG MATRIX	2017	IC50	5.0
627	CHEBI_8060	phenelzine	PR_P10632	Cytochrome P450 2C8	is_substrate_of	DIDEO_00000041	drug_central			398	IUPHAR	2017	Ki	5.0
628	CHEBI_5062	alfuzosin and finasteride	PR_P33261	Cytochrome P450 2C19	molecularly_interacts_with	RO_0002436	drug_central			763	DRUG MATRIX	2017	IC50	6.0
629	CHEBI_6715	medroxyprogesterone and ethinylestradiol	PR_P33261	Cytochrome P450 2C19	molecularly_interacts_with	RO_0002436	drug_central			782	DRUG MATRIX	2017	IC50	5.0
630	CHEBI_6375	lansoprazole, amoxicillin and clarithromycin	PR_P33261	Cytochrome P450 2C19	molecularly_interacts_with	RO_0002436	drug_central			773	DRUG MATRIX	2017	IC50	6.0
631	CHEBI_3764	clotrimazole	PR_P11712	Cytochrome P450 2C9	is_substrate_of	DIDEO_00000041	drug_central			406	DRUG MATRIX	2017	IC50	7.0
632	CHEBI_7496	nelfinavir	PR_P08684	Cytochrome P450 3A4	is_substrate_of	DIDEO_00000041	drug_central			635	DRUG MATRIX	2017	IC50	5.0
633	CHEBI_2663	amiodarone	PR_P08684	Cytochrome P450 3A4	molecularly_interacts_with	RO_0002436	drug_central			998	WOMBAT-PK	2017	Ki	6.0
634	CHEBI_47519	ketoconazole	PR_P08686	Cytochrome P450 21	molecularly_interacts_with	RO_0002436	drug_central			747	CHEMBL	2017	IC50	5.0
635	CHEBI_45409	ritonavir	PR_P08684	Cytochrome P450 3A4	is_substrate_of	DIDEO_00000041	drug_central			648	WOMBAT-PK	2017	IC50	7.0
636	CHEBI_3348	candesartan and amlodipine	PR_P11712	Cytochrome P450 2C9	molecularly_interacts_with	RO_0002436	drug_central			821	CHEMBL	2017	IC50	5.0
637	CHEBI_2896	astemizole	PR_P08684	Cytochrome P450 3A4	is_substrate_of	DIDEO_00000041	drug_central			576	WOMBAT-PK	2017	IC50	5.0
638	CHEBI_47519	ketoconazole	PR_P08686	Cytochrome P450 21	is_substrate_of	DIDEO_00000041	drug_central			332	CHEMBL	2017	IC50	5.0
639	CHEBI_6538	loratadine	PR_P33261	Cytochrome P450 2C19	molecularly_interacts_with	RO_0002436	drug_central			779	DRUG MATRIX	2017	IC50	7.0
640	CHEBI_45409	ritonavir	PR_P10635	Cytochrome P450 2D6	molecularly_interacts_with	RO_0002436	drug_central			976	DRUG MATRIX	2017	IC50	4.0
641	CHEBI_6030	isoniazid, combinations	PR_P20815	Cytochrome P450 3A5	is_substrate_of	DIDEO_00000041	drug_central			669	WOMBAT-PK	2017	IC50	4.0
642	CHEBI_48574	phenylbutazone and corticosteroids	PR_P11712	Cytochrome P450 2C9	is_substrate_of	DIDEO_00000041	drug_central			441	WOMBAT-PK	2017	Ki	4.0
643	CHEBI_6030	ethambutol and isoniazid	PR_P08684	Cytochrome P450 3A4	molecularly_interacts_with	RO_0002436	drug_central			1041	WOMBAT-PK	2017	IC50	5.0
644	CHEBI_28593	quinidine, combinations excl. psycholeptics	PR_P10635	Cytochrome P450 2D6	is_substrate_of	DIDEO_00000041	drug_central			547	SCIENTIFIC LITERATURE	2017	Ki	7.0
645	CHEBI_9249	stanozolol	PR_P10635	Cytochrome P450 2D6	molecularly_interacts_with	RO_0002436	drug_central			978	DRUG MATRIX	2017	IC50	5.0
646	CHEBI_6375	lansoprazole, amoxicillin and levofloxacin	PR_P10635	Cytochrome P450 2D6	molecularly_interacts_with	RO_0002436	drug_central			929	DRUG MATRIX	2017	IC50	5.0
647	CHEBI_6030	rifampicin, pyrazinamide and isoniazid	PR_P08684	Cytochrome P450 3A4	is_substrate_of	DIDEO_00000041	drug_central			619	WOMBAT-PK	2017	IC50	5.0
648	CHEBI_77069	eperisone	PR_P10635	Cytochrome P450 2D6	is_substrate_of	DIDEO_00000041	drug_central			497	DRUG MATRIX	2017	IC50	5.0
649	CHEBI_9566	thioridazine	PR_P10635	Cytochrome P450 2D6	molecularly_interacts_with	RO_0002436	drug_central			982	DRUG MATRIX	2017	IC50	5.0
650	CHEBI_8772	raloxifene	PR_P11712	Cytochrome P450 2C9	molecularly_interacts_with	RO_0002436	drug_central			867	DRUG MATRIX	2017	IC50	5.0
651	CHEBI_45285	rifampicin, pyrazinamide, ethambutol and isoniazid	PR_P08684	Cytochrome P450 3A4	is_substrate_of	DIDEO_00000041	drug_central			644	WOMBAT-PK	2017	IC50	6.0
652	CHEBI_4754	econazole	PR_P33261	Cytochrome P450 2C19	is_substrate_of	DIDEO_00000041	drug_central			346	DRUG MATRIX	2017	IC50	7.0
653	CHEBI_7582	nitrendipine	PR_P11712	Cytochrome P450 2C9	molecularly_interacts_with	RO_0002436	drug_central			856	DRUG MATRIX	2017	IC50	6.0
654	CHEBI_223316	artemisinin	PR_P05177	Cytochrome P450 1A2	molecularly_interacts_with	RO_0002436	drug_central			746	DRUG MATRIX	2017	IC50	5.0
655	CHEBI_44032	indinavir	PR_P08684	Cytochrome P450 3A4	is_substrate_of	DIDEO_00000041	drug_central			614	DRUG MATRIX	2017	IC50	6.0
656	CHEBI_17688	nicotine	PR_P11509	Cytochrome P450 2A6	is_substrate_of	DIDEO_00000041	drug_central			334	WOMBAT-PK	2017	IC50	5.0
657	CHEBI_45409	lopinavir and ritonavir	PR_P11712	Cytochrome P450 2C9	molecularly_interacts_with	RO_0002436	drug_central			869	DRUG MATRIX	2017	IC50	7.0
658	CHEBI_135737	lacidipine	PR_P08684	Cytochrome P450 3A4	is_substrate_of	DIDEO_00000041	drug_central			625	DRUG MATRIX	2017	IC50	6.0
659	CHEBI_7459	naloxone	PR_P10635	Cytochrome P450 2D6	is_substrate_of	DIDEO_00000041	drug_central			525	DRUG MATRIX	2017	IC50	5.0
660	CHEBI_6030	ethambutol and isoniazid	PR_P08684	Cytochrome P450 3A4	is_substrate_of	DIDEO_00000041	drug_central			615	WOMBAT-PK	2017	IC50	5.0
661	CHEBI_3764	clotrimazole	PR_P08684	Cytochrome P450 3A4	molecularly_interacts_with	RO_0002436	drug_central			1019	WOMBAT-PK	2017	IC50	7.0
662	CHEBI_9325	sulconazole	PR_P33261	Cytochrome P450 2C19	molecularly_interacts_with	RO_0002436	drug_central			798	DRUG MATRIX	2017	IC50	7.0
663	CHEBI_8405	primaquine	PR_P05177	Cytochrome P450 1A2	is_substrate_of	DIDEO_00000041	drug_central			322	DRUG MATRIX	2017	IC50	6.0
664	CHEBI_3348	candesartan	PR_P11712	Cytochrome P450 2C9	molecularly_interacts_with	RO_0002436	drug_central			820	CHEMBL	2017	IC50	5.0
2402	CHEBI_8426	probenecid	PR_Q9UNQ0	BCRP	molecularly_interacts_with	RO_0002436	FDA		888			2017		
665	CHEBI_6030	ethambutol and isoniazid	PR_P20815	Cytochrome P450 3A5	is_substrate_of	DIDEO_00000041	drug_central			667	WOMBAT-PK	2017	IC50	4.0
666	CHEBI_6923	miconazole, combinations	PR_P10635	Cytochrome P450 2D6	molecularly_interacts_with	RO_0002436	drug_central			946	DRUG MATRIX	2017	IC50	6.0
667	CHEBI_8673	pyrimethamine, combinations	PR_P11712	Cytochrome P450 2C9	molecularly_interacts_with	RO_0002436	drug_central			866	WOMBAT-PK	2017	Ki	4.0
668	CHEBI_47381	diclofenac	PR_P19224	UDP-glucuronosyltransferase 1-6	molecularly_interacts_with	RO_0002436	drug_central			1116	CHEMBL	2017	Ki	4.0
669	CHEBI_31687	idebenone	PR_P11712	Cytochrome P450 2C9	molecularly_interacts_with	RO_0002436	drug_central			842	DRUG MATRIX	2017	IC50	5.0
670	CHEBI_49575	diazepam	PR_P08684	Cytochrome P450 3A4	is_substrate_of	DIDEO_00000041	drug_central			599	WOMBAT-PK	2017	Ki	4.0
671	CHEBI_8461	promethazine, combinations	PR_P10635	Cytochrome P450 2D6	is_substrate_of	DIDEO_00000041	drug_central			540	WOMBAT-PK	2017	Ki	5.0
672	CHEBI_45409	dasabuvir, ombitasvir, paritaprevir and ritonavir	PR_P08684	Cytochrome P450 3A4	is_substrate_of	DIDEO_00000041	drug_central			645	WOMBAT-PK	2017	IC50	7.0
673	CHEBI_4754	econazole	PR_P05177	Cytochrome P450 1A2	molecularly_interacts_with	RO_0002436	drug_central			719	DRUG MATRIX	2017	IC50	6.0
674	CHEBI_47780	clomipramine	PR_P10635	Cytochrome P450 2D6	molecularly_interacts_with	RO_0002436	drug_central			910	WOMBAT-PK	2017	Ki	5.0
675	CHEBI_9948	verapamil	PR_P08684	Cytochrome P450 3A4	is_substrate_of	DIDEO_00000041	drug_central			655	IUPHAR	2017	Ki	6.0
676	CHEBI_6715	medroxyprogesterone	PR_P33261	Cytochrome P450 2C19	is_substrate_of	DIDEO_00000041	drug_central			365	DRUG MATRIX	2017	IC50	5.0
677	CHEBI_31624	fluorescein, combinations	PR_P33261	Cytochrome P450 2C19	is_substrate_of	DIDEO_00000041	drug_central			353	DRUG MATRIX	2017	IC50	6.0
678	CHEBI_6375	lansoprazole, amoxicillin and levofloxacin	PR_P10635	Cytochrome P450 2D6	is_substrate_of	DIDEO_00000041	drug_central			508	DRUG MATRIX	2017	IC50	5.0
679	CHEBI_46081	fluconazole	PR_P33261	Cytochrome P450 2C19	molecularly_interacts_with	RO_0002436	drug_central			766	CHEMBL	2017	IC50	5.0
680	CHEBI_9720	trihexyphenidyl	PR_P10635	Cytochrome P450 2D6	is_substrate_of	DIDEO_00000041	drug_central			562	DRUG MATRIX	2017	IC50	5.0
681	CHEBI_4877	rifampicin, pyrazinamide, ethambutol and isoniazid	PR_P08684	Cytochrome P450 3A4	molecularly_interacts_with	RO_0002436	drug_central			1036	WOMBAT-PK	2017	IC50	6.0
682	CHEBI_3348	candesartan	PR_P11712	Cytochrome P450 2C9	is_substrate_of	DIDEO_00000041	drug_central			403	CHEMBL	2017	IC50	5.0
683	CHEBI_8499	propranolol and other antihypertensives	PR_P05177	Cytochrome P450 1A2	is_substrate_of	DIDEO_00000041	drug_central			326	DRUG MATRIX	2017	IC50	5.0
684	CHEBI_7772	omeprazole, amoxicillin and clarithromycin	PR_P33261	Cytochrome P450 2C19	molecularly_interacts_with	RO_0002436	drug_central			790	WOMBAT-PK	2017	Ki	5.0
685	CHEBI_132922	ibuprofen, combinations	PR_P11712	Cytochrome P450 2C9	is_substrate_of	DIDEO_00000041	drug_central			420	WOMBAT-PK	2017	Ki	4.0
686	CHEBI_7825	oxiconazole	PR_P33261	Cytochrome P450 2C19	is_substrate_of	DIDEO_00000041	drug_central			392	DRUG MATRIX	2017	IC50	7.0
687	CHEBI_9948	trandolapril and verapamil	PR_P08684	Cytochrome P450 3A4	molecularly_interacts_with	RO_0002436	drug_central			1081	IUPHAR	2017	Ki	6.0
688	CHEBI_107736	metoclopramide	PR_P10635	Cytochrome P450 2D6	molecularly_interacts_with	RO_0002436	drug_central			944	DRUG MATRIX	2017	IC50	6.0
689	CHEBI_63619	propafenone	PR_P05177	Cytochrome P450 1A2	is_substrate_of	DIDEO_00000041	drug_central			324	DRUG MATRIX	2017	IC50	5.0
690	CHEBI_9241	spironolactone	PR_P33261	Cytochrome P450 2C19	molecularly_interacts_with	RO_0002436	drug_central			796	DRUG MATRIX	2017	IC50	5.0
691	CHEBI_9588	ticlopidine	PR_P20813	Cytochrome P450 2B6	molecularly_interacts_with	RO_0002436	drug_central			753	IUPHAR	2017	IC50	6.0
692	CHEBI_7772	omeprazole	PR_P11712	Cytochrome P450 2C9	is_substrate_of	DIDEO_00000041	drug_central			436	WOMBAT-PK	2017	Ki	4.0
693	CHEBI_135370	aprindine	PR_P10635	Cytochrome P450 2D6	molecularly_interacts_with	RO_0002436	drug_central			891	WOMBAT-PK	2017	Ki	7.0
694	CHEBI_7565	nifedipine and diuretics	PR_P08684	Cytochrome P450 3A4	is_substrate_of	DIDEO_00000041	drug_central			638	WOMBAT-PK	2017	IC50	5.0
695	CHEBI_480999	vinorelbine	PR_P08684	Cytochrome P450 3A4	molecularly_interacts_with	RO_0002436	drug_central			1084	DRUG MATRIX	2017	IC50	6.0
696	CHEBI_32223	tibolone	PR_P33261	Cytochrome P450 2C19	molecularly_interacts_with	RO_0002436	drug_central			802	DRUG MATRIX	2017	IC50	5.0
697	CHEBI_6413	letrozole	PR_P19099	Cytochrome P450 11B2, mitochondrial	molecularly_interacts_with	RO_0002436	drug_central			707	CHEMBL	2017	IC50	5.0
698	CHEBI_9168	sirolimus	PR_P08684	Cytochrome P450 3A4	is_substrate_of	DIDEO_00000041	drug_central			650	DRUG MATRIX	2017	IC50	5.0
699	CHEBI_8673	pyrimethamine, combinations	PR_P11712	Cytochrome P450 2C9	is_substrate_of	DIDEO_00000041	drug_central			445	WOMBAT-PK	2017	Ki	4.0
700	CHEBI_136007	methylnaltrexone bromide	PR_P10635	Cytochrome P450 2D6	is_substrate_of	DIDEO_00000041	drug_central			565	WOMBAT-PK	2017	Ki	5.0
701	CHEBI_7565	nifedipine	PR_P05177	Cytochrome P450 1A2	molecularly_interacts_with	RO_0002436	drug_central			727	DRUG MATRIX	2017	IC50	6.0
702	CHEBI_37924	atazanavir	PR_P11712	Cytochrome P450 2C9	is_substrate_of	DIDEO_00000041	drug_central			399	WOMBAT-PK	2017	Ki	4.0
703	CHEBI_3219	bupropion	PR_P33261	Cytochrome P450 2C19	is_substrate_of	DIDEO_00000041	drug_central			341	DRUG MATRIX	2017	IC50	5.0
704	CHEBI_4877	ethambutol and isoniazid	PR_P08684	Cytochrome P450 3A4	molecularly_interacts_with	RO_0002436	drug_central			1035	WOMBAT-PK	2017	IC50	6.0
705	CHEBI_68639	abiraterone	PR_P15538	Cytochrome P450 11B1, mitochondrial	is_substrate_of	DIDEO_00000041	drug_central			291	CHEMBL	2017	IC50	5.0
706	CHEBI_50692	mifepristone, combinations	PR_P08684	Cytochrome P450 3A4	is_substrate_of	DIDEO_00000041	drug_central			633	WOMBAT-PK	2017	Ki	6.0
707	CHEBI_85078	dapagliflozin	PR_P31639	Sodium/glucose cotransporter 2	molecularly_interacts_with	RO_0002436	drug_central			1135	CHEMBL	2017	EC50	8.0
708	CHEBI_6030	rifampicin and isoniazid	PR_P20815	Cytochrome P450 3A5	molecularly_interacts_with	RO_0002436	drug_central			1098	WOMBAT-PK	2017	IC50	4.0
709	CHEBI_45980	tacrine	PR_P10635	Cytochrome P450 2D6	is_substrate_of	DIDEO_00000041	drug_central			557	DRUG MATRIX	2017	IC50	6.0
710	CHEBI_7550	nicardipine	PR_P08684	Cytochrome P450 3A4	molecularly_interacts_with	RO_0002436	drug_central			1062	WOMBAT-PK	2017	IC50	6.0
711	CHEBI_5132	flutamide	PR_P05177	Cytochrome P450 1A2	molecularly_interacts_with	RO_0002436	drug_central			720	WOMBAT-PK	2017	Ki	5.0
712	CHEBI_39548	atorvastatin, acetylsalicylic acid and ramipril	PR_P08684	Cytochrome P450 3A4	is_substrate_of	DIDEO_00000041	drug_central			581	CHEMBL	2017	IC50	5.0
713	CHEBI_9448	terbinafine	PR_P10635	Cytochrome P450 2D6	is_substrate_of	DIDEO_00000041	drug_central			558	DRUG MATRIX	2017	IC50	6.0
714	CHEBI_5818	hydroxyzine	PR_P10635	Cytochrome P450 2D6	is_substrate_of	DIDEO_00000041	drug_central			500	WOMBAT-PK	2017	Ki	5.0
715	CHEBI_6532	loperamide	PR_P10635	Cytochrome P450 2D6	molecularly_interacts_with	RO_0002436	drug_central			935	DRUG MATRIX	2017	IC50	5.0
716	CHEBI_8461	promethazine	PR_P10635	Cytochrome P450 2D6	molecularly_interacts_with	RO_0002436	drug_central			962	WOMBAT-PK	2017	Ki	5.0
717	CHEBI_5062	finasteride	PR_P11712	Cytochrome P450 2C9	molecularly_interacts_with	RO_0002436	drug_central			832	DRUG MATRIX	2017	IC50	5.0
718	CHEBI_4031	ciclosporin	PR_P08684	Cytochrome P450 3A4	is_substrate_of	DIDEO_00000041	drug_central			597	WOMBAT-PK	2017	Ki	5.0
719	CHEBI_10023	voriconazole	PR_P11712	Cytochrome P450 2C9	molecularly_interacts_with	RO_0002436	drug_central			881	CHEMBL	2017	IC50	4.0
720	CHEBI_37924	atazanavir	PR_P05177	Cytochrome P450 1A2	molecularly_interacts_with	RO_0002436	drug_central			715	WOMBAT-PK	2017	Ki	4.0
721	CHEBI_47381	diclofenac and antiinfectives	PR_Q9HAW7	UDP-glucuronosyltransferase 1-7	is_substrate_of	DIDEO_00000041	drug_central			693	CHEMBL	2017	Ki	4.0
722	CHEBI_32215	thiamphenicol, combinations	PR_P33261	Cytochrome P450 2C19	is_substrate_of	DIDEO_00000041	drug_central			385	WOMBAT-PK	2017	IC50	5.0
723	CHEBI_47381	diclofenac, combinations	PR_Q9HAW8	UDP-glucuronosyltransferase 1-10	molecularly_interacts_with	RO_0002436	drug_central			1115	CHEMBL	2017	Ki	4.0
724	CHEBI_50730	montelukast, combinations	PR_P10632	Cytochrome P450 2C8	is_substrate_of	DIDEO_00000041	drug_central			397	WOMBAT-PK	2017	Ki	5.0
725	CHEBI_5138	fluvoxamine	PR_P05177	Cytochrome P450 1A2	molecularly_interacts_with	RO_0002436	drug_central			721	WOMBAT-PK	2017	Ki	5.0
726	CHEBI_10033	warfarin	PR_P08684	Cytochrome P450 3A4	is_substrate_of	DIDEO_00000041	drug_central			659	WOMBAT-PK	2017	Ki	3.0
727	CHEBI_45409	ombitasvir, paritaprevir and ritonavir	PR_P10635	Cytochrome P450 2D6	is_substrate_of	DIDEO_00000041	drug_central			552	DRUG MATRIX	2017	IC50	4.0
728	CHEBI_3720	cisapride	PR_P08684	Cytochrome P450 3A4	molecularly_interacts_with	RO_0002436	drug_central			1018	DRUG MATRIX	2017	IC50	6.0
729	CHEBI_7565	atenolol and nifedipine	PR_P05177	Cytochrome P450 1A2	molecularly_interacts_with	RO_0002436	drug_central			726	DRUG MATRIX	2017	IC50	6.0
730	CHEBI_4636	diphenhydramine	PR_P10635	Cytochrome P450 2D6	molecularly_interacts_with	RO_0002436	drug_central			913	WOMBAT-PK	2017	Ki	4.0
731	CHEBI_37924	atazanavir and cobicistat	PR_P22309	UDP-glucuronosyltransferase 1-1	molecularly_interacts_with	RO_0002436	drug_central			1109	WOMBAT-PK	2017	Ki	5.0
732	CHEBI_132922	ibuprofen	PR_P11712	Cytochrome P450 2C9	is_substrate_of	DIDEO_00000041	drug_central			419	WOMBAT-PK	2017	Ki	4.0
733	CHEBI_132922	ibuprofen, combinations	PR_P11712	Cytochrome P450 2C9	molecularly_interacts_with	RO_0002436	drug_central			840	WOMBAT-PK	2017	Ki	4.0
734	CHEBI_585948	ramipril and felodipine	PR_P11712	Cytochrome P450 2C9	molecularly_interacts_with	RO_0002436	drug_central			830	DRUG MATRIX	2017	IC50	5.0
735	CHEBI_9948	verapamil, combinations	PR_Q9UNQ0	ATP-binding cassette sub-family G member 2	molecularly_interacts_with	RO_0002436	drug_central			1133	CHEMBL	2017	EC50	4.0
736	CHEBI_8673	artesunate, sulphamethopyrazine and pyrimethamine	PR_P11712	Cytochrome P450 2C9	molecularly_interacts_with	RO_0002436	drug_central			864	WOMBAT-PK	2017	Ki	4.0
737	CHEBI_3764	clotrimazole	PR_P33261	Cytochrome P450 2C19	is_substrate_of	DIDEO_00000041	drug_central			345	DRUG MATRIX	2017	IC50	7.0
738	CHEBI_72291	emtricitabine, tenofovir alafenamide, elvitegravir and cobicistat	PR_P08684	Cytochrome P450 3A	is_substrate_of	DIDEO_00000041	drug_central			571	SCIENTIFIC LITERATURE	2017	Ki	6.0
739	CHEBI_27953	physostigmine	PR_P10635	Cytochrome P450 2D6	is_substrate_of	DIDEO_00000041	drug_central			535	DRUG MATRIX	2017	IC50	6.0
740	CHEBI_135737	lacidipine	PR_P11712	Cytochrome P450 2C9	molecularly_interacts_with	RO_0002436	drug_central			843	DRUG MATRIX	2017	IC50	5.0
741	CHEBI_681848	doxapram	PR_P10635	Cytochrome P450 2D6	is_substrate_of	DIDEO_00000041	drug_central			495	DRUG MATRIX	2017	IC50	7.0
742	CHEBI_7465	oxycodone and naltrexone	PR_P10635	Cytochrome P450 2D6	molecularly_interacts_with	RO_0002436	drug_central			943	DRUG MATRIX	2017	IC50	6.0
743	CHEBI_72291	emtricitabine, tenofovir alafenamide, darunavir and cobicistat	PR_P08684	Cytochrome P450 3A	molecularly_interacts_with	RO_0002436	drug_central			994	SCIENTIFIC LITERATURE	2017	Ki	6.0
744	CHEBI_6723	megestrol and ethinylestradiol	PR_P11712	Cytochrome P450 2C9	molecularly_interacts_with	RO_0002436	drug_central			849	DRUG MATRIX	2017	IC50	5.0
745	CHEBI_83326	tedizolid	NCBITaxon_46170	Staphylococcus aureus subsp. aureus	molecularly_interacts_with	RO_0002436	drug_central			1129	SCIENTIFIC LITERATURE	2017	MIC	5.0
746	CHEBI_3348	candesartan	PR_P08684	Cytochrome P450 3A4	is_substrate_of	DIDEO_00000041	drug_central			588	CHEMBL	2017	IC50	5.0
747	CHEBI_3647	chlorpromazine	PR_P10635	Cytochrome P450 2D6	molecularly_interacts_with	RO_0002436	drug_central			905	WOMBAT-PK	2017	Ki	5.0
748	CHEBI_10023	voriconazole	PR_P11712	Cytochrome P450 2C9	is_substrate_of	DIDEO_00000041	drug_central			460	CHEMBL	2017	IC50	4.0
749	CHEBI_45409	dasabuvir, ombitasvir, paritaprevir and ritonavir	PR_P08684	Cytochrome P450 3A4	molecularly_interacts_with	RO_0002436	drug_central			1072	WOMBAT-PK	2017	IC50	7.0
2404	CHEBI_3699	cimetidine	PR_P08183	P-gp	molecularly_interacts_with	RO_0002436	FDA		394		PL	2017		
750	CHEBI_7575	nimodipine	PR_P11712	Cytochrome P450 2C9	molecularly_interacts_with	RO_0002436	drug_central			854	DRUG MATRIX	2017	IC50	6.0
751	CHEBI_31401	cilostazol	PR_P11712	Cytochrome P450 2C9	molecularly_interacts_with	RO_0002436	drug_central			823	DRUG MATRIX	2017	IC50	5.0
752	CHEBI_31578	ethylestrenol	PR_P33261	Cytochrome P450 2C19	molecularly_interacts_with	RO_0002436	drug_central			762	DRUG MATRIX	2017	IC50	5.0
753	CHEBI_7862	oxymetazoline	PR_P10635	Cytochrome P450 2D6	is_substrate_of	DIDEO_00000041	drug_central			529	DRUG MATRIX	2017	IC50	6.0
754	CHEBI_6375	lansoprazole, tetracycline and metronidazole	PR_P33261	Cytochrome P450 2C19	molecularly_interacts_with	RO_0002436	drug_central			778	DRUG MATRIX	2017	IC50	6.0
755	CHEBI_17698	chloramphenicol	PR_P08684	Cytochrome P450 3A4	is_substrate_of	DIDEO_00000041	drug_central			591	WOMBAT-PK	2017	IC50	4.0
756	CHEBI_3374	capsaicin	PR_P05177	Cytochrome P450 1A2	molecularly_interacts_with	RO_0002436	drug_central			745	DRUG MATRIX	2017	IC50	5.0
757	CHEBI_7565	nifedipine	PR_P08684	Cytochrome P450 3A4	molecularly_interacts_with	RO_0002436	drug_central			1064	WOMBAT-PK	2017	IC50	5.0
758	CHEBI_132922	codeine and ibuprofen	PR_P11712	Cytochrome P450 2C9	molecularly_interacts_with	RO_0002436	drug_central			838	WOMBAT-PK	2017	Ki	4.0
759	CHEBI_50305	podophyllotoxin	PR_P08684	Cytochrome P450 3A4	molecularly_interacts_with	RO_0002436	drug_central			1089	DRUG MATRIX	2017	IC50	6.0
760	CHEBI_3738	clemastine	PR_P33261	Cytochrome P450 2C19	molecularly_interacts_with	RO_0002436	drug_central			758	DRUG MATRIX	2017	IC50	6.0
761	CHEBI_7772	omeprazole, amoxicillin and clarithromycin	PR_P05177	Cytochrome P450 1A2	is_substrate_of	DIDEO_00000041	drug_central			318	WOMBAT-PK	2017	IC50	4.0
762	CHEBI_9168	sirolimus	PR_P11712	Cytochrome P450 2C9	is_substrate_of	DIDEO_00000041	drug_central			451	DRUG MATRIX	2017	IC50	5.0
763	CHEBI_4562	dihydroergotamine	PR_P08684	Cytochrome P450 3A4	molecularly_interacts_with	RO_0002436	drug_central			1026	DRUG MATRIX	2017	IC50	5.0
764	CHEBI_4562	dihydroergotamine	PR_P08684	Cytochrome P450 3A4	is_substrate_of	DIDEO_00000041	drug_central			600	DRUG MATRIX	2017	IC50	5.0
765	CHEBI_9671	triamterene	PR_P10635	Cytochrome P450 2D6	molecularly_interacts_with	RO_0002436	drug_central			984	DRUG MATRIX	2017	IC50	5.0
766	CHEBI_6030	isoniazid, combinations	PR_P20815	Cytochrome P450 3A5	molecularly_interacts_with	RO_0002436	drug_central			1097	WOMBAT-PK	2017	IC50	4.0
767	CHEBI_6923	miconazole, combinations	PR_P08684	Cytochrome P450 3A4	molecularly_interacts_with	RO_0002436	drug_central			1057	DRUG MATRIX	2017	IC50	7.0
768	CHEBI_6541	losartan and amlodipine	PR_P11712	Cytochrome P450 2C9	molecularly_interacts_with	RO_0002436	drug_central			845	DRUG MATRIX	2017	IC50	5.0
769	CHEBI_39548	atorvastatin and acetylsalicylic acid	PR_P08684	Cytochrome P450 3A4	is_substrate_of	DIDEO_00000041	drug_central			583	CHEMBL	2017	IC50	5.0
770	CHEBI_8871	risperidone	PR_P10635	Cytochrome P450 2D6	is_substrate_of	DIDEO_00000041	drug_central			549	DRUG MATRIX	2017	IC50	5.0
771	CHEBI_6030	streptomycin and isoniazid	PR_P20815	Cytochrome P450 3A5	molecularly_interacts_with	RO_0002436	drug_central			1101	WOMBAT-PK	2017	IC50	4.0
772	CHEBI_47381	diclofenac and antiinfectives	PR_Q9HAW7	UDP-glucuronosyltransferase 1-7	molecularly_interacts_with	RO_0002436	drug_central			1121	CHEMBL	2017	Ki	4.0
773	CHEBI_50730	montelukast	PR_P10632	Cytochrome P450 2C8	molecularly_interacts_with	RO_0002436	drug_central			812	WOMBAT-PK	2017	Ki	5.0
774	CHEBI_47381	diclofenac and antiinfectives	PR_P19224	UDP-glucuronosyltransferase 1-6	is_substrate_of	DIDEO_00000041	drug_central			689	CHEMBL	2017	Ki	4.0
775	CHEBI_4659	disulfiram	PR_P05177	Cytochrome P450 1A2	is_substrate_of	DIDEO_00000041	drug_central			304	DRUG MATRIX	2017	IC50	5.0
776	CHEBI_9757	tropicamide	PR_P33261	Cytochrome P450 2C19	molecularly_interacts_with	RO_0002436	drug_central			804	DRUG MATRIX	2017	IC50	6.0
777	CHEBI_6343	labetalol and other diuretics	PR_P10635	Cytochrome P450 2D6	is_substrate_of	DIDEO_00000041	drug_central			504	DRUG MATRIX	2017	IC50	6.0
778	CHEBI_10100	zafirlukast	PR_P08684	Cytochrome P450 3A4	is_substrate_of	DIDEO_00000041	drug_central			660	WOMBAT-PK	2017	Ki	4.0
779	CHEBI_6541	losartan	PR_P11712	Cytochrome P450 2C9	molecularly_interacts_with	RO_0002436	drug_central			844	DRUG MATRIX	2017	IC50	5.0
780	CHEBI_6375	lansoprazole, combinations	PR_P10635	Cytochrome P450 2D6	molecularly_interacts_with	RO_0002436	drug_central			932	DRUG MATRIX	2017	IC50	5.0
781	CHEBI_7772	omeprazole, amoxicillin and metronidazole	PR_P33261	Cytochrome P450 2C19	molecularly_interacts_with	RO_0002436	drug_central			791	WOMBAT-PK	2017	Ki	5.0
782	CHEBI_51164	lisuride	PR_P10635	Cytochrome P450 2D6	molecularly_interacts_with	RO_0002436	drug_central			934	DRUG MATRIX	2017	IC50	7.0
783	CHEBI_6923	miconazole, combinations	PR_P11712	Cytochrome P450 2C9	molecularly_interacts_with	RO_0002436	drug_central			852	DRUG MATRIX	2017	IC50	6.0
784	CHEBI_83305	oritavancin	NCBITaxon_1313	Streptococcus pneumoniae	molecularly_interacts_with	RO_0002436	drug_central			1130	DRUG LABEL	2017	MIC	8.0
785	CHEBI_7772	omeprazole	PR_P05177	Cytochrome P450 1A2	molecularly_interacts_with	RO_0002436	drug_central			731	WOMBAT-PK	2017	IC50	4.0
786	CHEBI_47519	ketoconazole	PR_P15538	Cytochrome P450 11B1, mitochondrial	is_substrate_of	DIDEO_00000041	drug_central			288	SCIENTIFIC LITERATURE	2017	IC50	6.0
787	CHEBI_45409	ombitasvir, paritaprevir and ritonavir	PR_P11712	Cytochrome P450 2C9	molecularly_interacts_with	RO_0002436	drug_central			870	DRUG MATRIX	2017	IC50	7.0
788	CHEBI_9241	spironolactone	PR_P33261	Cytochrome P450 2C19	is_substrate_of	DIDEO_00000041	drug_central			381	DRUG MATRIX	2017	IC50	5.0
789	CHEBI_10100	zafirlukast	PR_P08684	Cytochrome P450 3A4	molecularly_interacts_with	RO_0002436	drug_central			1087	WOMBAT-PK	2017	Ki	4.0
790	CHEBI_46081	fluconazole	PR_P33261	Cytochrome P450 2C19	is_substrate_of	DIDEO_00000041	drug_central			351	CHEMBL	2017	IC50	5.0
791	CHEBI_7772	omeprazole, amoxicillin and clarithromycin	PR_P11712	Cytochrome P450 2C9	molecularly_interacts_with	RO_0002436	drug_central			858	WOMBAT-PK	2017	Ki	4.0
792	CHEBI_7640	nortriptyline	PR_P33261	Cytochrome P450 2C19	is_substrate_of	DIDEO_00000041	drug_central			373	DRUG MATRIX	2017	IC50	5.0
793	CHEBI_7565	nifedipine and diuretics	PR_P08684	Cytochrome P450 3A4	molecularly_interacts_with	RO_0002436	drug_central			1065	WOMBAT-PK	2017	IC50	5.0
794	CHEBI_6375	lansoprazole, amoxicillin and clarithromycin	PR_P10635	Cytochrome P450 2D6	molecularly_interacts_with	RO_0002436	drug_central			928	DRUG MATRIX	2017	IC50	5.0
795	CHEBI_31687	idebenone	PR_P33261	Cytochrome P450 2C19	molecularly_interacts_with	RO_0002436	drug_central			770	DRUG MATRIX	2017	IC50	6.0
796	CHEBI_72291	emtricitabine, tenofovir disoproxil, elvitegravir and cobicistat	PR_P08684	Cytochrome P450 3A	is_substrate_of	DIDEO_00000041	drug_central			572	SCIENTIFIC LITERATURE	2017	Ki	6.0
797	CHEBI_6343	labetalol	PR_P10635	Cytochrome P450 2D6	molecularly_interacts_with	RO_0002436	drug_central			924	DRUG MATRIX	2017	IC50	6.0
798	CHEBI_4754	econazole	PR_P33261	Cytochrome P450 2C19	molecularly_interacts_with	RO_0002436	drug_central			761	DRUG MATRIX	2017	IC50	7.0
799	CHEBI_28593	quinidine, combinations excl. psycholeptics	PR_P10635	Cytochrome P450 2D6	molecularly_interacts_with	RO_0002436	drug_central			970	SCIENTIFIC LITERATURE	2017	Ki	7.0
800	CHEBI_10033	warfarin	PR_P11712	Cytochrome P450 2C9	is_substrate_of	DIDEO_00000041	drug_central			461	WOMBAT-PK	2017	Ki	4.0
801	CHEBI_6030	rifampicin and isoniazid	PR_P08684	Cytochrome P450 3A4	molecularly_interacts_with	RO_0002436	drug_central			1044	WOMBAT-PK	2017	IC50	5.0
802	CHEBI_40009	cycloserine	PR_P08684	Cytochrome P450 3A4	is_substrate_of	DIDEO_00000041	drug_central			596	WOMBAT-PK	2017	IC50	4.0
803	CHEBI_45409	ritonavir	PR_P10635	Cytochrome P450 2D6	is_substrate_of	DIDEO_00000041	drug_central			553	DRUG MATRIX	2017	IC50	4.0
804	CHEBI_4031	ciclosporin	PR_Q5ABU7	Multidrug resistance protein 1	molecularly_interacts_with	RO_0002436	drug_central			1134	WOMBAT-PK	2017	EC50	6.0
805	CHEBI_6030	streptomycin and isoniazid	PR_P08684	Cytochrome P450 3A4	molecularly_interacts_with	RO_0002436	drug_central			1047	WOMBAT-PK	2017	IC50	5.0
806	CHEBI_8871	risperidone	PR_P10635	Cytochrome P450 2D6	molecularly_interacts_with	RO_0002436	drug_central			972	DRUG MATRIX	2017	IC50	5.0
807	CHEBI_9453	terfenadine	PR_P51589	Cytochrome P450 2J2	molecularly_interacts_with	RO_0002436	drug_central			990	CHEMBL	2017	IC50	5.0
808	CHEBI_135737	lacidipine	PR_P11712	Cytochrome P450 2C9	is_substrate_of	DIDEO_00000041	drug_central			422	DRUG MATRIX	2017	IC50	5.0
809	CHEBI_6030	rifampicin and isoniazid	PR_P08684	Cytochrome P450 3A4	is_substrate_of	DIDEO_00000041	drug_central			618	WOMBAT-PK	2017	IC50	5.0
810	CHEBI_31687	idebenone	PR_P10635	Cytochrome P450 2D6	is_substrate_of	DIDEO_00000041	drug_central			502	DRUG MATRIX	2017	IC50	5.0
811	CHEBI_18358	methoxsalen	PR_P05177	Cytochrome P450 1A2	molecularly_interacts_with	RO_0002436	drug_central			712	DRUG MATRIX	2017	IC50	7.0
812	CHEBI_8060	phenelzine	PR_P08684	Cytochrome P450 3A4	is_substrate_of	DIDEO_00000041	drug_central			641	DRUG MATRIX	2017	IC50	5.0
813	CHEBI_5693	hexachlorophene	PR_P05177	Cytochrome P450 1A2	molecularly_interacts_with	RO_0002436	drug_central			722	DRUG MATRIX	2017	IC50	5.0
814	CHEBI_4315	danazol	PR_P11712	Cytochrome P450 2C9	is_substrate_of	DIDEO_00000041	drug_central			407	DRUG MATRIX	2017	IC50	6.0
815	CHEBI_37924	atazanavir	PR_P08684	Cytochrome P450 3A4	is_substrate_of	DIDEO_00000041	drug_central			577	WOMBAT-PK	2017	Ki	5.0
816	CHEBI_47519	ketoconazole	PR_P22680	Cytochrome P450 7A1	molecularly_interacts_with	RO_0002436	drug_central			1107	CHEMBL	2017	IC50	6.0
817	CHEBI_3090	bicalutamide	PR_P33261	Cytochrome P450 2C19	molecularly_interacts_with	RO_0002436	drug_central			754	CHEMBL	2017	IC50	6.0
818	CHEBI_77032	bromhexine	PR_P10635	Cytochrome P450 2D6	molecularly_interacts_with	RO_0002436	drug_central			896	DRUG MATRIX	2017	IC50	6.0
819	CHEBI_47381	diclofenac	PR_Q9HAW8	UDP-glucuronosyltransferase 1-10	is_substrate_of	DIDEO_00000041	drug_central			685	CHEMBL	2017	Ki	4.0
820	CHEBI_8772	raloxifene	PR_P11712	Cytochrome P450 2C9	is_substrate_of	DIDEO_00000041	drug_central			446	DRUG MATRIX	2017	IC50	5.0
821	CHEBI_68639	abiraterone	PR_P05093	Cytochrome P450 17A1	molecularly_interacts_with	RO_0002436	drug_central			711	CHEMBL	2017	IC50	7.0
822	CHEBI_31515	domperidone	PR_P10635	Cytochrome P450 2D6	molecularly_interacts_with	RO_0002436	drug_central			915	WOMBAT-PK	2017	Ki	5.0
823	CHEBI_38561	fluvastatin	PR_P11712	Cytochrome P450 2C9	molecularly_interacts_with	RO_0002436	drug_central			835	DRUG MATRIX	2017	IC50	6.0
824	CHEBI_39548	atorvastatin, amlodipine and perindopril	PR_P08684	Cytochrome P450 3A4	is_substrate_of	DIDEO_00000041	drug_central			582	CHEMBL	2017	IC50	5.0
825	CHEBI_8499	propranolol and thiazides	PR_P05177	Cytochrome P450 1A2	molecularly_interacts_with	RO_0002436	drug_central			741	DRUG MATRIX	2017	IC50	5.0
826	CHEBI_47519	ketoconazole	PR_P05093	Cytochrome P450 17A1	molecularly_interacts_with	RO_0002436	drug_central			710	CHEMBL	2017	IC50	6.0
827	CHEBI_253342	alosetron	PR_P05177	Cytochrome P450 1A2	is_substrate_of	DIDEO_00000041	drug_central			300	DRUG MATRIX	2017	IC50	6.0
828	CHEBI_7825	oxiconazole	PR_P33261	Cytochrome P450 2C19	molecularly_interacts_with	RO_0002436	drug_central			807	DRUG MATRIX	2017	IC50	7.0
829	CHEBI_4754	econazole	PR_P11712	Cytochrome P450 2C9	molecularly_interacts_with	RO_0002436	drug_central			827	DRUG MATRIX	2017	IC50	6.0
830	CHEBI_27882	colchicine	PR_P08684	Cytochrome P450 3A4	is_substrate_of	DIDEO_00000041	drug_central			594	WOMBAT-PK	2017	Ki	4.0
831	CHEBI_8499	propranolol and other combinations	PR_P05177	Cytochrome P450 1A2	molecularly_interacts_with	RO_0002436	drug_central			740	DRUG MATRIX	2017	IC50	5.0
832	CHEBI_9566	thioridazine	PR_P33261	Cytochrome P450 2C19	is_substrate_of	DIDEO_00000041	drug_central			386	DRUG MATRIX	2017	IC50	5.0
833	CHEBI_47381	diclofenac	PR_Q9HAW8	UDP-glucuronosyltransferase 1-10	molecularly_interacts_with	RO_0002436	drug_central			1113	CHEMBL	2017	Ki	4.0
834	CHEBI_37924	atazanavir and cobicistat	PR_P11712	Cytochrome P450 2C9	molecularly_interacts_with	RO_0002436	drug_central			816	WOMBAT-PK	2017	Ki	4.0
835	CHEBI_6413	letrozole	PR_P19099	Cytochrome P450 11B2, mitochondrial	is_substrate_of	DIDEO_00000041	drug_central			294	CHEMBL	2017	IC50	5.0
2407	CHEBI_4953	exemestane	PR_P08183	P-gp	molecularly_interacts_with	RO_0002436	FDA		497		PL	2017		
836	CHEBI_64318	ergotamine	PR_P08684	Cytochrome P450 3A4	molecularly_interacts_with	RO_0002436	drug_central			1031	DRUG MATRIX	2017	IC50	6.0
837	CHEBI_7772	omeprazole	PR_P05177	Cytochrome P450 1A2	is_substrate_of	DIDEO_00000041	drug_central			317	WOMBAT-PK	2017	IC50	4.0
838	CHEBI_6919	mezlocillin	PR_P10632	Cytochrome P450 2C8	molecularly_interacts_with	RO_0002436	drug_central			811	WOMBAT-PK	2017	IC50	6.0
839	CHEBI_45285	rifampicin, pyrazinamide and isoniazid	PR_P20815	Cytochrome P450 3A5	molecularly_interacts_with	RO_0002436	drug_central			1104	WOMBAT-PK	2017	IC50	4.0
840	CHEBI_40009	cycloserine	PR_P08684	Cytochrome P450 3A4	molecularly_interacts_with	RO_0002436	drug_central			1022	WOMBAT-PK	2017	IC50	4.0
841	CHEBI_6874	methylergometrine and oxytocin	PR_P10635	Cytochrome P450 2D6	molecularly_interacts_with	RO_0002436	drug_central			940	DRUG MATRIX	2017	IC50	6.0
842	CHEBI_107736	metoclopramide	PR_P10635	Cytochrome P450 2D6	is_substrate_of	DIDEO_00000041	drug_central			521	DRUG MATRIX	2017	IC50	6.0
843	CHEBI_45409	ritonavir	PR_P11712	Cytochrome P450 2C9	is_substrate_of	DIDEO_00000041	drug_central			450	DRUG MATRIX	2017	IC50	7.0
844	CHEBI_37924	atazanavir and cobicistat	PR_P11712	Cytochrome P450 2C9	is_substrate_of	DIDEO_00000041	drug_central			400	WOMBAT-PK	2017	Ki	4.0
845	CHEBI_6723	megestrol	PR_P11712	Cytochrome P450 2C9	molecularly_interacts_with	RO_0002436	drug_central			847	DRUG MATRIX	2017	IC50	5.0
846	CHEBI_6375	lansoprazole, clarithromycin and tinidazole	PR_P10635	Cytochrome P450 2D6	molecularly_interacts_with	RO_0002436	drug_central			931	DRUG MATRIX	2017	IC50	5.0
847	CHEBI_7772	omeprazole, amoxicillin and clarithromycin	PR_P05177	Cytochrome P450 1A2	molecularly_interacts_with	RO_0002436	drug_central			732	WOMBAT-PK	2017	IC50	4.0
848	CHEBI_4513	dicoumarol	PR_P11712	Cytochrome P450 2C9	is_substrate_of	DIDEO_00000041	drug_central			408	WOMBAT-PK	2017	Ki	5.0
849	CHEBI_4877	ethambutol and isoniazid	PR_P20815	Cytochrome P450 3A5	molecularly_interacts_with	RO_0002436	drug_central			1093	WOMBAT-PK	2017	IC50	4.0
850	CHEBI_5118	fluoxetine	PR_P10635	Cytochrome P450 2D6	molecularly_interacts_with	RO_0002436	drug_central			919	DRUG MATRIX	2017	IC50	6.0
851	CHEBI_72291	cobicistat	PR_P08684	Cytochrome P450 3A	molecularly_interacts_with	RO_0002436	drug_central			992	SCIENTIFIC LITERATURE	2017	Ki	6.0
852	CHEBI_127342	atomoxetine	PR_P10635	Cytochrome P450 2D6	molecularly_interacts_with	RO_0002436	drug_central			892	WOMBAT-PK	2017	Ki	4.0
853	CHEBI_48574	phenylbutazone	PR_P11712	Cytochrome P450 2C9	molecularly_interacts_with	RO_0002436	drug_central			861	WOMBAT-PK	2017	Ki	4.0
854	CHEBI_7565	nifedipine, combinations	PR_P08684	Cytochrome P450 3A4	is_substrate_of	DIDEO_00000041	drug_central			639	WOMBAT-PK	2017	IC50	5.0
855	CHEBI_83305	oritavancin	NCBITaxon_46170	Staphylococcus aureus subsp. aureus	molecularly_interacts_with	RO_0002436	drug_central			1128	DRUG LABEL	2017	MIC	7.0
856	CHEBI_27953	physostigmine	PR_P10635	Cytochrome P450 2D6	molecularly_interacts_with	RO_0002436	drug_central			958	DRUG MATRIX	2017	IC50	6.0
857	CHEBI_9757	tropicamide	PR_P33261	Cytochrome P450 2C19	is_substrate_of	DIDEO_00000041	drug_central			389	DRUG MATRIX	2017	IC50	6.0
858	CHEBI_31578	ethylestrenol	PR_P33261	Cytochrome P450 2C19	is_substrate_of	DIDEO_00000041	drug_central			347	DRUG MATRIX	2017	IC50	5.0
859	CHEBI_9325	sulconazole	PR_P05177	Cytochrome P450 1A2	is_substrate_of	DIDEO_00000041	drug_central			328	DRUG MATRIX	2017	IC50	6.0
860	CHEBI_6413	letrozole	PR_P15538	Cytochrome P450 11B1, mitochondrial	molecularly_interacts_with	RO_0002436	drug_central			702	CHEMBL	2017	IC50	5.0
861	CHEBI_61049	tacrolimus	PR_P08684	Cytochrome P450 3A4	molecularly_interacts_with	RO_0002436	drug_central			1079	DRUG MATRIX	2017	IC50	6.0
862	CHEBI_44241	metyrapone	PR_P19099	Cytochrome P450 11B2, mitochondrial	is_substrate_of	DIDEO_00000041	drug_central			295	CHEMBL	2017	IC50	7.0
863	CHEBI_6723	megestrol and ethinylestradiol	PR_P11712	Cytochrome P450 2C9	is_substrate_of	DIDEO_00000041	drug_central			428	DRUG MATRIX	2017	IC50	5.0
864	CHEBI_37924	atazanavir and cobicistat	PR_P08684	Cytochrome P450 3A4	is_substrate_of	DIDEO_00000041	drug_central			578	WOMBAT-PK	2017	Ki	5.0
865	CHEBI_8060	phenelzine	PR_P33261	Cytochrome P450 2C19	is_substrate_of	DIDEO_00000041	drug_central			378	DRUG MATRIX	2017	IC50	6.0
866	CHEBI_9566	thioridazine	PR_P05177	Cytochrome P450 1A2	is_substrate_of	DIDEO_00000041	drug_central			330	DRUG MATRIX	2017	IC50	5.0
867	CHEBI_3545	cefapirin	PR_P10635	Cytochrome P450 2D6	is_substrate_of	DIDEO_00000041	drug_central			481	WOMBAT-PK	2017	IC50	4.0
868	CHEBI_4877	rifampicin, pyrazinamide, ethambutol and isoniazid	PR_P08684	Cytochrome P450 3A4	is_substrate_of	DIDEO_00000041	drug_central			610	WOMBAT-PK	2017	IC50	6.0
869	CHEBI_47381	diclofenac and antiinfectives	PR_Q9HAW8	UDP-glucuronosyltransferase 1-10	molecularly_interacts_with	RO_0002436	drug_central			1114	CHEMBL	2017	Ki	4.0
870	CHEBI_7789	orphenadrine (chloride)	PR_P10635	Cytochrome P450 2D6	molecularly_interacts_with	RO_0002436	drug_central			950	DRUG MATRIX	2017	IC50	6.0
871	CHEBI_7550	nicardipine	PR_P11712	Cytochrome P450 2C9	is_substrate_of	DIDEO_00000041	drug_central			432	WOMBAT-PK	2017	IC50	6.0
872	CHEBI_39548	atorvastatin, acetylsalicylic acid and perindopril	PR_P08684	Cytochrome P450 3A4	is_substrate_of	DIDEO_00000041	drug_central			580	CHEMBL	2017	IC50	5.0
873	CHEBI_6375	lansoprazole, combinations	PR_P10635	Cytochrome P450 2D6	is_substrate_of	DIDEO_00000041	drug_central			511	DRUG MATRIX	2017	IC50	5.0
874	CHEBI_5138	fluvoxamine	PR_P05177	Cytochrome P450 1A2	is_substrate_of	DIDEO_00000041	drug_central			308	WOMBAT-PK	2017	Ki	5.0
875	CHEBI_9757	tropicamide	PR_P11712	Cytochrome P450 2C9	is_substrate_of	DIDEO_00000041	drug_central			458	DRUG MATRIX	2017	IC50	6.0
876	CHEBI_6923	miconazole	PR_P10635	Cytochrome P450 2D6	is_substrate_of	DIDEO_00000041	drug_central			522	DRUG MATRIX	2017	IC50	6.0
877	CHEBI_9362	suprofen	PR_P11712	Cytochrome P450 2C9	molecularly_interacts_with	RO_0002436	drug_central			877	WOMBAT-PK	2017	Ki	4.0
878	CHEBI_3219	bupropion	PR_P33261	Cytochrome P450 2C19	molecularly_interacts_with	RO_0002436	drug_central			756	DRUG MATRIX	2017	IC50	5.0
879	CHEBI_6375	lansoprazole, amoxicillin and clarithromycin	PR_P33261	Cytochrome P450 2C19	is_substrate_of	DIDEO_00000041	drug_central			358	DRUG MATRIX	2017	IC50	6.0
880	CHEBI_6030	rifampicin, pyrazinamide and isoniazid	PR_P20815	Cytochrome P450 3A5	molecularly_interacts_with	RO_0002436	drug_central			1099	WOMBAT-PK	2017	IC50	4.0
881	CHEBI_52010	chlorphenamine, combinations	PR_P10635	Cytochrome P450 2D6	molecularly_interacts_with	RO_0002436	drug_central			904	WOMBAT-PK	2017	Ki	4.0
882	CHEBI_7496	nelfinavir	PR_P08684	Cytochrome P450 3A4	molecularly_interacts_with	RO_0002436	drug_central			1061	DRUG MATRIX	2017	IC50	5.0
883	CHEBI_6030	thioacetazone and isoniazid	PR_P20815	Cytochrome P450 3A5	is_substrate_of	DIDEO_00000041	drug_central			674	WOMBAT-PK	2017	IC50	4.0
884	CHEBI_3994	cyclizine	PR_P10635	Cytochrome P450 2D6	molecularly_interacts_with	RO_0002436	drug_central			911	DRUG MATRIX	2017	IC50	5.0
885	CHEBI_4877	ethambutol and isoniazid	PR_P20815	Cytochrome P450 3A5	is_substrate_of	DIDEO_00000041	drug_central			665	WOMBAT-PK	2017	IC50	4.0
886	CHEBI_3738	clemastine	PR_P10635	Cytochrome P450 2D6	is_substrate_of	DIDEO_00000041	drug_central			486	WOMBAT-PK	2017	Ki	5.0
887	CHEBI_32223	tibolone	PR_P33261	Cytochrome P450 2C19	is_substrate_of	DIDEO_00000041	drug_central			387	DRUG MATRIX	2017	IC50	5.0
888	CHEBI_8060	phenelzine	PR_P11712	Cytochrome P450 2C9	molecularly_interacts_with	RO_0002436	drug_central			860	DRUG MATRIX	2017	IC50	5.0
889	CHEBI_37941	clopidogrel	PR_P20813	Cytochrome P450 2B6	molecularly_interacts_with	RO_0002436	drug_central			752	WOMBAT-PK	2017	Ki	6.0
890	CHEBI_4877	rifampicin, pyrazinamide, ethambutol and isoniazid	PR_P20815	Cytochrome P450 3A5	molecularly_interacts_with	RO_0002436	drug_central			1094	WOMBAT-PK	2017	IC50	4.0
891	CHEBI_6076	itraconazole	PR_P08684	Cytochrome P450 3A4	is_substrate_of	DIDEO_00000041	drug_central			623	DRUG MATRIX	2017	IC50	6.0
892	CHEBI_6375	lansoprazole, tetracycline and metronidazole	PR_P10635	Cytochrome P450 2D6	molecularly_interacts_with	RO_0002436	drug_central			933	DRUG MATRIX	2017	IC50	5.0
893	CHEBI_44032	indinavir	PR_P08684	Cytochrome P450 3A4	molecularly_interacts_with	RO_0002436	drug_central			1040	DRUG MATRIX	2017	IC50	6.0
894	CHEBI_4562	dihydroergotamine, combinations	PR_P08684	Cytochrome P450 3A4	is_substrate_of	DIDEO_00000041	drug_central			601	DRUG MATRIX	2017	IC50	5.0
895	CHEBI_3348	candesartan and diuretics	PR_P08684	Cytochrome P450 3A4	is_substrate_of	DIDEO_00000041	drug_central			589	CHEMBL	2017	IC50	5.0
896	CHEBI_7565	nifedipine, combinations	PR_P08684	Cytochrome P450 3A4	molecularly_interacts_with	RO_0002436	drug_central			1066	WOMBAT-PK	2017	IC50	5.0
897	CHEBI_7494	nefazodone	PR_P08684	Cytochrome P450 3A4	is_substrate_of	DIDEO_00000041	drug_central			634	IUPHAR	2017	Ki	6.0
898	CHEBI_9948	verapamil, combinations	PR_P08684	Cytochrome P450 3A4	is_substrate_of	DIDEO_00000041	drug_central			656	IUPHAR	2017	Ki	6.0
899	CHEBI_6820	methapyrilene	PR_P10635	Cytochrome P450 2D6	molecularly_interacts_with	RO_0002436	drug_central			938	DRUG MATRIX	2017	IC50	5.0
900	CHEBI_6923	miconazole	PR_P11712	Cytochrome P450 2C9	is_substrate_of	DIDEO_00000041	drug_central			430	DRUG MATRIX	2017	IC50	6.0
901	CHEBI_3647	chlorpromazine	PR_P10635	Cytochrome P450 2D6	is_substrate_of	DIDEO_00000041	drug_central			484	WOMBAT-PK	2017	Ki	5.0
902	CHEBI_47381	diclofenac, combinations	PR_P22309	UDP-glucuronosyltransferase 1-1	molecularly_interacts_with	RO_0002436	drug_central			1112	CHEMBL	2017	Ki	4.0
903	CHEBI_47519	ketoconazole	PR_P19099	Cytochrome P450 11B2, mitochondrial	molecularly_interacts_with	RO_0002436	drug_central			706	SCIENTIFIC LITERATURE	2017	IC50	7.0
904	CHEBI_31515	domperidone	PR_P10635	Cytochrome P450 2D6	is_substrate_of	DIDEO_00000041	drug_central			494	WOMBAT-PK	2017	Ki	5.0
905	CHEBI_2687	amsacrine	PR_P10635	Cytochrome P450 2D6	molecularly_interacts_with	RO_0002436	drug_central			890	WOMBAT-PK	2017	Ki	5.0
906	CHEBI_47780	clomipramine	PR_P10635	Cytochrome P450 2D6	is_substrate_of	DIDEO_00000041	drug_central			489	WOMBAT-PK	2017	Ki	5.0
907	CHEBI_7582	enalapril and nitrendipine	PR_P11712	Cytochrome P450 2C9	is_substrate_of	DIDEO_00000041	drug_central			434	DRUG MATRIX	2017	IC50	6.0
908	CHEBI_27882	colchicine	PR_P08684	Cytochrome P450 3A4	molecularly_interacts_with	RO_0002436	drug_central			1020	WOMBAT-PK	2017	Ki	4.0
909	CHEBI_45409	dasabuvir, ombitasvir, paritaprevir and ritonavir	PR_P10635	Cytochrome P450 2D6	molecularly_interacts_with	RO_0002436	drug_central			973	DRUG MATRIX	2017	IC50	4.0
910	CHEBI_6715	medroxyprogesterone	PR_P33261	Cytochrome P450 2C19	molecularly_interacts_with	RO_0002436	drug_central			780	DRUG MATRIX	2017	IC50	5.0
911	CHEBI_3720	cisapride	PR_P10635	Cytochrome P450 2D6	is_substrate_of	DIDEO_00000041	drug_central			485	DRUG MATRIX	2017	IC50	7.0
912	CHEBI_45285	rifampicin, pyrazinamide and isoniazid	PR_P08684	Cytochrome P450 3A4	molecularly_interacts_with	RO_0002436	drug_central			1070	WOMBAT-PK	2017	IC50	6.0
913	CHEBI_9757	tropicamide	PR_P11712	Cytochrome P450 2C9	molecularly_interacts_with	RO_0002436	drug_central			879	DRUG MATRIX	2017	IC50	6.0
914	CHEBI_9652	tranylcypromine	PR_P11509	Cytochrome P450 2A6	molecularly_interacts_with	RO_0002436	drug_central			751	WOMBAT-PK	2017	Ki	7.0
915	CHEBI_4754	econazole	PR_P10635	Cytochrome P450 2D6	molecularly_interacts_with	RO_0002436	drug_central			917	DRUG MATRIX	2017	IC50	6.0
916	CHEBI_3764	clotrimazole	PR_P33261	Cytochrome P450 2C19	molecularly_interacts_with	RO_0002436	drug_central			760	DRUG MATRIX	2017	IC50	7.0
917	CHEBI_46081	fluconazole	PR_P08684	Cytochrome P450 3A4	molecularly_interacts_with	RO_0002436	drug_central			1038	CHEMBL	2017	IC50	5.0
918	CHEBI_7825	oxiconazole	PR_P10635	Cytochrome P450 2D6	molecularly_interacts_with	RO_0002436	drug_central			986	DRUG MATRIX	2017	IC50	6.0
919	CHEBI_8499	propranolol	PR_P10635	Cytochrome P450 2D6	is_substrate_of	DIDEO_00000041	drug_central			542	DRUG MATRIX	2017	IC50	5.0
920	CHEBI_10100	zafirlukast	PR_P11712	Cytochrome P450 2C9	is_substrate_of	DIDEO_00000041	drug_central			462	DRUG MATRIX	2017	IC50	5.0
921	CHEBI_6030	rifampicin, pyrazinamide and isoniazid	PR_P08684	Cytochrome P450 3A4	molecularly_interacts_with	RO_0002436	drug_central			1045	WOMBAT-PK	2017	IC50	5.0
922	CHEBI_4910	etomidate	PR_P19099	Cytochrome P450 11B2, mitochondrial	molecularly_interacts_with	RO_0002436	drug_central			705	CHEMBL	2017	IC50	10.0
923	CHEBI_5062	finasteride	PR_P33261	Cytochrome P450 2C19	is_substrate_of	DIDEO_00000041	drug_central			349	DRUG MATRIX	2017	IC50	6.0
924	CHEBI_39548	atorvastatin, amlodipine and perindopril	PR_P08684	Cytochrome P450 3A4	molecularly_interacts_with	RO_0002436	drug_central			1006	CHEMBL	2017	IC50	5.0
925	CHEBI_553827	bambuterol	PR_P10635	Cytochrome P450 2D6	is_substrate_of	DIDEO_00000041	drug_central			471	DRUG MATRIX	2017	IC50	5.0
926	CHEBI_37924	atazanavir and cobicistat	PR_P08684	Cytochrome P450 3A4	molecularly_interacts_with	RO_0002436	drug_central			1002	WOMBAT-PK	2017	Ki	5.0
927	CHEBI_5818	hydroxyzine	PR_P10635	Cytochrome P450 2D6	molecularly_interacts_with	RO_0002436	drug_central			921	WOMBAT-PK	2017	Ki	5.0
928	CHEBI_9588	ticlopidine	PR_P33261	Cytochrome P450 2C19	molecularly_interacts_with	RO_0002436	drug_central			803	DRUG MATRIX	2017	IC50	6.0
929	CHEBI_46081	azithromycin, fluconazole and secnidazole	PR_P08684	Cytochrome P450 3A4	is_substrate_of	DIDEO_00000041	drug_central			611	CHEMBL	2017	IC50	5.0
930	CHEBI_101278	diltiazem	PR_P08684	Cytochrome P450 3A4	molecularly_interacts_with	RO_0002436	drug_central			1028	DRUG MATRIX	2017	IC50	5.0
931	CHEBI_6030	isoniazid	PR_P20815	Cytochrome P450 3A5	is_substrate_of	DIDEO_00000041	drug_central			668	WOMBAT-PK	2017	IC50	4.0
932	CHEBI_7772	omeprazole, amoxicillin and metronidazole	PR_P33261	Cytochrome P450 2C19	is_substrate_of	DIDEO_00000041	drug_central			376	WOMBAT-PK	2017	Ki	5.0
933	CHEBI_38561	fluvastatin	PR_P11712	Cytochrome P450 2C9	is_substrate_of	DIDEO_00000041	drug_central			416	DRUG MATRIX	2017	IC50	6.0
934	CHEBI_31624	fluorescein	PR_P33261	Cytochrome P450 2C19	molecularly_interacts_with	RO_0002436	drug_central			767	DRUG MATRIX	2017	IC50	6.0
935	CHEBI_46081	fluconazole	PR_P08684	Cytochrome P450 3A4	is_substrate_of	DIDEO_00000041	drug_central			612	CHEMBL	2017	IC50	5.0
936	CHEBI_46081	azithromycin, fluconazole and secnidazole	PR_P11712	Cytochrome P450 2C9	molecularly_interacts_with	RO_0002436	drug_central			833	CHEMBL	2017	IC50	4.0
937	CHEBI_72291	atazanavir and cobicistat	PR_P08684	Cytochrome P450 3A	molecularly_interacts_with	RO_0002436	drug_central			991	SCIENTIFIC LITERATURE	2017	Ki	6.0
938	CHEBI_7772	omeprazole, amoxicillin and metronidazole	PR_P05177	Cytochrome P450 1A2	molecularly_interacts_with	RO_0002436	drug_central			733	WOMBAT-PK	2017	IC50	4.0
939	CHEBI_10033	warfarin	PR_P08684	Cytochrome P450 3A4	molecularly_interacts_with	RO_0002436	drug_central			1086	WOMBAT-PK	2017	Ki	3.0
940	CHEBI_585948	felodipine	PR_P11712	Cytochrome P450 2C9	molecularly_interacts_with	RO_0002436	drug_central			828	DRUG MATRIX	2017	IC50	5.0
941	CHEBI_7577	nisoldipine	PR_P05177	Cytochrome P450 1A2	molecularly_interacts_with	RO_0002436	drug_central			730	DRUG MATRIX	2017	IC50	6.0
942	CHEBI_72291	atazanavir and cobicistat	PR_P08684	Cytochrome P450 3A	is_substrate_of	DIDEO_00000041	drug_central			568	SCIENTIFIC LITERATURE	2017	Ki	6.0
943	CHEBI_8060	phenelzine	PR_P10635	Cytochrome P450 2D6	is_substrate_of	DIDEO_00000041	drug_central			533	DRUG MATRIX	2017	IC50	6.0
944	CHEBI_585948	felodipine	PR_P11712	Cytochrome P450 2C9	is_substrate_of	DIDEO_00000041	drug_central			410	DRUG MATRIX	2017	IC50	5.0
945	CHEBI_46081	azithromycin, fluconazole and secnidazole	PR_P33261	Cytochrome P450 2C19	is_substrate_of	DIDEO_00000041	drug_central			350	CHEMBL	2017	IC50	5.0
946	CHEBI_6762	mepyramine	PR_P10635	Cytochrome P450 2D6	molecularly_interacts_with	RO_0002436	drug_central			968	DRUG MATRIX	2017	IC50	6.0
947	CHEBI_3215	bupivacaine, combinations	PR_P10635	Cytochrome P450 2D6	is_substrate_of	DIDEO_00000041	drug_central			477	DRUG MATRIX	2017	IC50	6.0
948	CHEBI_37924	atazanavir	PR_P08684	Cytochrome P450 3A4	molecularly_interacts_with	RO_0002436	drug_central			1001	WOMBAT-PK	2017	Ki	5.0
949	CHEBI_9588	ticlopidine	PR_P10635	Cytochrome P450 2D6	is_substrate_of	DIDEO_00000041	drug_central			560	DRUG MATRIX	2017	IC50	5.0
950	CHEBI_6030	rifampicin, pyrazinamide, ethambutol and isoniazid	PR_P08684	Cytochrome P450 3A4	is_substrate_of	DIDEO_00000041	drug_central			620	WOMBAT-PK	2017	IC50	5.0
951	CHEBI_47381	diclofenac, combinations	PR_Q9HAW7	UDP-glucuronosyltransferase 1-7	molecularly_interacts_with	RO_0002436	drug_central			1122	CHEMBL	2017	Ki	4.0
952	CHEBI_50199	pefloxacin	PR_P05177	Cytochrome P450 1A2	is_substrate_of	DIDEO_00000041	drug_central			321	WOMBAT-PK	2017	Ki	4.0
953	CHEBI_47381	diclofenac and antiinfectives	PR_P22309	UDP-glucuronosyltransferase 1-1	is_substrate_of	DIDEO_00000041	drug_central			683	CHEMBL	2017	Ki	4.0
954	CHEBI_39548	atorvastatin, acetylsalicylic acid and perindopril	PR_P08684	Cytochrome P450 3A4	molecularly_interacts_with	RO_0002436	drug_central			1004	CHEMBL	2017	IC50	5.0
955	CHEBI_63632	topotecan	PR_P08684	Cytochrome P450 3A4	is_substrate_of	DIDEO_00000041	drug_central			653	DRUG MATRIX	2017	IC50	5.0
956	CHEBI_68639	abiraterone	PR_P08684	Cytochrome P450 3A4	molecularly_interacts_with	RO_0002436	drug_central			1090	CHEMBL	2017	IC50	5.0
957	CHEBI_4754	econazole	PR_P08684	Cytochrome P450 3A4	molecularly_interacts_with	RO_0002436	drug_central			1030	DRUG MATRIX	2017	IC50	7.0
958	CHEBI_47519	ketoconazole	PR_P15538	Cytochrome P450 11B1, mitochondrial	molecularly_interacts_with	RO_0002436	drug_central			701	SCIENTIFIC LITERATURE	2017	IC50	6.0
959	CHEBI_3738	clemastine	PR_P33261	Cytochrome P450 2C19	is_substrate_of	DIDEO_00000041	drug_central			343	DRUG MATRIX	2017	IC50	6.0
960	CHEBI_47381	diclofenac, combinations	PR_P22309	UDP-glucuronosyltransferase 1-1	is_substrate_of	DIDEO_00000041	drug_central			684	CHEMBL	2017	Ki	4.0
961	CHEBI_7825	oxiconazole	PR_P08684	Cytochrome P450 3A4	is_substrate_of	DIDEO_00000041	drug_central			661	DRUG MATRIX	2017	IC50	7.0
962	CHEBI_6541	losartan	PR_P11712	Cytochrome P450 2C9	is_substrate_of	DIDEO_00000041	drug_central			423	DRUG MATRIX	2017	IC50	5.0
963	CHEBI_5693	hexachlorophene	PR_P05177	Cytochrome P450 1A2	is_substrate_of	DIDEO_00000041	drug_central			309	DRUG MATRIX	2017	IC50	5.0
964	CHEBI_9753	troglitazone	PR_P11712	Cytochrome P450 2C9	is_substrate_of	DIDEO_00000041	drug_central			457	DRUG MATRIX	2017	IC50	5.0
965	CHEBI_6715	medroxyprogesterone and ethinylestradiol	PR_P33261	Cytochrome P450 2C19	is_substrate_of	DIDEO_00000041	drug_central			367	DRUG MATRIX	2017	IC50	5.0
966	CHEBI_63617	pergolide	PR_P10635	Cytochrome P450 2D6	molecularly_interacts_with	RO_0002436	drug_central			954	DRUG MATRIX	2017	IC50	6.0
967	CHEBI_9753	troglitazone	PR_P19224	UDP-glucuronosyltransferase 1-6	is_substrate_of	DIDEO_00000041	drug_central			691	CHEMBL	2017	Ki	4.0
968	CHEBI_253342	alosetron	PR_P05177	Cytochrome P450 1A2	molecularly_interacts_with	RO_0002436	drug_central			713	DRUG MATRIX	2017	IC50	6.0
969	CHEBI_6923	miconazole	PR_P10635	Cytochrome P450 2D6	molecularly_interacts_with	RO_0002436	drug_central			945	DRUG MATRIX	2017	IC50	6.0
970	CHEBI_3720	cisapride	PR_P10635	Cytochrome P450 2D6	molecularly_interacts_with	RO_0002436	drug_central			906	DRUG MATRIX	2017	IC50	7.0
971	CHEBI_47381	diclofenac and antiinfectives	PR_P22309	UDP-glucuronosyltransferase 1-1	molecularly_interacts_with	RO_0002436	drug_central			1111	CHEMBL	2017	Ki	4.0
972	CHEBI_61049	tacrolimus	PR_P08684	Cytochrome P450 3A4	is_substrate_of	DIDEO_00000041	drug_central			652	DRUG MATRIX	2017	IC50	6.0
973	CHEBI_6375	lansoprazole, combinations	PR_P33261	Cytochrome P450 2C19	is_substrate_of	DIDEO_00000041	drug_central			362	DRUG MATRIX	2017	IC50	6.0
974	CHEBI_9948	trandolapril and verapamil	PR_Q9UNQ0	ATP-binding cassette sub-family G member 2	molecularly_interacts_with	RO_0002436	drug_central			1131	CHEMBL	2017	EC50	4.0
975	CHEBI_24564	altretamine	PR_P05177	Cytochrome P450 1A2	molecularly_interacts_with	RO_0002436	drug_central			714	DRUG MATRIX	2017	IC50	5.0
976	CHEBI_3348	candesartan and diuretics	PR_P11712	Cytochrome P450 2C9	is_substrate_of	DIDEO_00000041	drug_central			404	CHEMBL	2017	IC50	5.0
977	CHEBI_681848	doxapram	PR_P10635	Cytochrome P450 2D6	molecularly_interacts_with	RO_0002436	drug_central			916	DRUG MATRIX	2017	IC50	7.0
978	CHEBI_28593	quinidine	PR_P10635	Cytochrome P450 2D6	molecularly_interacts_with	RO_0002436	drug_central			969	SCIENTIFIC LITERATURE	2017	Ki	7.0
979	CHEBI_8060	phenelzine	PR_P10635	Cytochrome P450 2D6	molecularly_interacts_with	RO_0002436	drug_central			956	DRUG MATRIX	2017	IC50	6.0
980	CHEBI_50730	montelukast, combinations	PR_P10632	Cytochrome P450 2C8	molecularly_interacts_with	RO_0002436	drug_central			813	WOMBAT-PK	2017	Ki	5.0
981	CHEBI_63617	pergolide	PR_P10635	Cytochrome P450 2D6	is_substrate_of	DIDEO_00000041	drug_central			531	DRUG MATRIX	2017	IC50	6.0
982	CHEBI_44241	metyrapone	PR_P15538	Cytochrome P450 11B1, mitochondrial	molecularly_interacts_with	RO_0002436	drug_central			703	CHEMBL	2017	IC50	7.0
983	CHEBI_47381	diclofenac, combinations	PR_Q9HAW8	UDP-glucuronosyltransferase 1-10	is_substrate_of	DIDEO_00000041	drug_central			687	CHEMBL	2017	Ki	4.0
984	CHEBI_8459	promazine	PR_P10635	Cytochrome P450 2D6	is_substrate_of	DIDEO_00000041	drug_central			537	DRUG MATRIX	2017	IC50	6.0
985	CHEBI_6919	mezlocillin	PR_P08684	Cytochrome P450 3A4	is_substrate_of	DIDEO_00000041	drug_central			628	WOMBAT-PK	2017	IC50	5.0
986	CHEBI_72291	cobicistat	PR_P08684	Cytochrome P450 3A	is_substrate_of	DIDEO_00000041	drug_central			569	SCIENTIFIC LITERATURE	2017	Ki	6.0
987	CHEBI_4325	dapsone	PR_P08684	Cytochrome P450 3A4	is_substrate_of	DIDEO_00000041	drug_central			598	WOMBAT-PK	2017	Ki	4.0
988	CHEBI_31360	carmofur	PR_P10635	Cytochrome P450 2D6	is_substrate_of	DIDEO_00000041	drug_central			479	DRUG MATRIX	2017	IC50	5.0
989	CHEBI_31360	carmofur	PR_P10635	Cytochrome P450 2D6	molecularly_interacts_with	RO_0002436	drug_central			900	DRUG MATRIX	2017	IC50	5.0
990	CHEBI_6375	lansoprazole, amoxicillin and metronidazole	PR_P10635	Cytochrome P450 2D6	is_substrate_of	DIDEO_00000041	drug_central			509	DRUG MATRIX	2017	IC50	5.0
991	CHEBI_47381	diclofenac	PR_P22309	UDP-glucuronosyltransferase 1-1	is_substrate_of	DIDEO_00000041	drug_central			682	CHEMBL	2017	Ki	4.0
992	CHEBI_32215	thiamphenicol	PR_P33261	Cytochrome P450 2C19	is_substrate_of	DIDEO_00000041	drug_central			384	WOMBAT-PK	2017	IC50	5.0
993	CHEBI_37924	atazanavir and cobicistat	PR_P22309	UDP-glucuronosyltransferase 1-1	is_substrate_of	DIDEO_00000041	drug_central			681	WOMBAT-PK	2017	Ki	5.0
994	CHEBI_5132	flutamide	PR_P05177	Cytochrome P450 1A2	is_substrate_of	DIDEO_00000041	drug_central			307	WOMBAT-PK	2017	Ki	5.0
995	CHEBI_41423	celecoxib	PR_P10635	Cytochrome P450 2D6	molecularly_interacts_with	RO_0002436	drug_central			901	DRUG MATRIX	2017	IC50	6.0
996	CHEBI_31687	idebenone	PR_P33261	Cytochrome P450 2C19	is_substrate_of	DIDEO_00000041	drug_central			355	DRUG MATRIX	2017	IC50	6.0
997	CHEBI_4659	disulfiram, combinations	PR_P05177	Cytochrome P450 1A2	is_substrate_of	DIDEO_00000041	drug_central			305	DRUG MATRIX	2017	IC50	5.0
998	CHEBI_31687	idebenone	PR_P11712	Cytochrome P450 2C9	is_substrate_of	DIDEO_00000041	drug_central			421	DRUG MATRIX	2017	IC50	5.0
999	CHEBI_45409	ombitasvir, paritaprevir and ritonavir	PR_P10635	Cytochrome P450 2D6	molecularly_interacts_with	RO_0002436	drug_central			975	DRUG MATRIX	2017	IC50	4.0
1000	CHEBI_44241	metyrapone	PR_P08684	Cytochrome P450 3A4	is_substrate_of	DIDEO_00000041	drug_central			627	DRUG MATRIX	2017	IC50	6.0
1001	CHEBI_6149	levobupivacaine	PR_P10635	Cytochrome P450 2D6	molecularly_interacts_with	RO_0002436	drug_central			886	DRUG MATRIX	2017	IC50	6.0
1002	CHEBI_7862	oxymetazoline	PR_P10635	Cytochrome P450 2D6	molecularly_interacts_with	RO_0002436	drug_central			952	DRUG MATRIX	2017	IC50	6.0
1003	CHEBI_37924	atazanavir and cobicistat	PR_P05177	Cytochrome P450 1A2	molecularly_interacts_with	RO_0002436	drug_central			716	WOMBAT-PK	2017	Ki	4.0
1004	CHEBI_6874	methylergometrine	PR_P10635	Cytochrome P450 2D6	molecularly_interacts_with	RO_0002436	drug_central			939	DRUG MATRIX	2017	IC50	6.0
1005	CHEBI_6920	mibefradil	PR_P08684	Cytochrome P450 3A4	is_substrate_of	DIDEO_00000041	drug_central			629	WOMBAT-PK	2017	Ki	6.0
1006	CHEBI_63621	saquinavir	PR_P08684	Cytochrome P450 3A4	is_substrate_of	DIDEO_00000041	drug_central			649	WOMBAT-PK	2017	IC50	5.0
1007	CHEBI_6030	isoniazid	PR_P08684	Cytochrome P450 3A4	molecularly_interacts_with	RO_0002436	drug_central			1042	WOMBAT-PK	2017	IC50	5.0
1008	CHEBI_4754	econazole	PR_P11712	Cytochrome P450 2C9	is_substrate_of	DIDEO_00000041	drug_central			409	DRUG MATRIX	2017	IC50	6.0
1009	CHEBI_136007	methylnaltrexone bromide	PR_P10635	Cytochrome P450 2D6	molecularly_interacts_with	RO_0002436	drug_central			988	WOMBAT-PK	2017	Ki	5.0
1010	CHEBI_3720	cisapride	PR_P08684	Cytochrome P450 3A4	is_substrate_of	DIDEO_00000041	drug_central			592	DRUG MATRIX	2017	IC50	6.0
1011	CHEBI_5062	alfuzosin and finasteride	PR_P11712	Cytochrome P450 2C9	molecularly_interacts_with	RO_0002436	drug_central			831	DRUG MATRIX	2017	IC50	5.0
1012	CHEBI_3348	candesartan and amlodipine	PR_P08684	Cytochrome P450 3A4	molecularly_interacts_with	RO_0002436	drug_central			1014	CHEMBL	2017	IC50	5.0
1013	CHEBI_6532	loperamide	PR_P10635	Cytochrome P450 2D6	is_substrate_of	DIDEO_00000041	drug_central			514	DRUG MATRIX	2017	IC50	5.0
1014	CHEBI_9757	tropicamide, combinations	PR_P11712	Cytochrome P450 2C9	is_substrate_of	DIDEO_00000041	drug_central			459	DRUG MATRIX	2017	IC50	6.0
1015	CHEBI_3738	clemastine, combinations	PR_P33261	Cytochrome P450 2C19	is_substrate_of	DIDEO_00000041	drug_central			344	DRUG MATRIX	2017	IC50	6.0
1016	CHEBI_47519	ketoconazole	PR_Q16850	Cytochrome P450 51	molecularly_interacts_with	RO_0002436	drug_central			1106	CHEMBL	2017	Ki	7.0
1017	CHEBI_45409	ritonavir	PR_P11712	Cytochrome P450 2C9	molecularly_interacts_with	RO_0002436	drug_central			871	DRUG MATRIX	2017	IC50	7.0
1018	CHEBI_5118	fluoxetine	PR_P10635	Cytochrome P450 2D6	is_substrate_of	DIDEO_00000041	drug_central			498	DRUG MATRIX	2017	IC50	6.0
1019	CHEBI_6723	megestrol	PR_P11712	Cytochrome P450 2C9	is_substrate_of	DIDEO_00000041	drug_central			426	DRUG MATRIX	2017	IC50	5.0
1020	CHEBI_4325	dapsone	PR_P08684	Cytochrome P450 3A4	molecularly_interacts_with	RO_0002436	drug_central			1024	WOMBAT-PK	2017	Ki	4.0
1021	CHEBI_4877	ethambutol	PR_P08684	Cytochrome P450 3A4	molecularly_interacts_with	RO_0002436	drug_central			1034	WOMBAT-PK	2017	IC50	6.0
1022	CHEBI_47519	ketoconazole	PR_P08684	Cytochrome P450 3A4	is_substrate_of	DIDEO_00000041	drug_central			624	WOMBAT-PK	2017	Ki	7.0
1023	CHEBI_31687	idebenone	PR_P08684	Cytochrome P450 3A4	is_substrate_of	DIDEO_00000041	drug_central			613	DRUG MATRIX	2017	IC50	5.0
1024	CHEBI_3125	bisacodyl, combinations	PR_P11712	Cytochrome P450 2C9	molecularly_interacts_with	RO_0002436	drug_central			819	DRUG MATRIX	2017	IC50	5.0
1025	CHEBI_8405	primaquine	PR_P05177	Cytochrome P450 1A2	molecularly_interacts_with	RO_0002436	drug_central			736	DRUG MATRIX	2017	IC50	6.0
1026	CHEBI_9948	trandolapril and verapamil	PR_P08684	Cytochrome P450 3A4	is_substrate_of	DIDEO_00000041	drug_central			654	IUPHAR	2017	Ki	6.0
1027	CHEBI_48273	rizatriptan	PR_P10635	Cytochrome P450 2D6	is_substrate_of	DIDEO_00000041	drug_central			554	WOMBAT-PK	2017	Ki	4.0
1028	CHEBI_7856	oxybutynin	PR_P33261	Cytochrome P450 2C19	is_substrate_of	DIDEO_00000041	drug_central			377	DRUG MATRIX	2017	IC50	6.0
1029	CHEBI_2663	amiodarone	PR_P08684	Cytochrome P450 3A4	is_substrate_of	DIDEO_00000041	drug_central			574	WOMBAT-PK	2017	Ki	6.0
1030	CHEBI_31624	fluorescein	PR_P33261	Cytochrome P450 2C19	is_substrate_of	DIDEO_00000041	drug_central			352	DRUG MATRIX	2017	IC50	6.0
1031	CHEBI_9123	sertraline	PR_P33261	Cytochrome P450 2C19	molecularly_interacts_with	RO_0002436	drug_central			794	DRUG MATRIX	2017	IC50	6.0
1032	CHEBI_39548	atorvastatin and acetylsalicylic acid	PR_P08684	Cytochrome P450 3A4	molecularly_interacts_with	RO_0002436	drug_central			1007	CHEMBL	2017	IC50	5.0
1033	CHEBI_28593	quinidine, combinations with psycholeptics	PR_P10635	Cytochrome P450 2D6	is_substrate_of	DIDEO_00000041	drug_central			548	SCIENTIFIC LITERATURE	2017	Ki	7.0
1034	CHEBI_3764	clotrimazole	PR_P11712	Cytochrome P450 2C9	molecularly_interacts_with	RO_0002436	drug_central			824	DRUG MATRIX	2017	IC50	7.0
1035	CHEBI_9566	thioridazine	PR_P33261	Cytochrome P450 2C19	molecularly_interacts_with	RO_0002436	drug_central			801	DRUG MATRIX	2017	IC50	5.0
1036	CHEBI_47519	ketoconazole	PR_P05108	Cytochrome P450 11A1	is_substrate_of	DIDEO_00000041	drug_central			286	CHEMBL	2017	IC50	5.0
1037	CHEBI_6402	leflunomide	PR_P05177	Cytochrome P450 1A2	is_substrate_of	DIDEO_00000041	drug_central			310	DRUG MATRIX	2017	IC50	6.0
1038	CHEBI_77780	sulfaphenazole	PR_P11712	Cytochrome P450 2C9	molecularly_interacts_with	RO_0002436	drug_central			876	DRUG MATRIX	2017	IC50	6.0
1039	CHEBI_50692	mifepristone	PR_P08684	Cytochrome P450 3A4	is_substrate_of	DIDEO_00000041	drug_central			632	WOMBAT-PK	2017	Ki	6.0
1040	CHEBI_4754	econazole	PR_P08684	Cytochrome P450 3A4	is_substrate_of	DIDEO_00000041	drug_central			604	DRUG MATRIX	2017	IC50	7.0
1041	CHEBI_8499	propranolol and other combinations	PR_P10635	Cytochrome P450 2D6	molecularly_interacts_with	RO_0002436	drug_central			966	DRUG MATRIX	2017	IC50	5.0
1042	CHEBI_46081	fluconazole	PR_P11712	Cytochrome P450 2C9	is_substrate_of	DIDEO_00000041	drug_central			415	CHEMBL	2017	IC50	4.0
1043	CHEBI_553827	bambuterol	PR_P10635	Cytochrome P450 2D6	molecularly_interacts_with	RO_0002436	drug_central			893	DRUG MATRIX	2017	IC50	5.0
1044	CHEBI_46081	fluconazole	PR_P11712	Cytochrome P450 2C9	molecularly_interacts_with	RO_0002436	drug_central			834	CHEMBL	2017	IC50	4.0
1045	CHEBI_4754	econazole	PR_P05177	Cytochrome P450 1A2	is_substrate_of	DIDEO_00000041	drug_central			306	DRUG MATRIX	2017	IC50	6.0
1046	CHEBI_7494	nefazodone	PR_P08684	Cytochrome P450 3A4	molecularly_interacts_with	RO_0002436	drug_central			1060	IUPHAR	2017	Ki	6.0
1047	CHEBI_6920	mibefradil	PR_P08684	Cytochrome P450 3A4	molecularly_interacts_with	RO_0002436	drug_central			1055	WOMBAT-PK	2017	Ki	6.0
1048	CHEBI_7825	oxiconazole	PR_P08684	Cytochrome P450 3A4	molecularly_interacts_with	RO_0002436	drug_central			1088	DRUG MATRIX	2017	IC50	7.0
1049	CHEBI_6715	medroxyprogesterone and estrogen	PR_P33261	Cytochrome P450 2C19	molecularly_interacts_with	RO_0002436	drug_central			781	DRUG MATRIX	2017	IC50	5.0
1050	CHEBI_3738	clemastine, combinations	PR_P33261	Cytochrome P450 2C19	molecularly_interacts_with	RO_0002436	drug_central			759	DRUG MATRIX	2017	IC50	6.0
1051	CHEBI_45979	tiabendazole	PR_P05177	Cytochrome P450 1A2	molecularly_interacts_with	RO_0002436	drug_central			743	DRUG MATRIX	2017	IC50	6.0
1052	CHEBI_31298	bopindolol	PR_P10635	Cytochrome P450 2D6	is_substrate_of	DIDEO_00000041	drug_central			473	DRUG MATRIX	2017	IC50	5.0
1053	CHEBI_63621	saquinavir	PR_P08684	Cytochrome P450 3A4	molecularly_interacts_with	RO_0002436	drug_central			1076	WOMBAT-PK	2017	IC50	5.0
1054	CHEBI_8461	prednisolone and promethazine	PR_P10635	Cytochrome P450 2D6	is_substrate_of	DIDEO_00000041	drug_central			538	WOMBAT-PK	2017	Ki	5.0
1055	CHEBI_50730	montelukast	PR_P10632	Cytochrome P450 2C8	is_substrate_of	DIDEO_00000041	drug_central			396	WOMBAT-PK	2017	Ki	5.0
1056	CHEBI_4877	ethambutol and isoniazid	PR_P08684	Cytochrome P450 3A4	is_substrate_of	DIDEO_00000041	drug_central			609	WOMBAT-PK	2017	IC50	6.0
1057	CHEBI_3348	candesartan and diuretics	PR_P11712	Cytochrome P450 2C9	molecularly_interacts_with	RO_0002436	drug_central			822	CHEMBL	2017	IC50	5.0
1058	CHEBI_9325	sulconazole	PR_P33261	Cytochrome P450 2C19	is_substrate_of	DIDEO_00000041	drug_central			383	DRUG MATRIX	2017	IC50	7.0
1059	CHEBI_7936	paroxetine	PR_P10635	Cytochrome P450 2D6	molecularly_interacts_with	RO_0002436	drug_central			953	DRUG MATRIX	2017	IC50	6.0
1060	CHEBI_3238	butenafine	PR_P10635	Cytochrome P450 2D6	is_substrate_of	DIDEO_00000041	drug_central			478	DRUG MATRIX	2017	IC50	6.0
1061	CHEBI_63619	propafenone	PR_P10635	Cytochrome P450 2D6	is_substrate_of	DIDEO_00000041	drug_central			541	DRUG MATRIX	2017	IC50	5.0
1062	CHEBI_7459	oxycodone and naloxone	PR_P10635	Cytochrome P450 2D6	molecularly_interacts_with	RO_0002436	drug_central			949	DRUG MATRIX	2017	IC50	5.0
1063	CHEBI_46081	azithromycin, fluconazole and secnidazole	PR_P33261	Cytochrome P450 2C19	molecularly_interacts_with	RO_0002436	drug_central			765	CHEMBL	2017	IC50	5.0
1064	CHEBI_9249	stanozolol	PR_P10635	Cytochrome P450 2D6	is_substrate_of	DIDEO_00000041	drug_central			555	DRUG MATRIX	2017	IC50	5.0
1065	CHEBI_7565	nifedipine and diuretics	PR_P05177	Cytochrome P450 1A2	is_substrate_of	DIDEO_00000041	drug_central			314	DRUG MATRIX	2017	IC50	6.0
1066	CHEBI_9620	tolnaftate	PR_P33261	Cytochrome P450 2C19	is_substrate_of	DIDEO_00000041	drug_central			393	DRUG MATRIX	2017	IC50	5.0
1067	CHEBI_6375	lansoprazole	PR_P33261	Cytochrome P450 2C19	is_substrate_of	DIDEO_00000041	drug_central			357	DRUG MATRIX	2017	IC50	6.0
1068	CHEBI_64318	ergotamine, combinations with psycholeptics	PR_P08684	Cytochrome P450 3A4	molecularly_interacts_with	RO_0002436	drug_central			1033	DRUG MATRIX	2017	IC50	6.0
1069	CHEBI_6375	lansoprazole, amoxicillin and metronidazole	PR_P33261	Cytochrome P450 2C19	molecularly_interacts_with	RO_0002436	drug_central			775	DRUG MATRIX	2017	IC50	6.0
1070	CHEBI_3764	clotrimazole	PR_P08684	Cytochrome P450 3A4	is_substrate_of	DIDEO_00000041	drug_central			593	WOMBAT-PK	2017	IC50	7.0
1071	CHEBI_6375	lansoprazole	PR_P33261	Cytochrome P450 2C19	molecularly_interacts_with	RO_0002436	drug_central			772	DRUG MATRIX	2017	IC50	6.0
1072	CHEBI_4659	disulfiram	PR_P05177	Cytochrome P450 1A2	molecularly_interacts_with	RO_0002436	drug_central			717	DRUG MATRIX	2017	IC50	5.0
1073	CHEBI_6030	rifampicin and isoniazid	PR_P20815	Cytochrome P450 3A5	is_substrate_of	DIDEO_00000041	drug_central			670	WOMBAT-PK	2017	IC50	4.0
1074	CHEBI_6874	methylergometrine and oxytocin	PR_P10635	Cytochrome P450 2D6	is_substrate_of	DIDEO_00000041	drug_central			518	DRUG MATRIX	2017	IC50	6.0
1075	CHEBI_7856	oxybutynin	PR_P33261	Cytochrome P450 2C19	molecularly_interacts_with	RO_0002436	drug_central			792	DRUG MATRIX	2017	IC50	6.0
1076	CHEBI_6030	isoniazid, combinations	PR_P08684	Cytochrome P450 3A4	is_substrate_of	DIDEO_00000041	drug_central			617	WOMBAT-PK	2017	IC50	5.0
1077	CHEBI_3738	clemastine, combinations	PR_P10635	Cytochrome P450 2D6	is_substrate_of	DIDEO_00000041	drug_central			487	WOMBAT-PK	2017	Ki	5.0
1078	CHEBI_9588	ticlopidine	PR_P20813	Cytochrome P450 2B6	is_substrate_of	DIDEO_00000041	drug_central			338	IUPHAR	2017	IC50	6.0
1079	CHEBI_6375	lansoprazole, amoxicillin and levofloxacin	PR_P33261	Cytochrome P450 2C19	is_substrate_of	DIDEO_00000041	drug_central			359	DRUG MATRIX	2017	IC50	6.0
1080	CHEBI_7582	nitrendipine	PR_P33261	Cytochrome P450 2C19	molecularly_interacts_with	RO_0002436	drug_central			787	DRUG MATRIX	2017	IC50	5.0
1081	CHEBI_3125	bisacodyl	PR_P11712	Cytochrome P450 2C9	is_substrate_of	DIDEO_00000041	drug_central			401	DRUG MATRIX	2017	IC50	5.0
1082	CHEBI_8435	prochlorperazine	PR_P10635	Cytochrome P450 2D6	is_substrate_of	DIDEO_00000041	drug_central			536	DRUG MATRIX	2017	IC50	6.0
1083	CHEBI_7936	paroxetine	PR_P10635	Cytochrome P450 2D6	is_substrate_of	DIDEO_00000041	drug_central			530	DRUG MATRIX	2017	IC50	6.0
1084	CHEBI_3753	clomifene	PR_P10635	Cytochrome P450 2D6	is_substrate_of	DIDEO_00000041	drug_central			488	DRUG MATRIX	2017	IC50	5.0
1085	CHEBI_52010	chlorphenamine	PR_P10635	Cytochrome P450 2D6	molecularly_interacts_with	RO_0002436	drug_central			903	WOMBAT-PK	2017	Ki	4.0
1086	CHEBI_7575	nimodipine	PR_P33261	Cytochrome P450 2C19	is_substrate_of	DIDEO_00000041	drug_central			370	DRUG MATRIX	2017	IC50	5.0
1087	CHEBI_6076	itraconazole	PR_P08684	Cytochrome P450 3A4	molecularly_interacts_with	RO_0002436	drug_central			1049	DRUG MATRIX	2017	IC50	6.0
1088	CHEBI_9753	troglitazone	PR_P19224	UDP-glucuronosyltransferase 1-6	molecularly_interacts_with	RO_0002436	drug_central			1119	CHEMBL	2017	Ki	4.0
1089	CHEBI_51164	lisuride	PR_P10635	Cytochrome P450 2D6	is_substrate_of	DIDEO_00000041	drug_central			513	DRUG MATRIX	2017	IC50	7.0
1090	CHEBI_7550	nicardipine	PR_P08684	Cytochrome P450 3A4	is_substrate_of	DIDEO_00000041	drug_central			636	WOMBAT-PK	2017	IC50	6.0
1091	CHEBI_45409	dasabuvir, ombitasvir, paritaprevir and ritonavir	PR_P10635	Cytochrome P450 2D6	is_substrate_of	DIDEO_00000041	drug_central			550	DRUG MATRIX	2017	IC50	4.0
1092	CHEBI_40050	amprenavir	PR_P08684	Cytochrome P450 3A4	molecularly_interacts_with	RO_0002436	drug_central			999	DRUG MATRIX	2017	IC50	6.0
1093	CHEBI_6375	lansoprazole, clarithromycin and tinidazole	PR_P10635	Cytochrome P450 2D6	is_substrate_of	DIDEO_00000041	drug_central			510	DRUG MATRIX	2017	IC50	5.0
1094	CHEBI_10023	voriconazole	PR_P33261	Cytochrome P450 2C19	molecularly_interacts_with	RO_0002436	drug_central			806	CHEMBL	2017	IC50	4.0
1095	CHEBI_3223	buspirone	PR_P08684	Cytochrome P450 3A4	is_substrate_of	DIDEO_00000041	drug_central			587	WOMBAT-PK	2017	Ki	5.0
2503	CHEBI_47519	ketoconazole	PR_P08684	CYP3A4	inhibits	RO_0002449	FDA		178		PL	2017		
1096	CHEBI_50305	podophyllotoxin	PR_P33261	Cytochrome P450 2C19	molecularly_interacts_with	RO_0002436	drug_central			808	DRUG MATRIX	2017	IC50	5.0
1097	CHEBI_7582	enalapril and nitrendipine	PR_P33261	Cytochrome P450 2C19	is_substrate_of	DIDEO_00000041	drug_central			371	DRUG MATRIX	2017	IC50	5.0
1098	CHEBI_9249	stanozolol	PR_P11712	Cytochrome P450 2C9	molecularly_interacts_with	RO_0002436	drug_central			873	DRUG MATRIX	2017	IC50	5.0
1099	CHEBI_9325	sulconazole	PR_P11712	Cytochrome P450 2C9	is_substrate_of	DIDEO_00000041	drug_central			453	DRUG MATRIX	2017	IC50	6.0
1100	CHEBI_48273	rizatriptan	PR_P10635	Cytochrome P450 2D6	molecularly_interacts_with	RO_0002436	drug_central			977	WOMBAT-PK	2017	Ki	4.0
1101	CHEBI_8060	phenelzine	PR_P08684	Cytochrome P450 3A4	molecularly_interacts_with	RO_0002436	drug_central			1068	DRUG MATRIX	2017	IC50	5.0
1102	CHEBI_6030	streptomycin and isoniazid	PR_P08684	Cytochrome P450 3A4	is_substrate_of	DIDEO_00000041	drug_central			621	WOMBAT-PK	2017	IC50	5.0
1103	CHEBI_5296	gemfibrozil	PR_P11712	Cytochrome P450 2C9	molecularly_interacts_with	RO_0002436	drug_central			836	WOMBAT-PK	2017	Ki	4.0
1104	CHEBI_7640	nortriptyline	PR_P33261	Cytochrome P450 2C19	molecularly_interacts_with	RO_0002436	drug_central			788	DRUG MATRIX	2017	IC50	5.0
1105	CHEBI_2675	amoxapine	PR_P10635	Cytochrome P450 2D6	molecularly_interacts_with	RO_0002436	drug_central			889	DRUG MATRIX	2017	IC50	5.0
1106	CHEBI_47519	ketoconazole	PR_P19099	Cytochrome P450 11B2, mitochondrial	is_substrate_of	DIDEO_00000041	drug_central			293	SCIENTIFIC LITERATURE	2017	IC50	7.0
1107	CHEBI_4672	docetaxel	PR_P08684	Cytochrome P450 3A4	is_substrate_of	DIDEO_00000041	drug_central			603	DRUG MATRIX	2017	IC50	5.0
1108	CHEBI_9325	sulconazole	PR_P10635	Cytochrome P450 2D6	is_substrate_of	DIDEO_00000041	drug_central			556	DRUG MATRIX	2017	IC50	6.0
1109	CHEBI_31687	idebenone	PR_P08684	Cytochrome P450 3A4	molecularly_interacts_with	RO_0002436	drug_central			1039	DRUG MATRIX	2017	IC50	5.0
1110	CHEBI_39548	atorvastatin	PR_P08684	Cytochrome P450 3A4	is_substrate_of	DIDEO_00000041	drug_central			579	CHEMBL	2017	IC50	5.0
1111	CHEBI_9168	sirolimus	PR_P33261	Cytochrome P450 2C19	is_substrate_of	DIDEO_00000041	drug_central			380	DRUG MATRIX	2017	IC50	5.0
1112	CHEBI_4026	cyclophosphamide	PR_P08684	Cytochrome P450 3A4	molecularly_interacts_with	RO_0002436	drug_central			1021	WOMBAT-PK	2017	IC50	5.0
1113	CHEBI_6919	mezlocillin	PR_P08684	Cytochrome P450 3A4	molecularly_interacts_with	RO_0002436	drug_central			1054	WOMBAT-PK	2017	IC50	5.0
1114	CHEBI_6919	mezlocillin	PR_P11712	Cytochrome P450 2C9	is_substrate_of	DIDEO_00000041	drug_central			429	WOMBAT-PK	2017	IC50	4.0
1115	CHEBI_6538	loratadine	PR_P33261	Cytochrome P450 2C19	is_substrate_of	DIDEO_00000041	drug_central			364	DRUG MATRIX	2017	IC50	7.0
1116	CHEBI_45409	lopinavir and ritonavir	PR_P08684	Cytochrome P450 3A4	molecularly_interacts_with	RO_0002436	drug_central			1073	WOMBAT-PK	2017	IC50	7.0
1117	CHEBI_45285	pyrazinamide	PR_P20815	Cytochrome P450 3A5	molecularly_interacts_with	RO_0002436	drug_central			1103	WOMBAT-PK	2017	IC50	4.0
1118	CHEBI_6030	thioacetazone and isoniazid	PR_P08684	Cytochrome P450 3A4	molecularly_interacts_with	RO_0002436	drug_central			1048	WOMBAT-PK	2017	IC50	5.0
1119	CHEBI_3348	candesartan and diuretics	PR_P08684	Cytochrome P450 3A4	molecularly_interacts_with	RO_0002436	drug_central			1015	CHEMBL	2017	IC50	5.0
1120	CHEBI_7825	oxiconazole	PR_P11712	Cytochrome P450 2C9	molecularly_interacts_with	RO_0002436	drug_central			884	DRUG MATRIX	2017	IC50	5.0
1121	CHEBI_4877	rifampicin, pyrazinamide, ethambutol and isoniazid	PR_P20815	Cytochrome P450 3A5	is_substrate_of	DIDEO_00000041	drug_central			666	WOMBAT-PK	2017	IC50	4.0
1122	CHEBI_6375	lansoprazole, tetracycline and metronidazole	PR_P33261	Cytochrome P450 2C19	is_substrate_of	DIDEO_00000041	drug_central			363	DRUG MATRIX	2017	IC50	6.0
1123	CHEBI_7565	nifedipine, combinations	PR_P05177	Cytochrome P450 1A2	is_substrate_of	DIDEO_00000041	drug_central			315	DRUG MATRIX	2017	IC50	6.0
1124	CHEBI_37941	clopidogrel	PR_P20813	Cytochrome P450 2B6	is_substrate_of	DIDEO_00000041	drug_central			337	WOMBAT-PK	2017	Ki	6.0
1125	CHEBI_9249	stanozolol	PR_P33261	Cytochrome P450 2C19	is_substrate_of	DIDEO_00000041	drug_central			382	DRUG MATRIX	2017	IC50	7.0
1126	CHEBI_47519	ketoconazole	PR_P08684	Cytochrome P450 3A4	molecularly_interacts_with	RO_0002436	drug_central			1050	WOMBAT-PK	2017	Ki	7.0
1127	CHEBI_5118	fluoxetine and psycholeptics	PR_P10635	Cytochrome P450 2D6	molecularly_interacts_with	RO_0002436	drug_central			920	DRUG MATRIX	2017	IC50	6.0
1128	CHEBI_9757	tropicamide, combinations	PR_P33261	Cytochrome P450 2C19	is_substrate_of	DIDEO_00000041	drug_central			390	DRUG MATRIX	2017	IC50	6.0
1129	CHEBI_37924	atazanavir and cobicistat	PR_P05177	Cytochrome P450 1A2	is_substrate_of	DIDEO_00000041	drug_central			303	WOMBAT-PK	2017	Ki	4.0
1130	CHEBI_8499	propranolol	PR_P10635	Cytochrome P450 2D6	molecularly_interacts_with	RO_0002436	drug_central			965	DRUG MATRIX	2017	IC50	5.0
1131	CHEBI_7465	bupropion and naltrexone	PR_P10635	Cytochrome P450 2D6	molecularly_interacts_with	RO_0002436	drug_central			941	DRUG MATRIX	2017	IC50	6.0
1132	CHEBI_8673	pyrimethamine	PR_P11712	Cytochrome P450 2C9	is_substrate_of	DIDEO_00000041	drug_central			444	WOMBAT-PK	2017	Ki	4.0
1133	CHEBI_9325	sulconazole	PR_P10635	Cytochrome P450 2D6	molecularly_interacts_with	RO_0002436	drug_central			979	DRUG MATRIX	2017	IC50	6.0
1134	CHEBI_47381	diclofenac and antiinfectives	PR_Q9HAW8	UDP-glucuronosyltransferase 1-10	is_substrate_of	DIDEO_00000041	drug_central			686	CHEMBL	2017	Ki	4.0
1135	CHEBI_47381	diclofenac and antiinfectives	PR_O60656	UDP-glucuronosyltransferase 1-9	molecularly_interacts_with	RO_0002436	drug_central			1125	CHEMBL	2017	Ki	4.0
1136	CHEBI_9168	sirolimus	PR_P11712	Cytochrome P450 2C9	molecularly_interacts_with	RO_0002436	drug_central			872	DRUG MATRIX	2017	IC50	5.0
1137	CHEBI_6375	lansoprazole, amoxicillin and levofloxacin	PR_P33261	Cytochrome P450 2C19	molecularly_interacts_with	RO_0002436	drug_central			774	DRUG MATRIX	2017	IC50	6.0
1138	CHEBI_9757	tropicamide, combinations	PR_P11712	Cytochrome P450 2C9	molecularly_interacts_with	RO_0002436	drug_central			880	DRUG MATRIX	2017	IC50	6.0
1139	CHEBI_3738	clemastine, combinations	PR_P10635	Cytochrome P450 2D6	molecularly_interacts_with	RO_0002436	drug_central			908	WOMBAT-PK	2017	Ki	5.0
1140	CHEBI_7772	omeprazole, amoxicillin and metronidazole	PR_P05177	Cytochrome P450 1A2	is_substrate_of	DIDEO_00000041	drug_central			319	WOMBAT-PK	2017	IC50	4.0
1141	CHEBI_68639	abiraterone	PR_P15538	Cytochrome P450 11B1, mitochondrial	molecularly_interacts_with	RO_0002436	drug_central			704	CHEMBL	2017	IC50	5.0
1142	CHEBI_45409	ombitasvir, paritaprevir and ritonavir	PR_P08684	Cytochrome P450 3A4	molecularly_interacts_with	RO_0002436	drug_central			1074	WOMBAT-PK	2017	IC50	7.0
1143	CHEBI_39548	atorvastatin and amlodipine	PR_P08684	Cytochrome P450 3A4	molecularly_interacts_with	RO_0002436	drug_central			1008	CHEMBL	2017	IC50	5.0
1144	CHEBI_5296	gemfibrozil	PR_P10632	Cytochrome P450 2C8	molecularly_interacts_with	RO_0002436	drug_central			810	WOMBAT-PK	2017	Ki	5.0
1145	CHEBI_28462	ajmaline	PR_P10635	Cytochrome P450 2D6	molecularly_interacts_with	RO_0002436	drug_central			887	DRUG MATRIX	2017	IC50	6.0
1146	CHEBI_9325	sulconazole	PR_P08684	Cytochrome P450 3A4	is_substrate_of	DIDEO_00000041	drug_central			651	DRUG MATRIX	2017	IC50	7.0
1147	CHEBI_3181	bromocriptine	PR_P08684	Cytochrome P450 3A4	is_substrate_of	DIDEO_00000041	drug_central			586	DRUG MATRIX	2017	IC50	5.0
1148	CHEBI_7936	paroxetine	PR_P05177	Cytochrome P450 1A2	molecularly_interacts_with	RO_0002436	drug_central			734	WOMBAT-PK	2017	IC50	4.0
1149	CHEBI_47381	diclofenac and antiinfectives	PR_P19224	UDP-glucuronosyltransferase 1-6	molecularly_interacts_with	RO_0002436	drug_central			1117	CHEMBL	2017	Ki	4.0
1150	CHEBI_3753	clomifene	PR_P10635	Cytochrome P450 2D6	molecularly_interacts_with	RO_0002436	drug_central			909	DRUG MATRIX	2017	IC50	5.0
1151	CHEBI_50692	mifepristone	PR_P08684	Cytochrome P450 3A4	molecularly_interacts_with	RO_0002436	drug_central			1058	WOMBAT-PK	2017	Ki	6.0
1152	CHEBI_7772	omeprazole, amoxicillin and clarithromycin	PR_P33261	Cytochrome P450 2C19	is_substrate_of	DIDEO_00000041	drug_central			375	WOMBAT-PK	2017	Ki	5.0
1153	CHEBI_9948	verapamil	PR_P08684	Cytochrome P450 3A4	molecularly_interacts_with	RO_0002436	drug_central			1082	IUPHAR	2017	Ki	6.0
1154	CHEBI_8081	phentolamine	PR_P10635	Cytochrome P450 2D6	is_substrate_of	DIDEO_00000041	drug_central			534	DRUG MATRIX	2017	IC50	5.0
1155	CHEBI_4910	etomidate	PR_P19099	Cytochrome P450 11B2, mitochondrial	is_substrate_of	DIDEO_00000041	drug_central			292	CHEMBL	2017	IC50	10.0
1156	CHEBI_37924	atazanavir	PR_P05177	Cytochrome P450 1A2	is_substrate_of	DIDEO_00000041	drug_central			302	WOMBAT-PK	2017	Ki	4.0
1157	CHEBI_7789	orphenadrine, combinations	PR_P10635	Cytochrome P450 2D6	is_substrate_of	DIDEO_00000041	drug_central			528	DRUG MATRIX	2017	IC50	6.0
1158	CHEBI_135370	aprindine	PR_P10635	Cytochrome P450 2D6	is_substrate_of	DIDEO_00000041	drug_central			469	WOMBAT-PK	2017	Ki	7.0
1159	CHEBI_28462	ajmaline	PR_P10635	Cytochrome P450 2D6	is_substrate_of	DIDEO_00000041	drug_central			465	DRUG MATRIX	2017	IC50	6.0
1160	CHEBI_10023	voriconazole	PR_P08684	Cytochrome P450 3A4	molecularly_interacts_with	RO_0002436	drug_central			1085	CHEMBL	2017	IC50	4.0
1161	CHEBI_6820	methapyrilene	PR_P10635	Cytochrome P450 2D6	is_substrate_of	DIDEO_00000041	drug_central			516	DRUG MATRIX	2017	IC50	5.0
1162	CHEBI_3181	bromocriptine	PR_P08684	Cytochrome P450 3A4	molecularly_interacts_with	RO_0002436	drug_central			1011	DRUG MATRIX	2017	IC50	5.0
1163	CHEBI_45409	dasabuvir, ombitasvir, paritaprevir and ritonavir	PR_P11712	Cytochrome P450 2C9	molecularly_interacts_with	RO_0002436	drug_central			868	DRUG MATRIX	2017	IC50	7.0
1164	CHEBI_45409	ombitasvir, paritaprevir and ritonavir	PR_P08684	Cytochrome P450 3A4	is_substrate_of	DIDEO_00000041	drug_central			647	WOMBAT-PK	2017	IC50	7.0
1165	CHEBI_4754	econazole	PR_P10635	Cytochrome P450 2D6	is_substrate_of	DIDEO_00000041	drug_central			496	DRUG MATRIX	2017	IC50	6.0
1166	CHEBI_2687	amsacrine	PR_P10635	Cytochrome P450 2D6	is_substrate_of	DIDEO_00000041	drug_central			468	WOMBAT-PK	2017	Ki	5.0
1167	CHEBI_7825	oxiconazole	PR_P11712	Cytochrome P450 2C9	is_substrate_of	DIDEO_00000041	drug_central			463	DRUG MATRIX	2017	IC50	5.0
1168	CHEBI_5441	glibenclamide	PR_P11712	Cytochrome P450 2C9	molecularly_interacts_with	RO_0002436	drug_central			837	DRUG MATRIX	2017	IC50	5.0
1169	CHEBI_6532	loperamide, combinations	PR_P10635	Cytochrome P450 2D6	is_substrate_of	DIDEO_00000041	drug_central			515	DRUG MATRIX	2017	IC50	5.0
1170	CHEBI_9720	trihexyphenidyl	PR_P10635	Cytochrome P450 2D6	molecularly_interacts_with	RO_0002436	drug_central			985	DRUG MATRIX	2017	IC50	5.0
1171	CHEBI_39548	atorvastatin	PR_P08684	Cytochrome P450 3A4	molecularly_interacts_with	RO_0002436	drug_central			1003	CHEMBL	2017	IC50	5.0
1172	CHEBI_9620	tolnaftate	PR_P33261	Cytochrome P450 2C19	molecularly_interacts_with	RO_0002436	drug_central			809	DRUG MATRIX	2017	IC50	5.0
1173	CHEBI_6874	methylergometrine	PR_P10635	Cytochrome P450 2D6	is_substrate_of	DIDEO_00000041	drug_central			517	DRUG MATRIX	2017	IC50	6.0
1174	CHEBI_3545	cefapirin	PR_P20815	Cytochrome P450 3A5	molecularly_interacts_with	RO_0002436	drug_central			1091	WOMBAT-PK	2017	IC50	5.0
1175	CHEBI_3994	cyclizine, combinations	PR_P10635	Cytochrome P450 2D6	molecularly_interacts_with	RO_0002436	drug_central			912	DRUG MATRIX	2017	IC50	5.0
1176	CHEBI_101278	diltiazem	PR_P08684	Cytochrome P450 3A4	is_substrate_of	DIDEO_00000041	drug_central			602	DRUG MATRIX	2017	IC50	5.0
1177	CHEBI_6343	labetalol and thiazides	PR_P10635	Cytochrome P450 2D6	molecularly_interacts_with	RO_0002436	drug_central			926	DRUG MATRIX	2017	IC50	6.0
1178	CHEBI_52010	chlorphenamine, combinations	PR_P10635	Cytochrome P450 2D6	is_substrate_of	DIDEO_00000041	drug_central			483	WOMBAT-PK	2017	Ki	4.0
1179	CHEBI_77032	bromhexine	PR_P10635	Cytochrome P450 2D6	is_substrate_of	DIDEO_00000041	drug_central			475	DRUG MATRIX	2017	IC50	6.0
1180	CHEBI_47381	diclofenac, combinations	PR_O60656	UDP-glucuronosyltransferase 1-9	is_substrate_of	DIDEO_00000041	drug_central			698	CHEMBL	2017	Ki	4.0
1181	CHEBI_7582	nitrendipine	PR_P33261	Cytochrome P450 2C19	is_substrate_of	DIDEO_00000041	drug_central			372	DRUG MATRIX	2017	IC50	5.0
2506	CHEBI_5296	gemfibrozil	PR_P08183	P-gp	molecularly_interacts_with	RO_0002436	FDA		520		PL	2017		
1182	CHEBI_4910	etomidate	PR_P15538	Cytochrome P450 11B1, mitochondrial	is_substrate_of	DIDEO_00000041	drug_central			287	CHEMBL	2017	IC50	9.0
1183	CHEBI_31624	fluorescein, combinations	PR_P33261	Cytochrome P450 2C19	molecularly_interacts_with	RO_0002436	drug_central			768	DRUG MATRIX	2017	IC50	6.0
1184	CHEBI_72291	darunavir and cobicistat	PR_P08684	Cytochrome P450 3A	molecularly_interacts_with	RO_0002436	drug_central			993	SCIENTIFIC LITERATURE	2017	Ki	6.0
1185	CHEBI_9325	sulconazole	PR_P08684	Cytochrome P450 3A4	molecularly_interacts_with	RO_0002436	drug_central			1078	DRUG MATRIX	2017	IC50	7.0
1186	CHEBI_64318	ergotamine, combinations with psycholeptics	PR_P08684	Cytochrome P450 3A4	is_substrate_of	DIDEO_00000041	drug_central			607	DRUG MATRIX	2017	IC50	6.0
1187	CHEBI_52010	chlorphenamine	PR_P10635	Cytochrome P450 2D6	is_substrate_of	DIDEO_00000041	drug_central			482	WOMBAT-PK	2017	Ki	4.0
1188	CHEBI_4031	ciclosporin	PR_P08684	Cytochrome P450 3A4	molecularly_interacts_with	RO_0002436	drug_central			1023	WOMBAT-PK	2017	Ki	5.0
1189	CHEBI_31401	cilostazol	PR_P11712	Cytochrome P450 2C9	is_substrate_of	DIDEO_00000041	drug_central			405	DRUG MATRIX	2017	IC50	5.0
1190	CHEBI_9168	sirolimus	PR_P08684	Cytochrome P450 3A4	molecularly_interacts_with	RO_0002436	drug_central			1077	DRUG MATRIX	2017	IC50	5.0
1191	CHEBI_6375	lansoprazole, clarithromycin and tinidazole	PR_P33261	Cytochrome P450 2C19	molecularly_interacts_with	RO_0002436	drug_central			776	DRUG MATRIX	2017	IC50	6.0
1192	CHEBI_8673	artesunate, sulphamethopyrazine and pyrimethamine	PR_P11712	Cytochrome P450 2C9	is_substrate_of	DIDEO_00000041	drug_central			443	WOMBAT-PK	2017	Ki	4.0
1193	CHEBI_2896	astemizole	PR_P08684	Cytochrome P450 3A4	molecularly_interacts_with	RO_0002436	drug_central			1000	WOMBAT-PK	2017	IC50	5.0
1194	CHEBI_9588	ticlopidine	PR_P11509	Cytochrome P450 2A6	is_substrate_of	DIDEO_00000041	drug_central			335	WOMBAT-PK	2017	Ki	6.0
1195	CHEBI_31859	modafinil	PR_P05177	Cytochrome P450 1A2	is_substrate_of	DIDEO_00000041	drug_central			311	WOMBAT-PK	2017	Ki	4.0
1196	CHEBI_7459	naloxone	PR_P10635	Cytochrome P450 2D6	molecularly_interacts_with	RO_0002436	drug_central			948	DRUG MATRIX	2017	IC50	5.0
1197	CHEBI_49575	diazepam	PR_P08684	Cytochrome P450 3A4	molecularly_interacts_with	RO_0002436	drug_central			1025	WOMBAT-PK	2017	Ki	4.0
1198	CHEBI_6375	lansoprazole	PR_P10635	Cytochrome P450 2D6	is_substrate_of	DIDEO_00000041	drug_central			506	DRUG MATRIX	2017	IC50	5.0
1199	CHEBI_45409	dasabuvir, ombitasvir, paritaprevir and ritonavir	PR_P11712	Cytochrome P450 2C9	is_substrate_of	DIDEO_00000041	drug_central			447	DRUG MATRIX	2017	IC50	7.0
1200	CHEBI_3348	candesartan	PR_P08684	Cytochrome P450 3A4	molecularly_interacts_with	RO_0002436	drug_central			1013	CHEMBL	2017	IC50	5.0
1201	CHEBI_9757	tropicamide, combinations	PR_P33261	Cytochrome P450 2C19	molecularly_interacts_with	RO_0002436	drug_central			805	DRUG MATRIX	2017	IC50	6.0
1202	CHEBI_45285	rifampicin, pyrazinamide, ethambutol and isoniazid	PR_P20815	Cytochrome P450 3A5	molecularly_interacts_with	RO_0002436	drug_central			1105	WOMBAT-PK	2017	IC50	4.0
1203	CHEBI_6923	miconazole, combinations	PR_P11712	Cytochrome P450 2C9	is_substrate_of	DIDEO_00000041	drug_central			431	DRUG MATRIX	2017	IC50	6.0
1204	CHEBI_8499	propranolol	PR_P05177	Cytochrome P450 1A2	molecularly_interacts_with	RO_0002436	drug_central			739	DRUG MATRIX	2017	IC50	5.0
1205	CHEBI_45409	lopinavir and ritonavir	PR_P11712	Cytochrome P450 2C9	is_substrate_of	DIDEO_00000041	drug_central			448	DRUG MATRIX	2017	IC50	7.0
1206	CHEBI_6030	thioacetazone and isoniazid	PR_P08684	Cytochrome P450 3A4	is_substrate_of	DIDEO_00000041	drug_central			622	WOMBAT-PK	2017	IC50	5.0
1207	CHEBI_6343	labetalol	PR_P10635	Cytochrome P450 2D6	is_substrate_of	DIDEO_00000041	drug_central			503	DRUG MATRIX	2017	IC50	6.0
1208	CHEBI_47381	diclofenac	PR_Q9HAW7	UDP-glucuronosyltransferase 1-7	is_substrate_of	DIDEO_00000041	drug_central			692	CHEMBL	2017	Ki	4.0
1209	CHEBI_8461	promethazine, combinations	PR_P10635	Cytochrome P450 2D6	molecularly_interacts_with	RO_0002436	drug_central			963	WOMBAT-PK	2017	Ki	5.0
1210	CHEBI_7575	nimodipine	PR_P33261	Cytochrome P450 2C19	molecularly_interacts_with	RO_0002436	drug_central			785	DRUG MATRIX	2017	IC50	5.0
1211	CHEBI_7565	nifedipine	PR_P08684	Cytochrome P450 3A4	is_substrate_of	DIDEO_00000041	drug_central			637	WOMBAT-PK	2017	IC50	5.0
1212	CHEBI_6375	lansoprazole, clarithromycin and tinidazole	PR_P33261	Cytochrome P450 2C19	is_substrate_of	DIDEO_00000041	drug_central			361	DRUG MATRIX	2017	IC50	6.0
1213	CHEBI_135590	ambroxol	PR_P10635	Cytochrome P450 2D6	is_substrate_of	DIDEO_00000041	drug_central			466	DRUG MATRIX	2017	IC50	6.0
1214	CHEBI_44915	propofol	PR_P11712	Cytochrome P450 2C9	is_substrate_of	DIDEO_00000041	drug_central			442	WOMBAT-PK	2017	IC50	4.0
1215	CHEBI_45285	pyrazinamide	PR_P08684	Cytochrome P450 3A4	molecularly_interacts_with	RO_0002436	drug_central			1069	WOMBAT-PK	2017	IC50	6.0
1216	CHEBI_45285	rifampicin, pyrazinamide and isoniazid	PR_P08684	Cytochrome P450 3A4	is_substrate_of	DIDEO_00000041	drug_central			643	WOMBAT-PK	2017	IC50	6.0
1217	CHEBI_6762	mepyramine	PR_P10635	Cytochrome P450 2D6	is_substrate_of	DIDEO_00000041	drug_central			545	DRUG MATRIX	2017	IC50	6.0
1218	CHEBI_41423	celecoxib	PR_P10635	Cytochrome P450 2D6	is_substrate_of	DIDEO_00000041	drug_central			480	DRUG MATRIX	2017	IC50	6.0
1219	CHEBI_7772	omeprazole, amoxicillin and metronidazole	PR_P11712	Cytochrome P450 2C9	molecularly_interacts_with	RO_0002436	drug_central			859	WOMBAT-PK	2017	Ki	4.0
1220	CHEBI_9566	thioridazine	PR_P05177	Cytochrome P450 1A2	molecularly_interacts_with	RO_0002436	drug_central			744	DRUG MATRIX	2017	IC50	5.0
1221	CHEBI_39548	atorvastatin and ezetimibe	PR_P08684	Cytochrome P450 3A4	is_substrate_of	DIDEO_00000041	drug_central			585	CHEMBL	2017	IC50	5.0
1222	CHEBI_4877	ethambutol	PR_P20815	Cytochrome P450 3A5	molecularly_interacts_with	RO_0002436	drug_central			1092	WOMBAT-PK	2017	IC50	4.0
1223	CHEBI_3545	cefapirin	PR_P10635	Cytochrome P450 2D6	molecularly_interacts_with	RO_0002436	drug_central			902	WOMBAT-PK	2017	IC50	4.0
1224	CHEBI_8426	probenecid	PR_Q9HAW7	UDP-glucuronosyltransferase 1-7	is_substrate_of	DIDEO_00000041	drug_central			695	CHEMBL	2017	Ki	4.0
1225	CHEBI_10093	yohimbine	PR_P10635	Cytochrome P450 2D6	is_substrate_of	DIDEO_00000041	drug_central			564	DRUG MATRIX	2017	IC50	5.0
1226	CHEBI_17698	chloramphenicol	PR_P08684	Cytochrome P450 3A4	molecularly_interacts_with	RO_0002436	drug_central			1017	WOMBAT-PK	2017	IC50	4.0
1227	CHEBI_3125	bisacodyl	PR_P11712	Cytochrome P450 2C9	molecularly_interacts_with	RO_0002436	drug_central			818	DRUG MATRIX	2017	IC50	5.0
1228	CHEBI_8060	phenelzine	PR_P10632	Cytochrome P450 2C8	molecularly_interacts_with	RO_0002436	drug_central			814	IUPHAR	2017	Ki	5.0
1229	CHEBI_585948	ramipril and felodipine	PR_P11712	Cytochrome P450 2C9	is_substrate_of	DIDEO_00000041	drug_central			411	DRUG MATRIX	2017	IC50	5.0
1230	CHEBI_480999	vinorelbine	PR_P08684	Cytochrome P450 3A4	is_substrate_of	DIDEO_00000041	drug_central			657	DRUG MATRIX	2017	IC50	6.0
1231	CHEBI_7772	omeprazole	PR_P11712	Cytochrome P450 2C9	molecularly_interacts_with	RO_0002436	drug_central			857	WOMBAT-PK	2017	Ki	4.0
1232	CHEBI_68639	abiraterone	PR_P19099	Cytochrome P450 11B2, mitochondrial	is_substrate_of	DIDEO_00000041	drug_central			296	CHEMBL	2017	IC50	5.0
1233	CHEBI_68639	abiraterone	PR_P08684	Cytochrome P450 3A4	is_substrate_of	DIDEO_00000041	drug_central			662	CHEMBL	2017	IC50	5.0
1234	CHEBI_7443	nabumetone	PR_P05177	Cytochrome P450 1A2	molecularly_interacts_with	RO_0002436	drug_central			725	DRUG MATRIX	2017	IC50	5.0
1235	CHEBI_9948	verapamil, combinations	PR_P08684	Cytochrome P450 3A4	molecularly_interacts_with	RO_0002436	drug_central			1083	IUPHAR	2017	Ki	6.0
1236	CHEBI_4026	cyclophosphamide	PR_P08684	Cytochrome P450 3A4	is_substrate_of	DIDEO_00000041	drug_central			595	WOMBAT-PK	2017	IC50	5.0
1237	CHEBI_50199	pefloxacin	PR_P05177	Cytochrome P450 1A2	molecularly_interacts_with	RO_0002436	drug_central			735	WOMBAT-PK	2017	Ki	4.0
1238	CHEBI_9652	tranylcypromine	PR_P11509	Cytochrome P450 2A6	is_substrate_of	DIDEO_00000041	drug_central			336	WOMBAT-PK	2017	Ki	7.0
1239	CHEBI_135737	lacidipine	PR_P33261	Cytochrome P450 2C19	molecularly_interacts_with	RO_0002436	drug_central			771	DRUG MATRIX	2017	IC50	5.0
1240	CHEBI_63619	propafenone	PR_P05177	Cytochrome P450 1A2	molecularly_interacts_with	RO_0002436	drug_central			738	DRUG MATRIX	2017	IC50	5.0
1241	CHEBI_47381	diclofenac, combinations	PR_Q9HAW7	UDP-glucuronosyltransferase 1-7	is_substrate_of	DIDEO_00000041	drug_central			694	CHEMBL	2017	Ki	4.0
1242	CHEBI_585948	metoprolol and felodipine	PR_P11712	Cytochrome P450 2C9	molecularly_interacts_with	RO_0002436	drug_central			829	DRUG MATRIX	2017	IC50	5.0
1243	CHEBI_8435	prochlorperazine	PR_P05177	Cytochrome P450 1A2	molecularly_interacts_with	RO_0002436	drug_central			737	DRUG MATRIX	2017	IC50	5.0
1244	CHEBI_45285	rifampicin, pyrazinamide and isoniazid	PR_P20815	Cytochrome P450 3A5	is_substrate_of	DIDEO_00000041	drug_central			676	WOMBAT-PK	2017	IC50	4.0
1245	CHEBI_6149	levobupivacaine	PR_P10635	Cytochrome P450 2D6	is_substrate_of	DIDEO_00000041	drug_central			464	DRUG MATRIX	2017	IC50	6.0
1246	CHEBI_9123	sertraline	PR_P33261	Cytochrome P450 2C19	is_substrate_of	DIDEO_00000041	drug_central			379	DRUG MATRIX	2017	IC50	6.0
1247	CHEBI_44241	metyrapone	PR_P08684	Cytochrome P450 3A4	molecularly_interacts_with	RO_0002436	drug_central			1053	DRUG MATRIX	2017	IC50	6.0
1248	CHEBI_132922	ibuprofen	PR_P11712	Cytochrome P450 2C9	molecularly_interacts_with	RO_0002436	drug_central			839	WOMBAT-PK	2017	Ki	4.0
1249	CHEBI_7465	bupropion and naltrexone	PR_P10635	Cytochrome P450 2D6	is_substrate_of	DIDEO_00000041	drug_central			519	DRUG MATRIX	2017	IC50	6.0
1250	CHEBI_47381	diclofenac	PR_Q9HAW7	UDP-glucuronosyltransferase 1-7	molecularly_interacts_with	RO_0002436	drug_central			1120	CHEMBL	2017	Ki	4.0
1251	CHEBI_6923	miconazole, combinations	PR_P33261	Cytochrome P450 2C19	molecularly_interacts_with	RO_0002436	drug_central			784	DRUG MATRIX	2017	IC50	7.0
1252	CHEBI_6030	isoniazid	PR_P08684	Cytochrome P450 3A4	is_substrate_of	DIDEO_00000041	drug_central			616	WOMBAT-PK	2017	IC50	5.0
1253	CHEBI_6030	rifampicin, pyrazinamide, ethambutol and isoniazid	PR_P20815	Cytochrome P450 3A5	molecularly_interacts_with	RO_0002436	drug_central			1100	WOMBAT-PK	2017	IC50	4.0
1254	CHEBI_44241	metyrapone	PR_P15538	Cytochrome P450 11B1, mitochondrial	is_substrate_of	DIDEO_00000041	drug_central			290	CHEMBL	2017	IC50	7.0
1255	CHEBI_3219	bupropion and naltrexone	PR_P33261	Cytochrome P450 2C19	is_substrate_of	DIDEO_00000041	drug_central			342	DRUG MATRIX	2017	IC50	5.0
1256	CHEBI_5296	gemfibrozil	PR_P10632	Cytochrome P450 2C8	is_substrate_of	DIDEO_00000041	drug_central			394	WOMBAT-PK	2017	Ki	5.0
1257	CHEBI_47381	diclofenac	PR_P22309	UDP-glucuronosyltransferase 1-1	molecularly_interacts_with	RO_0002436	drug_central			1110	CHEMBL	2017	Ki	4.0
1258	CHEBI_6541	losartan and amlodipine	PR_P11712	Cytochrome P450 2C9	is_substrate_of	DIDEO_00000041	drug_central			424	DRUG MATRIX	2017	IC50	5.0
1259	CHEBI_8459	promazine	PR_P10635	Cytochrome P450 2D6	molecularly_interacts_with	RO_0002436	drug_central			960	DRUG MATRIX	2017	IC50	6.0
1260	CHEBI_7465	naltrexone	PR_P10635	Cytochrome P450 2D6	is_substrate_of	DIDEO_00000041	drug_central			520	DRUG MATRIX	2017	IC50	6.0
1261	CHEBI_5062	finasteride	PR_P11712	Cytochrome P450 2C9	is_substrate_of	DIDEO_00000041	drug_central			413	DRUG MATRIX	2017	IC50	5.0
1262	CHEBI_47381	diclofenac and antiinfectives	PR_O60656	UDP-glucuronosyltransferase 1-9	is_substrate_of	DIDEO_00000041	drug_central			697	CHEMBL	2017	Ki	4.0
1263	CHEBI_39548	atorvastatin and ezetimibe	PR_P08684	Cytochrome P450 3A4	molecularly_interacts_with	RO_0002436	drug_central			1009	CHEMBL	2017	IC50	5.0
1264	CHEBI_9588	ticlopidine	PR_P10635	Cytochrome P450 2D6	molecularly_interacts_with	RO_0002436	drug_central			983	DRUG MATRIX	2017	IC50	5.0
1265	CHEBI_4636	diphenhydramine	PR_P10635	Cytochrome P450 2D6	is_substrate_of	DIDEO_00000041	drug_central			492	WOMBAT-PK	2017	Ki	4.0
1266	CHEBI_3994	cyclizine, combinations	PR_P10635	Cytochrome P450 2D6	is_substrate_of	DIDEO_00000041	drug_central			491	DRUG MATRIX	2017	IC50	5.0
1267	CHEBI_7772	omeprazole	PR_P33261	Cytochrome P450 2C19	molecularly_interacts_with	RO_0002436	drug_central			789	WOMBAT-PK	2017	Ki	5.0
1268	CHEBI_3215	bupivacaine	PR_P10635	Cytochrome P450 2D6	molecularly_interacts_with	RO_0002436	drug_central			897	DRUG MATRIX	2017	IC50	6.0
1269	CHEBI_3545	cefapirin	PR_P20815	Cytochrome P450 3A5	is_substrate_of	DIDEO_00000041	drug_central			663	WOMBAT-PK	2017	IC50	5.0
1270	CHEBI_9546	thiomersal	PR_P10635	Cytochrome P450 2D6	molecularly_interacts_with	RO_0002436	drug_central			989	DRUG MATRIX	2017	IC50	5.0
1271	CHEBI_3374	capsaicin	PR_P05177	Cytochrome P450 1A2	is_substrate_of	DIDEO_00000041	drug_central			331	DRUG MATRIX	2017	IC50	5.0
1272	CHEBI_8435	prochlorperazine	PR_P10635	Cytochrome P450 2D6	molecularly_interacts_with	RO_0002436	drug_central			959	DRUG MATRIX	2017	IC50	6.0
1273	CHEBI_6375	lansoprazole	PR_P10635	Cytochrome P450 2D6	molecularly_interacts_with	RO_0002436	drug_central			927	DRUG MATRIX	2017	IC50	5.0
1274	CHEBI_47381	diclofenac	PR_P19224	UDP-glucuronosyltransferase 1-6	is_substrate_of	DIDEO_00000041	drug_central			688	CHEMBL	2017	Ki	4.0
1275	CHEBI_5062	finasteride	PR_P33261	Cytochrome P450 2C19	molecularly_interacts_with	RO_0002436	drug_central			764	DRUG MATRIX	2017	IC50	6.0
1276	CHEBI_8060	phenelzine	PR_P33261	Cytochrome P450 2C19	molecularly_interacts_with	RO_0002436	drug_central			793	DRUG MATRIX	2017	IC50	6.0
1277	CHEBI_6923	miconazole	PR_P11712	Cytochrome P450 2C9	molecularly_interacts_with	RO_0002436	drug_central			851	DRUG MATRIX	2017	IC50	6.0
1278	CHEBI_64318	ergotamine, combinations excl. psycholeptics	PR_P08684	Cytochrome P450 3A4	is_substrate_of	DIDEO_00000041	drug_central			606	DRUG MATRIX	2017	IC50	6.0
1279	CHEBI_9453	terfenadine	PR_P51589	Cytochrome P450 2J2	is_substrate_of	DIDEO_00000041	drug_central			567	CHEMBL	2017	IC50	5.0
1280	CHEBI_46081	azithromycin, fluconazole and secnidazole	PR_P11712	Cytochrome P450 2C9	is_substrate_of	DIDEO_00000041	drug_central			414	CHEMBL	2017	IC50	4.0
1281	CHEBI_4638	benproperine	PR_P10635	Cytochrome P450 2D6	is_substrate_of	DIDEO_00000041	drug_central			472	DRUG MATRIX	2017	IC50	6.0
1282	CHEBI_7789	orphenadrine (citrate)	PR_P10635	Cytochrome P450 2D6	is_substrate_of	DIDEO_00000041	drug_central			527	DRUG MATRIX	2017	IC50	6.0
1283	CHEBI_7772	omeprazole, amoxicillin and clarithromycin	PR_P11712	Cytochrome P450 2C9	is_substrate_of	DIDEO_00000041	drug_central			437	WOMBAT-PK	2017	Ki	4.0
1284	CHEBI_17688	nicotine	PR_P11509	Cytochrome P450 2A6	molecularly_interacts_with	RO_0002436	drug_central			749	WOMBAT-PK	2017	IC50	5.0
1285	CHEBI_9546	thiomersal	PR_P10635	Cytochrome P450 2D6	is_substrate_of	DIDEO_00000041	drug_central			566	DRUG MATRIX	2017	IC50	5.0
1286	CHEBI_85078	metformin and dapagliflozin	PR_P31639	Sodium/glucose cotransporter 2	molecularly_interacts_with	RO_0002436	drug_central			1136	CHEMBL	2017	EC50	8.0
1287	CHEBI_77780	sulfafenazol	PR_P11712	Cytochrome P450 2C9	molecularly_interacts_with	RO_0002436	drug_central			875	DRUG MATRIX	2017	IC50	6.0
1288	CHEBI_7459	hydromorphone and naloxone	PR_P10635	Cytochrome P450 2D6	is_substrate_of	DIDEO_00000041	drug_central			524	DRUG MATRIX	2017	IC50	5.0
1289	CHEBI_4672	docetaxel	PR_P08684	Cytochrome P450 3A4	molecularly_interacts_with	RO_0002436	drug_central			1029	DRUG MATRIX	2017	IC50	5.0
2169	CHEBI_38545	rosuvastatin	PR_Q9NPD5	OATP1B3	transports	RO_0002020	FDA		778		"15289793"	2017	auc_percent_change	608.2000122070312
2170	CHEBI_64022	d-nebivolol	PR_P10635	CYP2D6	is_substrate_of	DIDEO_00000041	FDA		594		NDA 021742	2017	auc_percent_change	726.5
2171	CHEBI_68595	telaprevir	PR_P08684	CYP3A4	is_substrate_of	DIDEO_00000041	FDA		692		NDA 201917	2017	auc_percent_change	219.8000030517578
2175	CHEBI_136049	mirodenafil-not approved in US	PR_P08684	CYP3A4	is_substrate_of	DIDEO_00000041	FDA		633		"20110038"	2017	auc_percent_change	389.29998779296875
2178	CHEBI_50122	rosiglitazone	PR_P10632	CYP2C8	is_substrate_of	DIDEO_00000041	FDA		676		"12898007"	2017	auc_percent_change	129.0
2180	CHEBI_63660	pravastatin	PR_Q8TCC7	OAT3	is_substrate_of	DIDEO_00000041	FDA		761		"8356729"	2017	auc_percent_change	2183.5
2182	CHEBI_73275	ospemifene	PR_P08684	CYP3A4	is_substrate_of	DIDEO_00000041	FDA		644		"23852652"	2017	auc_percent_change	178.1999969482422
2184	CHEBI_28445	vincristine	PR_P08684	CYP3A4	is_substrate_of	DIDEO_00000041	FDA		707		"2790693"	2017	auc_percent_change	244.8000030517578
2185	CHEBI_8805	repaglinide	PR_P08183	P-gp	transports	RO_0002020	FDA		768		"12687332"	2017	auc_percent_change	1830.4000244140625
2188	CHEBI_47657	roflumilast	PR_P05177	CYP1A2	is_substrate_of	DIDEO_00000041	FDA		674		"17596106"	2017	auc_percent_change	155.39999389648438
2190	CHEBI_5050	fexofenadine	PR_O15245	OCT1	transports	RO_0002020	FDA		931			2017	auc_percent_change	4.840000152587891
2191	PC_3009355	vicriviroc-not approved in US	PR_P08684	CYP3A4	is_substrate_of	DIDEO_00000041	FDA		706		"21348539"	2017	auc_percent_change	437.3999938964844
2196	CHEBI_63632	topotecan	PR_Q9UNQ0	BCRP	is_substrate_of	DIDEO_00000041	FDA		794		"12089223"	2017	auc_percent_change	142.89999389648438
2197	CHEBI_136049	mirodenafil-not approved in US	PR_P10635	CYP2D6	is_substrate_of	DIDEO_00000041	FDA		632		"20110038"	2017	auc_percent_change	389.29998779296875
2198	CHEBI_70735	lurasidone	PR_P08183	P-gp	transports	RO_0002020	FDA		835		NDA 200603	2017	auc_percent_change	830.0
2203	CHEBI_3558	cerivastatin	PR_Q9UNQ0	BCRP	is_substrate_of	DIDEO_00000041	FDA		724		"10096257"	2017	auc_percent_change	375.29998779296875
2211	CHEBI_82960	raltegravir	PR_P08183	P-gp	transports	RO_0002020	FDA		765		"19143531"	2017	auc_percent_change	210.89999389648438
2214	CHEBI_135949	ambrisentan	PR_P33261	CYP2C19	is_substrate_of	DIDEO_00000041	FDA		565		"20811346"	2017	auc_percent_change	121.30000305175781
2215	CHEBI_32246	tolvaptan	PR_P08183	P-gp	transports	RO_0002020	FDA		841		"21988334"	2017	auc_percent_change	439.70001220703125
2218	CHEBI_71200	tofacitinib	PR_P08183	P-gp	transports	RO_0002020	FDA		790		NDA 203214	2017	auc_percent_change	103.19999694824219
2221	CHEBI_6931	midazolam (iv)	PR_P08684	CYP3A4	is_substrate_of	DIDEO_00000041	FDA		809		"19302901"	2017	auc_percent_change	686.7999877929688
2224	CHEBI_36796	duloxetine	PR_P10635	"2D6"	is_substrate_of	DIDEO_00000041	FDA		598		"18307373"	2017	auc_percent_change	460.0
2232	CHEBI_63660	pravastatin	PR_Q8TCC7	OAT3	transports	RO_0002020	FDA		924			2017	auc_percent_change	22.84000015258789
2234	CHEBI_63632	topotecan	PR_Q86VL8	MATE2K	transports	RO_0002020	FDA		792		"12089223"	2017	auc_percent_change	142.89999389648438
2239	CHEBI_6541	losartan	PR_P11712	CYP2C9	is_substrate_of	DIDEO_00000041	FDA		626		"19221727"	2017	auc_percent_change	108.5
2241	CHEBI_3558	cerivastatin	PR_P10632	CYP2C8	is_substrate_of	DIDEO_00000041	FDA		581		"10096257"	2017	auc_percent_change	375.29998779296875
2245	CHEBI_3655	chlorzoxazone	PR_P05177	CYP1A2	is_substrate_of	DIDEO_00000041	FDA		584		"10579149"	2017	auc_percent_change	691.7999877929688
2246	CHEBI_66910	axitinib	PR_P08684	CYP3A	is_substrate_of	DIDEO_00000041	FDA		574		"20740300"	2017	auc_percent_change	105.80000305175781
2250	CHEBI_70735	lurasidone	PR_P08684	CYP3A4	is_substrate_of	DIDEO_00000041	FDA		806		NDA 200603	2017	auc_percent_change	830.0
2252	CHEBI_50659	dronedarone	PR_P08183	P-gp	transports	RO_0002020	FDA		830		NDA 022425	2017	auc_percent_change	2383.300048828125
2255	CHEBI_31547	eplerenone	PR_P08684	CYP3A4	is_substrate_of	DIDEO_00000041	FDA		813		"15204695"	2017	auc_percent_change	438.70001220703125
2256	CHEBI_5050	fexofenadine	PR_P08183	P-gp	transports	RO_0002020	FDA		934			2017	auc_percent_change	4.840000152587891
2257	CHEBI_72297	lomitapide	PR_P08684	CYP3A4	is_substrate_of	DIDEO_00000041	FDA		800		NDA 203858	2017	auc_percent_change	2626.199951171875
2262	CHEBI_7772	(S)-omeprazole 	PR_Q14242	P-gp(omeprazole)	transports	RO_0002020	FDA		711		"16550734"	2017	auc_percent_change	127.19999694824219
2264	CHEBI_72297	lomitapide	PR_P05177	CYP1A2	is_substrate_of	DIDEO_00000041	FDA		623		NDA 203858	2017	auc_percent_change	2626.199951171875
2265	CHEBI_87681	ranolazine	PR_P08183	P-gp	transports	RO_0002020	FDA		847		"15778423"	2017	auc_percent_change	264.29998779296875
2267	CHEBI_68579	rivaroxaban	PR_Q9UNQ0	BCRP	transports	RO_0002020	FDA		928			2017	auc_percent_change	2.5799999237060547
2269	CHEBI_68558	ticagrelor	PR_P08684	CYP3A4	is_substrate_of	DIDEO_00000041	FDA		696		"022433�"	2017	auc_percent_change	632.0
2278	CHEBI_87681	ranolazine	PR_P10635	CYP2D6	is_substrate_of	DIDEO_00000041	FDA		664		"15778423"	2017	auc_percent_change	264.29998779296875
2282	CHEBI_48390	cinacalcet	PR_P08183	P-gp	transports	RO_0002020	FDA		856		"17518508"	2017	auc_percent_change	102.9000015258789
2283	CHEBI_9139	sildenafil	PR_P08183	P-gp	transports	RO_0002020	FDA		780		"10930961"	2017	auc_percent_change	889.4000244140625
2284	CHEBI_49603	lapatinib	PR_P08183	P-gp	transports	RO_0002020	FDA		845		"19371315"	2017	auc_percent_change	266.79998779296875
2287	CHEBI_63632	topotecan	PR_Q9UNQ0	BCRP	transports	RO_0002020	FDA		920			2017	auc_percent_change	2.430000066757202
2290	CHEBI_7772	omeprazole	PR_P08183	P-gp	transports	RO_0002020	FDA		755		"11932962"	2017	auc_percent_change	529.2999877929688
2291	CHEBI_71200	tofacitinib	PR_P08684	CYP3A4	is_substrate_of	DIDEO_00000041	FDA		826		NDA 203214	2017	auc_percent_change	103.19999694824219
2294	CHEBI_135929	silodosin	PR_P08183	P-gp	transports	RO_0002020	FDA		782		NDA 22206	2017	auc_percent_change	208.60000610351562
2298	CHEBI_31236	aripiprazole	PR_P08684	CYP3A4	is_substrate_of	DIDEO_00000041	FDA		568		"21739267"	2017	auc_percent_change	136.10000610351562
2299	CHEBI_68579	rivaroxaban	PR_P08183	P-gp	transports	RO_0002020	FDA		771		"23305158"	2017	auc_percent_change	157.60000610351562
2300	CHEBI_68534	enzalutamide	PR_P08684	CYP3A4	is_substrate_of	DIDEO_00000041	FDA		604		NDA 203415	2017	auc_percent_change	325.5
2303	CHEBI_66901	ivacaftor	PR_P08684	CYP3A4	is_substrate_of	DIDEO_00000041	FDA		807		NDA 203188	2017	auc_percent_change	745.0
2305	CHEBI_9168	sirolimus	PR_Q9NPD5	OATP1B3	transports	RO_0002020	FDA		784		"23408534"	2017	auc_percent_change	2512.300048828125
2307	CHEBI_52172	nilotinib	PR_P08684	CYP3A4	is_substrate_of	DIDEO_00000041	FDA		819		"20702754"	2017	auc_percent_change	210.60000610351562
2308	CHEBI_72297	lomitapide	PR_P08684	CYP3A4	is_substrate_of	DIDEO_00000041	FDA		625		NDA 203858	2017	auc_percent_change	2626.199951171875
2311	CHEBI_66876	avanafil	PR_P08183	P-gp	transports	RO_0002020	FDA		832		NDA 202276	2017	auc_percent_change	1183.199951171875
2313	CHEBI_68478	everolimus	PR_P08183	P-gp	transports	RO_0002020	FDA		730		"15831774"	2017	auc_percent_change	1371.0999755859375
2314	CHEBI_38545	rosuvastatin	PR_Q9UNQ0	BCRP	is_substrate_of	DIDEO_00000041	FDA		774		"15289793"	2017	auc_percent_change	608.2000122070312
2316	CHEBI_6375	lansoprazole	PR_P33261	CYP2C19	is_substrate_of	DIDEO_00000041	FDA		616		"15496639"	2017	auc_percent_change	282.70001220703125
2317	CHEBI_72297	lomitapide	PR_P20813	CYP2B6	is_substrate_of	DIDEO_00000041	FDA		624		NDA 203858	2017	auc_percent_change	2626.199951171875
2318	CHEBI_68621	boceprevir	PR_Q9UNQ0	BCRP	is_substrate_of	DIDEO_00000041	FDA		720		NDA 202258	2017	auc_percent_change	119.9000015258789
2319	CHEBI_61049	tacrolimus	PR_P08684	CYP3A	is_substrate_of	DIDEO_00000041	FDA		688		"21618566"	2017	auc_percent_change	7697.60009765625
2321	CHEBI_28445	vincristine	PR_P08183	P-gp	transports	RO_0002020	FDA		796		"2790693"	2017	auc_percent_change	244.8000030517578
2322	CHEBI_71940	tadalafil	PR_P08684	CYP3A4	is_substrate_of	DIDEO_00000041	FDA		814		NDA 021368	2017	auc_percent_change	311.5
2325	PC_3009355	vicriviroc-not approved in US	PR_P11712	CYP2C9	is_substrate_of	DIDEO_00000041	FDA		704		"21348539"	2017	auc_percent_change	437.3999938964844
2326	CHEBI_9139	sildenafil	PR_P08684	CYP3A4	is_substrate_of	DIDEO_00000041	FDA		682		"10930961"	2017	auc_percent_change	889.4000244140625
2328	CHEBI_66910	axitinib	PR_P08684	CYP3A4	is_substrate_of	DIDEO_00000041	FDA		825		"20740300"	2017	auc_percent_change	105.80000305175781
2330	CHEBI_38561	fluvastatin	PR_P08684	CYP3A4	is_substrate_of	DIDEO_00000041	FDA		611		"11907637"	2017	auc_percent_change	254.6999969482422
2334	CHEBI_63632	topotecan	PR_P08183	P-gp	transports	RO_0002020	FDA		795		"12089223"	2017	auc_percent_change	142.89999389648438
2336	PC_3009355	vicriviroc-not approved in US	PR_P20815	CYP3A5	is_substrate_of	DIDEO_00000041	FDA		705		"21348539"	2017	auc_percent_change	437.3999938964844
2337	CHEBI_72289	elvitegravir (GS-9137)	PR_P22309	UGT1A1/3	is_substrate_of	DIDEO_00000041	FDA		602		NDA 203100	2017	auc_percent_change	1888.300048828125
2339	CHEBI_135967	casopitant	PR_P08183	P-gp	transports	RO_0002020	FDA		833		"20124517"	2017	auc_percent_change	1106.300048828125
2340	CHEBI_32246	tolvaptan	PR_P08183	P-gp	transports	RO_0002020	FDA		791		"21988334"	2017	auc_percent_change	439.70001220703125
2342	CHEBI_71200	tofacitinib	PR_P08684	CYP3A4	is_substrate_of	DIDEO_00000041	FDA		699		NDA 203214	2017	auc_percent_change	103.19999694824219
2345	CHEBI_72296	apixaban	PR_P08183	P-gp	transports	RO_0002020	FDA		937			2017	auc_percent_change	1.9900000095367432
2346	CHEBI_71200	tofacitinib	PR_P33261	CYP2C19	is_substrate_of	DIDEO_00000041	FDA		700		NDA 203214	2017	auc_percent_change	103.19999694824219
2347	CHEBI_38561	fluvastatin	PR_P11712	CYP2C9	is_substrate_of	DIDEO_00000041	FDA		609		"11907637"	2017	auc_percent_change	254.6999969482422
2348	CHEBI_63608	maraviroc	PR_Q9Y6L6	OATP1B1	transports	RO_0002020	FDA		750		"18333864"	2017	auc_percent_change	897.9000244140625
2350	CHEBI_65173	iloperidone	PR_P10635	CYP2D6	is_substrate_of	DIDEO_00000041	FDA		612		NDA 022192	2017	auc_percent_change	131.39999389648438
2301	CHEBI_8426	probenecid	PR_O15245	OCT1	molecularly_interacts_with	RO_0002436	FDA		358		PL	2017		
2352	CHEBI_9168	sirolimus	PR_P08684	CYP3A4	is_substrate_of	DIDEO_00000041	FDA		687		"23408534"	2017	auc_percent_change	2512.300048828125
2354	CHEBI_40050	amprenavir	PR_P08684	CYP3A4	is_substrate_of	DIDEO_00000041	FDA		566		"12496743"	2017	auc_percent_change	302.29998779296875
2356	CHEBI_49603	lapatinib	PR_P08183	P-gp	transports	RO_0002020	FDA		743		"19371315"	2017	auc_percent_change	266.79998779296875
2359	CHEBI_72297	lomitapide	PR_P08183	P-gp	transports	RO_0002020	FDA		829		NDA 203858	2017	auc_percent_change	2626.199951171875
2361	CHEBI_63632	topotecan	PR_P08183	P-gp	transports	RO_0002020	FDA		918			2017	auc_percent_change	2.430000066757202
2362	CHEBI_135920	fesoterodine	PR_P10635	CYP2D6(5-HMT)	is_substrate_of	DIDEO_00000041	FDA		607		"19347334"	2017	auc_percent_change	131.1999969482422
2366	CHEBI_9168	sirolimus	PR_P08183	P-gp	transports	RO_0002020	FDA		783		"23408534"	2017	auc_percent_change	2512.300048828125
2371	CHEBI_50122	rosiglitazone	PR_P08183	P-gp	transports	RO_0002020	FDA		773		"12898007"	2017	auc_percent_change	129.0
2375	CHEBI_66876	avanafil	PR_P08684	CYP3A	is_substrate_of	DIDEO_00000041	FDA		570		NDA 202276	2017	auc_percent_change	1183.199951171875
2377	CHEBI_8871	risperidone	PR_P10635	CYP2D6	is_substrate_of	DIDEO_00000041	FDA		669		"11985287"	2017	auc_percent_change	315.29998779296875
2381	CHEBI_10023	voriconazole (po)	PR_P11712	CYP2C9	is_substrate_of	DIDEO_00000041	FDA		708		"16890574�"	2017	auc_percent_change	806.7999877929688
2382	CHEBI_68621	boceprevir	PR_P08684	CYP3A4	is_substrate_of	DIDEO_00000041	FDA		824		NDA 202258	2017	auc_percent_change	119.9000015258789
2385	CHEBI_367163	darunavir	PR_P08183	P-gp	transports	RO_0002020	FDA		727		"19131522"	2017	auc_percent_change	969.5
2387	CHEBI_9398	tamsulosin	PR_P10635	CYP2D6	is_substrate_of	DIDEO_00000041	FDA		690		"21496064"	2017	auc_percent_change	183.5
2390	CHEBI_68610	linagliptin	PR_Q9NPD5	OATP1B3	transports	RO_0002020	FDA		747		TRADJENTA PL	2017	auc_percent_change	101.4000015258789
2391	CHEBI_40050	amprenavir	PR_P08183	P-gp	transports	RO_0002020	FDA		714		"12496743"	2017	auc_percent_change	302.29998779296875
2401	CHEBI_48390	cinacalcet	PR_P08684	CYP3A4	is_substrate_of	DIDEO_00000041	FDA		586		"17518508"	2017	auc_percent_change	102.9000015258789
2403	CHEBI_5050	fexofenadine	PR_Q9NPD5	OATP1B3	transports	RO_0002020	FDA		933			2017	auc_percent_change	4.840000152587891
2405	CHEBI_71272	saxagliptin	PR_P08183	P-gp	transports	RO_0002020	FDA		779		NDA 022350	2017	auc_percent_change	266.6000061035156
2406	CHEBI_38545	rosuvastatin	PR_Q8TCC7	OAT3	is_substrate_of	DIDEO_00000041	FDA		777		"15289793"	2017	auc_percent_change	608.2000122070312
2408	CHEBI_6931	midazolam (po)	PR_P08684	CYP3A4	is_substrate_of	DIDEO_00000041	FDA		631		"20147896"	2017	auc_percent_change	2590.89990234375
2409	CHEBI_135853	tirilazad	PR_P08684	CYP3A4	is_substrate_of	DIDEO_00000041	FDA		815		"8627582"	2017	auc_percent_change	308.6000061035156
2415	CHEBI_39112	bosutinib	PR_P08183	P-gp	transports	RO_0002020	FDA		837		"21148045"	2017	auc_percent_change	714.5999755859375
2416	CHEBI_64022	nebivolol (racemic)	PR_P10635	CYP2D6	is_substrate_of	DIDEO_00000041	FDA		635		"20489028"	2017	auc_percent_change	557.0999755859375
2419	CHEBI_7496	nelfinavir	PR_Q14242	p-gp	transports	RO_0002020	FDA		751		"12949316"	2017	auc_percent_change	146.1999969482422
2422	CHEBI_63629	tizanidine	PR_P05177	CYP1A2	is_substrate_of	DIDEO_00000041	FDA		698		"15060511"	2017	auc_percent_change	3172.699951171875
2423	CHEBI_49603	lapatinib	PR_P08684	CYP3A4	is_substrate_of	DIDEO_00000041	FDA		816		"19371315"	2017	auc_percent_change	266.79998779296875
2426	CHEBI_66910	axitinib	PR_Q9UNQ0	BCRP	is_substrate_of	DIDEO_00000041	FDA		717		"20740300"	2017	auc_percent_change	105.80000305175781
2427	CHEBI_68610	linagliptin	PR_P08183	P-gp	transports	RO_0002020	FDA		745		TRADJENTA PL	2017	auc_percent_change	101.4000015258789
2429	CHEBI_50122	rosiglitazone	PR_P11712	"2C9"	is_substrate_of	DIDEO_00000041	FDA		677		"12898007"	2017	auc_percent_change	129.0
2432	CHEBI_71272	saxagliptin	PR_P20815	CYP3A5	is_substrate_of	DIDEO_00000041	FDA		679		NDA 022350	2017	auc_percent_change	266.6000061035156
2437	CHEBI_49603	lapatinib	PR_Q9UNQ0	BCRP	is_substrate_of	DIDEO_00000041	FDA		744		"19371315"	2017	auc_percent_change	266.79998779296875
2440	CHEBI_32020	pitavastatin	PR_P35503	UGT1A3	is_substrate_of	DIDEO_00000041	FDA		656		"23831870"	2017	auc_percent_change	428.3999938964844
2448	CHEBI_9398	tamsulosin	PR_P08684	CYP3A4	is_substrate_of	DIDEO_00000041	FDA		691		"21496064"	2017	auc_percent_change	183.5
2449	CHEBI_48390	cinacalcet	PR_P05177	CYP1A2	is_substrate_of	DIDEO_00000041	FDA		587		"17518508"	2017	auc_percent_change	102.9000015258789
2452	CHEBI_71940	tadalafil	PR_P08183	P-gp	transports	RO_0002020	FDA		843		NDA 021368	2017	auc_percent_change	311.5
2456	CHEBI_32020	pitavastatin	PR_Q9Y6L6	OATP1B1	transports	RO_0002020	FDA		759		"23831870"	2017	auc_percent_change	428.3999938964844
2457	CHEBI_135929	silodosin	PR_P08684	CYP3A4	is_substrate_of	DIDEO_00000041	FDA		820		NDA 22206	2017	auc_percent_change	208.60000610351562
2461	CHEBI_38545	rosuvastatin	PR_P11712	CYP2C9	is_substrate_of	DIDEO_00000041	FDA		678		"15289793"	2017	auc_percent_change	608.2000122070312
2466	CHEBI_8107	phenytoin	PR_P05177	CYP1A2	is_substrate_of	DIDEO_00000041	FDA		648		"11808866"	2017	auc_percent_change	133.10000610351562
2468	CHEBI_66876	avanafil		CYP2C	is_substrate_of	DIDEO_00000041	FDA		571		NDA 202276	2017	auc_percent_change	1183.199951171875
2470	CHEBI_135920	fesoterodine	PR_P08183	P-gp	transports	RO_0002020	FDA		852		"19347334"	2017	auc_percent_change	131.1999969482422
2471	CHEBI_51141	alfuzosin	PR_P08183	P-gp	transports	RO_0002020	FDA		850		NDA 021287	2017	auc_percent_change	197.0
2474	CHEBI_38561	fluvastatin	PR_P08183	P-gp	transports	RO_0002020	FDA		737		"11907637"	2017	auc_percent_change	254.6999969482422
2475	CHEBI_6931	midazolam (iv)	PR_P08684	CYP3A4	is_substrate_of	DIDEO_00000041	FDA		630		"19302901"	2017	auc_percent_change	686.7999877929688
2481	CHEBI_50659	dronedarone	PR_P08684	CYP3A4	is_substrate_of	DIDEO_00000041	FDA		596		NDA 022425	2017	auc_percent_change	2383.300048828125
2488	CHEBI_6541	losartan	PR_P08684	CYP3A4	is_substrate_of	DIDEO_00000041	FDA		627		"19221727"	2017	auc_percent_change	108.5
2494	CHEBI_5050	fexofenadine	PR_Q86VL8	MATE2K	transports	RO_0002020	FDA		932			2017	auc_percent_change	4.840000152587891
2495	CHEBI_71272	saxagliptin	PR_P08684	CYP3A4	is_substrate_of	DIDEO_00000041	FDA		817		NDA 022350	2017	auc_percent_change	266.6000061035156
2496	CHEBI_6541	losartan	PR_P08183	P-gp	transports	RO_0002020	FDA		748		"19221727"	2017	auc_percent_change	108.5
2500	CHEBI_5050	fexofenadine	PR_Q96FL8	MATE1	transports	RO_0002020	FDA		733		"19225389"	2017	auc_percent_change	384.29998779296875
2501	CHEBI_8107	phenytoin	PR_P10632	CYP2C8	is_substrate_of	DIDEO_00000041	FDA		647		"11808866"	2017	auc_percent_change	133.10000610351562
2502	CHEBI_31528	ebastine	PR_P51589	CYP2J2	is_substrate_of	DIDEO_00000041	FDA		600		"15752381"	2017	auc_percent_change	4149.7998046875
2504	CHEBI_68558	ticagrelor	PR_P08183	P-gp	transports	RO_0002020	FDA		789		"022433�"	2017	auc_percent_change	632.0
2505	CHEBI_71272	saxagliptin	PR_P08183	P-gp	transports	RO_0002020	FDA		921			2017	auc_percent_change	3.6700000762939453
2507	CHEBI_32246	tolvaptan	PR_P08684	CYP3A4	is_substrate_of	DIDEO_00000041	FDA		701		"21988334"	2017	auc_percent_change	439.70001220703125
2514	CHEBI_5050	fexofenadine	PR_Q9NPD5	OATP1B3	transports	RO_0002020	FDA		735		"19225389"	2017	auc_percent_change	384.29998779296875
2517	CHEBI_66910	axitinib	PR_P08183	P-gp	transports	RO_0002020	FDA		715		"20740300"	2017	auc_percent_change	105.80000305175781
2519	CHEBI_52172	nilotinib	PR_Q9Y6L6	OATP1B1	transports	RO_0002020	FDA		754		"20702754"	2017	auc_percent_change	210.60000610351562
2526	CHEBI_8107	phenytoin	PR_P11712	CYP2C9	is_substrate_of	DIDEO_00000041	FDA		651		"11808866"	2017	auc_percent_change	133.10000610351562
2527	CHEBI_52172	nilotinib	PR_P08684	CYP3A4	is_substrate_of	DIDEO_00000041	FDA		639		"20702754"	2017	auc_percent_change	210.60000610351562
2530	CHEBI_135967	casopitant-not approved in USA	PR_P08684	CYP3A4	is_substrate_of	DIDEO_00000041	FDA		580		"20124517"	2017	auc_percent_change	1106.300048828125
2532	CHEBI_135967	casopitant	PR_P08684	CYP3A4	is_substrate_of	DIDEO_00000041	FDA		804		"20124517"	2017	auc_percent_change	1106.300048828125
2536	CHEBI_49603	lapatinib	PR_P20815	CYP3A5	is_substrate_of	DIDEO_00000041	FDA		618		"19371315"	2017	auc_percent_change	266.79998779296875
2537	CHEBI_39112	bosutinib	PR_P08684	CYP3A4	is_substrate_of	DIDEO_00000041	FDA		808		"21148045"	2017	auc_percent_change	714.5999755859375
2539	CHEBI_9168	sirolimus	PR_Q9Y6L6	OATP1B1	transports	RO_0002020	FDA		785		"23408534"	2017	auc_percent_change	2512.300048828125
2543	CHEBI_72297	lomitapide	PR_P10632	CYP2C8	is_substrate_of	DIDEO_00000041	FDA		621		NDA 203858	2017	auc_percent_change	2626.199951171875
2545	CHEBI_32020	pitavastatin	PR_P11712	CYP2C9	is_substrate_of	DIDEO_00000041	FDA		657		"23831870"	2017	auc_percent_change	428.3999938964844
2547	CHEBI_8707	quetiapine	PR_P08183	P-gp	transports	RO_0002020	FDA		840		"16390352"	2017	auc_percent_change	520.4000244140625
2549	CHEBI_3558	cerivastatin	PR_Q9Y6L6	OATP1B1	transports	RO_0002020	FDA		725		"10096257"	2017	auc_percent_change	375.29998779296875
2552	CHEBI_82960	raltegravir	PR_Q9UNQ0	BCRP	is_substrate_of	DIDEO_00000041	FDA		766		"19143531"	2017	auc_percent_change	210.89999389648438
2559	CHEBI_5050	fexofenadine	PR_Q8TCC7	OAT3	transports	RO_0002020	FDA		929			2017	auc_percent_change	4.840000152587891
2561	CHEBI_7772	omeprazole	PR_P08684	CYP3A4	is_substrate_of	DIDEO_00000041	FDA		641		"11932962"	2017	auc_percent_change	529.2999877929688
2562	CHEBI_68478	everolimus	PR_P08684	CYP3A4	is_substrate_of	DIDEO_00000041	FDA		606		"15831774"	2017	auc_percent_change	1371.0999755859375
2563	CHEBI_68534	enzalutamide	PR_P10632	CYP2C8	is_substrate_of	DIDEO_00000041	FDA		603		NDA 203415	2017	auc_percent_change	325.5
2566	CHEBI_127342	atomoxetine	PR_P10635	CYP2D6	is_substrate_of	DIDEO_00000041	FDA		569		"12412820"	2017	auc_percent_change	605.7000122070312
2576	CHEBI_10023	voriconazole (po)	PR_P33261	CYP2C19	is_substrate_of	DIDEO_00000041	FDA		710		"16890574�"	2017	auc_percent_change	806.7999877929688
2578	CHEBI_66910	axitinib	PR_P33261	CYP2C19	is_substrate_of	DIDEO_00000041	FDA		573		"20740300"	2017	auc_percent_change	105.80000305175781
2581	CHEBI_68579	rivaroxaban	PR_P08684	CYP3A4	is_substrate_of	DIDEO_00000041	FDA		822		"23305158"	2017	auc_percent_change	157.60000610351562
2585	CHEBI_63660	pravastatin	PR_Q9Y6L6	OATP1B1	transports	RO_0002020	FDA		923			2017	auc_percent_change	22.84000015258789
2586	CHEBI_70735	lurasidone	PR_P08684	CYP3A4	is_substrate_of	DIDEO_00000041	FDA		628		NDA 200603	2017	auc_percent_change	830.0
2588	CHEBI_8707	quetiapine	PR_P08684	CYP3A4	is_substrate_of	DIDEO_00000041	FDA		811		"16390352"	2017	auc_percent_change	520.4000244140625
2589	CHEBI_8768	rabeprazole	PR_P33261	CYP2C19	is_substrate_of	DIDEO_00000041	FDA		662		"16487224�"	2017	auc_percent_change	181.89999389648438
2592	CHEBI_68478	everolimus	PR_P08684	CYP3A4	is_substrate_of	DIDEO_00000041	FDA		802		"15831774"	2017	auc_percent_change	1371.0999755859375
2594	CHEBI_71200	tofacitinib	PR_P08183	P-gp	transports	RO_0002020	FDA		855		NDA 203214	2017	auc_percent_change	103.19999694824219
2600	CHEBI_367163	darunavir	PR_Q9Y6L6	OATP1B1	transports	RO_0002020	FDA		728		"19131522"	2017	auc_percent_change	969.5
2601	CHEBI_72297	lomitapide	PR_P33261	CYP2C19	is_substrate_of	DIDEO_00000041	FDA		622		NDA 203858	2017	auc_percent_change	2626.199951171875
2609	CHEBI_135949	ambrisentan	PR_P08183	P-gp	transports	RO_0002020	FDA		713		"20811346"	2017	auc_percent_change	121.30000305175781
2610	CHEBI_45409	ritonavir	PR_P08183	P-gp	transports	RO_0002020	FDA		770		"22403324"	2017	auc_percent_change	382.6000061035156
2612	CHEBI_5050	fexofenadine	PR_Q96FL8	MATE1	transports	RO_0002020	FDA		930			2017	auc_percent_change	4.840000152587891
2572	CHEBI_47519	ketoconazole		CYP2C	inhibits	RO_0002449	FDA		26		PL	2017		
2616	CHEBI_63608	maraviroc	PR_Q9Y6L6	OATP1B1	transports	RO_0002020	FDA		936			2017	auc_percent_change	9.979999542236328
2617	CHEBI_51141	alfuzosin	PR_P08684	CYP3A4	is_substrate_of	DIDEO_00000041	FDA		821		NDA 021287	2017	auc_percent_change	197.0
2618	CHEBI_31528	ebastine	PR_P08684	CYP3A4	is_substrate_of	DIDEO_00000041	FDA		799		"15752381"	2017	auc_percent_change	4149.7998046875
2619	CHEBI_63608	maraviroc	PR_P08183	P-gp	transports	RO_0002020	FDA		935			2017	auc_percent_change	9.979999542236328
2620	CHEBI_38561	fluvastatin	PR_Q9UNQ0	BCRP	is_substrate_of	DIDEO_00000041	FDA		739		"11907637"	2017	auc_percent_change	254.6999969482422
2621	CHEBI_5050	fexofenadine	PR_O15245	OCT1	transports	RO_0002020	FDA		736		"19225389"	2017	auc_percent_change	384.29998779296875
2624	CHEBI_681850	conivaptan	PR_P08183	P-gp	transports	RO_0002020	FDA		834		NDA 021697	2017	auc_percent_change	982.2000122070312
2630	CHEBI_8228	pioglitazone	PR_P10632	CYP2C8	is_substrate_of	DIDEO_00000041	FDA		654		"22625877"	2017	auc_percent_change	366.3999938964844
2637	CHEBI_68579	rivaroxaban	PR_P08684	CYP3A4	is_substrate_of	DIDEO_00000041	FDA		671		"23305158"	2017	auc_percent_change	157.60000610351562
2647	CHEBI_5050	fexofenadine	PR_Q86VL8	MATE2K	transports	RO_0002020	FDA		731		"19225389"	2017	auc_percent_change	384.29998779296875
2658	CHEBI_49575	diazepam	PR_P08684	CYP3A4	is_substrate_of	DIDEO_00000041	FDA		592		"9625273"	2017	auc_percent_change	224.10000610351562
2662	CHEBI_38545	rosuvastatin	PR_Q9Y6L6	OATP1B1	transports	RO_0002020	FDA		776		"15289793"	2017	auc_percent_change	608.2000122070312
2664	CHEBI_66910	axitinib	PR_P05177	CYP1A2	is_substrate_of	DIDEO_00000041	FDA		575		"20740300"	2017	auc_percent_change	105.80000305175781
2666	CHEBI_66901	ivacaftor	PR_P08183	P-gp	transports	RO_0002020	FDA		836		NDA 203188	2017	auc_percent_change	745.0
2622	CHEBI_28901	busulfan	PR_P33260	CYP2C18	inhibits	RO_0002449	FDA		939		PL	2017		
2668	CHEBI_68579	rivaroxaban	PR_P08183	P-gp	transports	RO_0002020	FDA		851		"23305158"	2017	auc_percent_change	157.60000610351562
2679	CHEBI_7772	omeprazole	PR_P10632	CYP2C8	is_substrate_of	DIDEO_00000041	FDA		640		"11932962"	2017	auc_percent_change	529.2999877929688
2680	CHEBI_32020	pitavastatin	PR_P10632	CYP2C8	is_substrate_of	DIDEO_00000041	FDA		658		"23831870"	2017	auc_percent_change	428.3999938964844
2682	CHEBI_135929	silodosin	PR_P08684	CYP3A4	is_substrate_of	DIDEO_00000041	FDA		685		NDA 22206	2017	auc_percent_change	208.60000610351562
2684	CHEBI_8707	quetiapine	PR_P08684	CYP3A4	is_substrate_of	DIDEO_00000041	FDA		660		"16390352"	2017	auc_percent_change	520.4000244140625
2690	CHEBI_2569	alfentanil	PR_P08684	CYP3A	is_substrate_of	DIDEO_00000041	FDA		560		"19225389"	2017	auc_percent_change	3550.0
2692	CHEBI_66910	axitinib	PR_P08183	P-gp	transports	RO_0002020	FDA		854		"20740300"	2017	auc_percent_change	105.80000305175781
2693	CHEBI_36796	duloxetine	PR_P05177	CYP1A2	is_substrate_of	DIDEO_00000041	FDA		597		"18307373"	2017	auc_percent_change	460.0
2694	CHEBI_9168	sirolimus	PR_P20815	CYP3A5	is_substrate_of	DIDEO_00000041	FDA		686		"23408534"	2017	auc_percent_change	2512.300048828125
2697	CHEBI_87681	ranolazine	PR_P08684	CYP3A4	is_substrate_of	DIDEO_00000041	FDA		665		"15778423"	2017	auc_percent_change	264.29998779296875
2701	CHEBI_6931	midazolam (iv)	PR_P08183	P-gp	transports	RO_0002020	FDA		838		"19302901"	2017	auc_percent_change	686.7999877929688
2703	CHEBI_135949	ambrisentan	PR_P08684	CYP3A4	is_substrate_of	DIDEO_00000041	FDA		564		"20811346"	2017	auc_percent_change	121.30000305175781
2704	CHEBI_66910	axitinib	PR_P22309	UGT1A1	is_substrate_of	DIDEO_00000041	FDA		572		"20740300"	2017	auc_percent_change	105.80000305175781
2707	CHEBI_72289	elvitegravir (GS-9137)	PR_P08183	P-gp	transports	RO_0002020	FDA		729		NDA 203100	2017	auc_percent_change	1888.300048828125
2708	CHEBI_8805	repaglinide	PR_P08684	CYP3A4	is_substrate_of	DIDEO_00000041	FDA		667		"12687332"	2017	auc_percent_change	1830.4000244140625
2711	CHEBI_7496	nelfinavir	PR_P08684	CYP3A	is_substrate_of	DIDEO_00000041	FDA		637		"12949316"	2017	auc_percent_change	146.1999969482422
2714	CHEBI_681850	conivaptan	PR_P08684	CYP3A4	is_substrate_of	DIDEO_00000041	FDA		805		NDA 021697	2017	auc_percent_change	982.2000122070312
2669	CHEBI_47519	ketoconazole	PR_P08684	CYP3A4	inhibits	RO_0002449	FDA		63		PL	2017		
2721	CHEBI_135929	silodosin	PR_P08183	P-gp	transports	RO_0002020	FDA		849		NDA 22206	2017	auc_percent_change	208.60000610351562
2730	CHEBI_49603	lapatinib	PR_P08684	CYP3A4	is_substrate_of	DIDEO_00000041	FDA		619		"19371315"	2017	auc_percent_change	266.79998779296875
2731	CHEBI_49575	diazepam	PR_P33261	CYP2C19	is_substrate_of	DIDEO_00000041	FDA		593		"9625273"	2017	auc_percent_change	224.10000610351562
2735	CHEBI_135920	fesoterodine	PR_P08684	CYP3A4	is_substrate_of	DIDEO_00000041	FDA		608		"19347334"	2017	auc_percent_change	131.1999969482422
2736	CHEBI_31528	ebastine	PR_P08684	CYP3A4	is_substrate_of	DIDEO_00000041	FDA		599		"15752381"	2017	auc_percent_change	4149.7998046875
2756	CHEBI_8107	phenytoin	PR_P33261	CYP2C19	is_substrate_of	DIDEO_00000041	FDA		649		"11808866"	2017	auc_percent_change	133.10000610351562
2758	CHEBI_367163	darunavir	PR_P08684	CYP3A	is_substrate_of	DIDEO_00000041	FDA		591		"19131522"	2017	auc_percent_change	969.5
2760	CHEBI_9139	sildenafil	PR_P11712	CYP2C9	is_substrate_of	DIDEO_00000041	FDA		681		"10930961"	2017	auc_percent_change	889.4000244140625
2761	CHEBI_6375	lansoprazole	PR_P08183	P-gp	transports	RO_0002020	FDA		742		"15496639"	2017	auc_percent_change	282.70001220703125
2762	CHEBI_68579	rivaroxaban	PR_P08183	P-gp	transports	RO_0002020	FDA		927			2017	auc_percent_change	2.5799999237060547
2765	CHEBI_52172	nilotinib	PR_Q9NPD5	OATP1B3	transports	RO_0002020	FDA		753		"20702754"	2017	auc_percent_change	210.60000610351562
2767	CHEBI_73275	ospemifene	PR_P33261	CYP2C19	is_substrate_of	DIDEO_00000041	FDA		645		"23852652"	2017	auc_percent_change	178.1999969482422
2768	CHEBI_31547	eplerenone	PR_P08684	CYP3A4	is_substrate_of	DIDEO_00000041	FDA		605		"15204695"	2017	auc_percent_change	438.70001220703125
2771	CHEBI_32020	pitavastatin	PR_P16662	UGT2B7	is_substrate_of	DIDEO_00000041	FDA		659		"23831870"	2017	auc_percent_change	428.3999938964844
2772	CHEBI_68579	rivaroxaban	PR_Q9UNQ0	BCRP	is_substrate_of	DIDEO_00000041	FDA		772		"23305158"	2017	auc_percent_change	157.60000610351562
2773	CHEBI_68478	everolimus	PR_P08183	P-gp	transports	RO_0002020	FDA		831		"15831774"	2017	auc_percent_change	1371.0999755859375
2774	CHEBI_65173	iloperidone	PR_P08684	CYP3A4	is_substrate_of	DIDEO_00000041	FDA		613		NDA 022192	2017	auc_percent_change	131.39999389648438
2776	CHEBI_71272	saxagliptin	PR_P08684	CYP3A4	is_substrate_of	DIDEO_00000041	FDA		680		NDA 022350	2017	auc_percent_change	266.6000061035156
2777	CHEBI_7772	(S)-omeprazole 	PR_P33261	CYP2C19	is_substrate_of	DIDEO_00000041	FDA		559		"16550734"	2017	auc_percent_change	127.19999694824219
2783	CHEBI_52172	nilotinib	PR_P08183	P-gp	transports	RO_0002020	FDA		848		"20702754"	2017	auc_percent_change	210.60000610351562
2785	CHEBI_8871	risperidone	PR_P08183	P-gp	transports	RO_0002020	FDA		769		"11985287"	2017	auc_percent_change	315.29998779296875
2786	CHEBI_45409	ritonavir	PR_P08684	CYP3A	is_substrate_of	DIDEO_00000041	FDA		670		"22403324"	2017	auc_percent_change	382.6000061035156
2787	CHEBI_66910	axitinib	PR_Q9NPD5	OATP1B3	transports	RO_0002020	FDA		716		"20740300"	2017	auc_percent_change	105.80000305175781
2791	CHEBI_9139	sildenafil	PR_Q9UNQ0	BCRP	is_substrate_of	DIDEO_00000041	FDA		781		"10930961"	2017	auc_percent_change	889.4000244140625
2792	CHEBI_8890	ropivacaine	PR_P05177	CYP1A2	is_substrate_of	DIDEO_00000041	FDA		675		"10049910"	2017	auc_percent_change	452.5
2796	CHEBI_68621	boceprevir	PR_P08183	P-gp	transports	RO_0002020	FDA		853		NDA 202258	2017	auc_percent_change	119.9000015258789
2798	CHEBI_68621	boceprevir	PR_P08684	CYP3A	is_substrate_of	DIDEO_00000041	FDA		577		NDA 202258	2017	auc_percent_change	119.9000015258789
2800	CHEBI_68558	ticagrelor	PR_P08684	CYP3A4	is_substrate_of	DIDEO_00000041	FDA		810		"022433�"	2017	auc_percent_change	632.0
2802	CHEBI_87681	ranolazine	PR_P08684	CYP3A4	is_substrate_of	DIDEO_00000041	FDA		818		"15778423"	2017	auc_percent_change	264.29998779296875
2811	CHEBI_135929	silodosin	PR_P16662	UGT2B7	is_substrate_of	DIDEO_00000041	FDA		683		NDA 22206	2017	auc_percent_change	208.60000610351562
2812	CHEBI_38561	fluvastatin	PR_Q9Y6L6	OATP1B1	transports	RO_0002020	FDA		740		"11907637"	2017	auc_percent_change	254.6999969482422
2813	CHEBI_7772	omeprazole	PR_P33261	CYP2C19	is_substrate_of	DIDEO_00000041	FDA		642		"11932962"	2017	auc_percent_change	529.2999877929688
2817	CHEBI_68558	ticagrelor	PR_P08183	P-gp	transports	RO_0002020	FDA		839		"022433�"	2017	auc_percent_change	632.0
2819	CHEBI_10023	voriconazole (po)	PR_P08684	CYP3A4	is_substrate_of	DIDEO_00000041	FDA		709		"16890574�"	2017	auc_percent_change	806.7999877929688
2820	CHEBI_68579	rivaroxaban	PR_P51589	CYP2J2	is_substrate_of	DIDEO_00000041	FDA		672		"23305158"	2017	auc_percent_change	157.60000610351562
2821	CHEBI_8805	repaglinide	PR_P10632	CYP2C8	is_substrate_of	DIDEO_00000041	FDA		666		"12687332"	2017	auc_percent_change	1830.4000244140625
2825	CHEBI_39112	bosutinib	PR_P08183	P-gp	transports	RO_0002020	FDA		721		"21148045"	2017	auc_percent_change	714.5999755859375
2830	CHEBI_32020	pitavastatin	PR_Q9UNQ0	BCRP	is_substrate_of	DIDEO_00000041	FDA		758		"23831870"	2017	auc_percent_change	428.3999938964844
2833	CHEBI_71940	tadalafil	PR_P08684	CYP3A4	is_substrate_of	DIDEO_00000041	FDA		689		NDA 021368	2017	auc_percent_change	311.5
2835	CHEBI_87681	ranolazine	PR_P08183	P-gp	transports	RO_0002020	FDA		767		"15778423"	2017	auc_percent_change	264.29998779296875
2837	CHEBI_601027	aliskiren	PR_P08684	CYP3A4	is_substrate_of	DIDEO_00000041	FDA		562		"20400651"	2017	auc_percent_change	533.0999755859375
2840	CHEBI_8228	pioglitazone	PR_P08684	CYP3A4	is_substrate_of	DIDEO_00000041	FDA		655		"22625877"	2017	auc_percent_change	366.3999938964844
2842	CHEBI_52172	nilotinib	PR_P08183	P-gp	transports	RO_0002020	FDA		752		"20702754"	2017	auc_percent_change	210.60000610351562
2843	CHEBI_72289	elvitegravir (GS-9137)	PR_P08684	CYP3A	is_substrate_of	DIDEO_00000041	FDA		601		NDA 203100	2017	auc_percent_change	1888.300048828125
2844	CHEBI_7496	nelfinavir	PR_P33261	CYP2C19	is_substrate_of	DIDEO_00000041	FDA		638		"12949316"	2017	auc_percent_change	146.1999969482422
2845	CHEBI_3558	cerivastatin	PR_Q9NPD5	OATP1B3	transports	RO_0002020	FDA		723		"10096257"	2017	auc_percent_change	375.29998779296875
2846	CHEBI_3558	cerivastatin	PR_P08183	P-gp	transports	RO_0002020	FDA		722		"10096257"	2017	auc_percent_change	375.29998779296875
2850	CHEBI_135853	tirilazad	PR_P08183	P-gp	transports	RO_0002020	FDA		844		"8627582"	2017	auc_percent_change	308.6000061035156
2852	CHEBI_61049	tacrolimus	PR_P08183	P-gp	transports	RO_0002020	FDA		786		"21618566"	2017	auc_percent_change	7697.60009765625
2853	CHEBI_8107	phenytoin	PR_P10635	CYP2D6	is_substrate_of	DIDEO_00000041	FDA		646		"11808866"	2017	auc_percent_change	133.10000610351562
2855	CHEBI_63660	pravastatin	PR_Q9Y6L6	OATP1B1	transports	RO_0002020	FDA		763		"8356729"	2017	auc_percent_change	2183.5
2861	CHEBI_72296	apixaban	PR_Q9UNQ0	BCRP	transports	RO_0002020	FDA		938			2017	auc_percent_change	1.9900000095367432
2864	CHEBI_7772	(S)-omeprazole 	PR_P08684	CYP3A4	is_substrate_of	DIDEO_00000041	FDA		558		"16550734"	2017	auc_percent_change	127.19999694824219
2867	CHEBI_5050	fexofenadine	PR_P08183	P-gp	transports	RO_0002020	FDA		732		"19225389"	2017	auc_percent_change	384.29998779296875
2870	CHEBI_39112	bosutinib	PR_P08684	CYP3A4	is_substrate_of	DIDEO_00000041	FDA		578		"21148045"	2017	auc_percent_change	714.5999755859375
2873	CHEBI_32020	pitavastatin	PR_P08183	P-gp	transports	RO_0002020	FDA		756		"23831870"	2017	auc_percent_change	428.3999938964844
2875	CHEBI_71200	tofacitinib	PR_P08183	P-gp	transports	RO_0002020	FDA		926			2017	auc_percent_change	2.0299999713897705
2877	CHEBI_63660	pravastatin	PR_Q9UNQ0	BCRP	transports	RO_0002020	FDA		925			2017	auc_percent_change	22.84000015258789
2882	CHEBI_47657	roflumilast	PR_P08684	CYP3A4.	is_substrate_of	DIDEO_00000041	FDA		673		"17596106"	2017	auc_percent_change	155.39999389648438
2883	CHEBI_51141	alfuzosin	PR_P08183	P-gp	transports	RO_0002020	FDA		712		NDA 021287	2017	auc_percent_change	197.0
2884	CHEBI_135920	fesoterodine	PR_P08684	CYP3A4	is_substrate_of	DIDEO_00000041	FDA		823		"19347334"	2017	auc_percent_change	131.1999969482422
2886	CHEBI_63632	topotecan	PR_Q96FL8	MATE1	transports	RO_0002020	FDA		793		"12089223"	2017	auc_percent_change	142.89999389648438
2892	CHEBI_8768	rabeprazole	PR_P08684	CYP3A4	is_substrate_of	DIDEO_00000041	FDA		661		"16487224�"	2017	auc_percent_change	181.89999389648438
2893	CHEBI_9467	tetrabenazine	PR_P10635	CYP2D6	is_substrate_of	DIDEO_00000041	FDA		694		NDA 021894	2017	auc_percent_change	300.0
2894	CHEBI_8228	pioglitazone	PR_P04798	CYP1A1	is_substrate_of	DIDEO_00000041	FDA		653		"22625877"	2017	auc_percent_change	366.3999938964844
2895	CHEBI_48390	cinacalcet	PR_P08684	CYP3A4	is_substrate_of	DIDEO_00000041	FDA		827		"17518508"	2017	auc_percent_change	102.9000015258789
2897	CHEBI_71272	saxagliptin	PR_P08183	P-gp	transports	RO_0002020	FDA		846		NDA 022350	2017	auc_percent_change	266.6000061035156
2902	CHEBI_49603	lapatinib	PR_P10632	CYP2C8	is_substrate_of	DIDEO_00000041	FDA		617		"19371315"	2017	auc_percent_change	266.79998779296875
2903	CHEBI_31236	aripiprazole	PR_P10635	CYP2D6	is_substrate_of	DIDEO_00000041	FDA		567		"21739267"	2017	auc_percent_change	136.10000610351562
2904	CHEBI_32020	pitavastatin	PR_Q9NPD5	OATP1B3	transports	RO_0002020	FDA		757		"23831870"	2017	auc_percent_change	428.3999938964844
2907	CHEBI_68621	boceprevir	PR_P08183	P-gp	transports	RO_0002020	FDA		719		NDA 202258	2017	auc_percent_change	119.9000015258789
2910	CHEBI_31528	ebastine	PR_P08183	P-gp	transports	RO_0002020	FDA		828		"15752381"	2017	auc_percent_change	4149.7998046875
2913	CHEBI_681850	conivaptan	PR_P08183	P-gp	transports	RO_0002020	FDA		726		NDA 021697	2017	auc_percent_change	982.2000122070312
2914	CHEBI_135853	tirilazad	PR_P08684	CYP3A4	is_substrate_of	DIDEO_00000041	FDA		697		"8627582"	2017	auc_percent_change	308.6000061035156
2915	CHEBI_3655	chlorzoxazone	PR_P05181	CYP2E1	is_substrate_of	DIDEO_00000041	FDA		583		"10579149"	2017	auc_percent_change	691.7999877929688
2917	CHEBI_63608	maraviroc	PR_P08684	CYP3A4	is_substrate_of	DIDEO_00000041	FDA		629		"18333864"	2017	auc_percent_change	897.9000244140625
2921	CHEBI_82960	raltegravir	PR_P22309	UGT1A1	is_substrate_of	DIDEO_00000041	FDA		663		"19143531"	2017	auc_percent_change	210.89999389648438
2922	CHEBI_68610	linagliptin	PR_O15244	OCT2	transports	RO_0002020	FDA		746		TRADJENTA PL	2017	auc_percent_change	101.4000015258789
2935	CHEBI_6375	lansoprazole	PR_P08684	CYP3A	is_substrate_of	DIDEO_00000041	FDA		615		"15496639"	2017	auc_percent_change	282.70001220703125
2942	CHEBI_66910	axitinib	PR_Q9Y6L6	OATP1B1	transports	RO_0002020	FDA		718		"20740300"	2017	auc_percent_change	105.80000305175781
2943	CHEBI_27732	caffeine	PR_P05177	CYP1A2	is_substrate_of	DIDEO_00000041	FDA		579		"16236038"	2017	auc_percent_change	1271.5
2944	CHEBI_68595	telaprevir	PR_P08183	P-gp	transports	RO_0002020	FDA		787		NDA 201917	2017	auc_percent_change	219.8000030517578
2953	CHEBI_9434	telmisartan	PR_Q9NPD5	OATP1B3	transports	RO_0002020	FDA		788		�17322141, MICARDIS PL	2017	auc_percent_change	132.3000030517578
2957	CHEBI_38561	fluvastatin	PR_P10632	CYP2C8	is_substrate_of	DIDEO_00000041	FDA		610		"11907637"	2017	auc_percent_change	254.6999969482422
2959	CHEBI_66901	ivacaftor	PR_P08183	P-gp	transports	RO_0002020	FDA		741		NDA 203188	2017	auc_percent_change	745.0
2961	CHEBI_66901	ivacaftor	PR_P08684	CYP3A	is_substrate_of	DIDEO_00000041	FDA		614		NDA 203188	2017	auc_percent_change	745.0
2972	CHEBI_5050	fexofenadine	PR_Q8TCC7	OAT3	is_substrate_of	DIDEO_00000041	FDA		734		"19225389"	2017	auc_percent_change	384.29998779296875
2973	CHEBI_63660	pravastatin	PR_Q9NPD5	OATP1B3	transports	RO_0002020	FDA		922			2017	auc_percent_change	22.84000015258789
2974	CHEBI_135929	silodosin	PR_P00352	ADH/ALDH	is_substrate_of	DIDEO_00000041	FDA		684		NDA 22206	2017	auc_percent_change	208.60000610351562
2975	CHEBI_66876	avanafil	PR_P08684	CYP3A4	is_substrate_of	DIDEO_00000041	FDA		803		NDA 202276	2017	auc_percent_change	1183.199951171875
2978	CHEBI_49603	lapatinib	PR_P33261	CYP2C19	is_substrate_of	DIDEO_00000041	FDA		620		"19371315"	2017	auc_percent_change	266.79998779296875
2979	CHEBI_31547	eplerenone	PR_P08183	P-gp	transports	RO_0002020	FDA		842		"15204695"	2017	auc_percent_change	438.70001220703125
2981	CHEBI_73275	ospemifene	PR_P11712	CYP2C9	is_substrate_of	DIDEO_00000041	FDA		643		"23852652"	2017	auc_percent_change	178.1999969482422
2688	CHEBI_6923	miconazole	PR_P11712	CYP2C9	inhibits	RO_0002449	FDA		116		"12527704"	2017		
2986	CHEBI_68606	rilpivirine	PR_P08684	CYP3A	is_substrate_of	DIDEO_00000041	FDA		668		NDA 202022	2017	auc_percent_change	140.39999389648438
2988	CHEBI_681850	conivaptan	PR_P08684	CYP3A	is_substrate_of	DIDEO_00000041	FDA		588		NDA 021697	2017	auc_percent_change	982.2000122070312
2995	CHEBI_63660	pravastatin	PR_Q9UNQ0	BCRP	is_substrate_of	DIDEO_00000041	FDA		762		"8356729"	2017	auc_percent_change	2183.5
2999	CHEBI_8107	phenytoin	PR_P05181	CYP2E1	is_substrate_of	DIDEO_00000041	FDA		650		"11808866"	2017	auc_percent_change	133.10000610351562
3003	CHEBI_82960	raltegravir	PR_Q4U2R8	OAT1	transports	RO_0002020	FDA		764		"19143531"	2017	auc_percent_change	210.89999389648438
3009	CHEBI_38561	fluvastatin	PR_Q9NPD5	OATP1B3	transports	RO_0002020	FDA		738		"11907637"	2017	auc_percent_change	254.6999969482422
3011	CHEBI_63632	topotecan	PR_Q96FL8	MATE1	transports	RO_0002020	FDA		917			2017	auc_percent_change	2.430000066757202
3018	CHEBI_63632	topotecan	PR_Q86VL8	MATE2K	transports	RO_0002020	FDA		919			2017	auc_percent_change	2.430000066757202
3024	CHEBI_8107	phenytoin	PR_P11509	CYP2A6	is_substrate_of	DIDEO_00000041	FDA		652		"11808866"	2017	auc_percent_change	133.10000610351562
3025	CHEBI_51141	alfuzosin	PR_P08684	CYP3A	is_substrate_of	DIDEO_00000041	FDA		561		NDA 021287	2017	auc_percent_change	197.0
3029	CHEBI_32246	tolvaptan	PR_P08684	CYP3A4	is_substrate_of	DIDEO_00000041	FDA		812		"21988334"	2017	auc_percent_change	439.70001220703125
3031	CHEBI_3558	cerivastatin	PR_P08684	CYP3A4	is_substrate_of	DIDEO_00000041	FDA		582		"10096257"	2017	auc_percent_change	375.29998779296875
3033	CHEBI_63608	maraviroc	PR_P08183	P-gp	transports	RO_0002020	FDA		749		"18333864"	2017	auc_percent_change	897.9000244140625
3036	CHEBI_63660	pravastatin	PR_Q9NPD5	OATP1B3	transports	RO_0002020	FDA		760		"8356729"	2017	auc_percent_change	2183.5
3037	CHEBI_38545	rosuvastatin	PR_P08183	P-gp	transports	RO_0002020	FDA		775		"15289793"	2017	auc_percent_change	608.2000122070312
3043	CHEBI_48390	cinacalcet	PR_P10635	CYP2D6	is_substrate_of	DIDEO_00000041	FDA		585		"17518508"	2017	auc_percent_change	102.9000015258789
3045	CHEBI_50659	dronedarone	PR_P08684	CYP3A4	is_substrate_of	DIDEO_00000041	FDA		801		NDA 022425	2017	auc_percent_change	2383.300048828125
1	CHEBI_38561	fluvastatin	PR_Q9Y6L6	oatp1b1	is_substrate_of	DIDEO_00000041	dikb	195			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
2	CHEBI_32020	pitavastatin	PR_Q9NPD5	oatp1b3	is_substrate_of	DIDEO_00000041	dikb	164			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
3	CHEBI_45783	imatinib	PR_P08183	p-glycoprotein	is_substrate_of	DIDEO_00000041	dikb	190			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
4	CHEBI_63629	tizanidine	PR_P05177	cyp1a2	is_substrate_of	DIDEO_00000041	dikb	120			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
5	CHEBI_4636	diphenhydramine	PR_P10635	cyp2d6	inhibits	RO_0002449	dikb	472			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
6	CHEBI_38561	fluvastatin	PR_P08684	cyp3a4	is_substrate_of	DIDEO_00000041	dikb	99			http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?id=3237	2017		
7	CHEBI_50659	dronedarone	PR_P08183	p-glycoprotein	inhibits	RO_0002449	dikb	499			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
8	CHEBI_6916	mexiletine	PR_P05177	cyp1a2	inhibits	RO_0002449	dikb	532			http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/resource/structuredProductLabelMetadata/AB73778B-6794-441C-B127-610A6D0733EA	2017		
9	CHEBI_4995	felbamate	PR_P33261	cyp2c19	inhibits	RO_0002449	dikb	583			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
10	CHEBI_3732	clarithromycin	PR_P08684	cyp3a4	is_substrate_of	DIDEO_00000041	dikb	215			http://www.ncbi.nlm.nih.gov/pubmed/9152603	2017		
11	CHEBI_10119	ziprasidone	PR_P08684	cyp3a4	is_substrate_of	DIDEO_00000041	dikb	238			http://www.ncbi.nlm.nih.gov/pubmed/10771452	2017		
12	CHEBI_10023	voriconazole	PR_P08684	cyp3a4	inhibits	RO_0002449	dikb	603			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
13	CHEBI_46081	fluconazole	PR_P11712	cyp2c9	inhibits	RO_0002449	dikb	539			http://www.ncbi.nlm.nih.gov/pubmed/8801057	2017		
14	CHEBI_101278	diltiazem	PR_P08684	cyp3a4	inhibits	RO_0002449	dikb	420			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
15	CHEBI_2611	alprazolam	PR_P08684	cyp3a4	inhibits	RO_0002449	dikb	255			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
16	CHEBI_601027	aliskiren	PR_P08183	p-glycoprotein	is_substrate_of	DIDEO_00000041	dikb	95			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
17	CHEBI_6923	miconazole	PR_P11712	cyp2c9	inhibits	RO_0002449	dikb	287			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
18	CHEBI_63660	pravastatin	PR_Q9Y6L6	oatp1b1	is_substrate_of	DIDEO_00000041	dikb	75			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
19	CHEBI_36791	escitalopram	PR_P33261	cyp2c19	is_substrate_of	DIDEO_00000041	dikb	144			http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/resource/structuredProductLabelMetadata/13bb8267-1cab-43e5-acae-55a4d957630a	2017		
20	CHEBI_61049	tacrolimus	PR_P08684	cyp3a4	is_substrate_of	DIDEO_00000041	dikb	73			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
21	CHEBI_4975	famotidine	PR_P05177	cyp1a2	inhibits	RO_0002449	dikb	582			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
22	CHEBI_2611	alprazolam	PR_P08684	cyp3a4	is_substrate_of	DIDEO_00000041	dikb	9			http://www.ncbi.nlm.nih.gov/pubmed/12124305	2017		
23	CHEBI_4031	cyclosporine	PR_P08684	cyp3a4	is_substrate_of	DIDEO_00000041	dikb	206			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
24	CHEBI_9168	sirolimus	PR_P08183	p-glycoprotein	is_substrate_of	DIDEO_00000041	dikb	235			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
25	CHEBI_6076	itraconazole	PR_P08183	p-glycoprotein	inhibits	RO_0002449	dikb	550			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
26	PC_64718	beta-hydroxy-simvastatin	PR_P08684	cyp3a4	is_substrate_of	DIDEO_00000041	dikb	88			http://www.ncbi.nlm.nih.gov/pubmed/9542477	2017		
27	CHEBI_9948	verapamil	PR_P05177	cyp1a2	inhibits	RO_0002449	dikb	382			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
28	CHEBI_63589	etravirine	PR_P11712	cyp2c9	inhibits	RO_0002449	dikb	296			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
29	CHEBI_8871	risperidone	PR_P10635	cyp2d6	is_substrate_of	DIDEO_00000041	dikb	198			http://www.ncbi.nlm.nih.gov/pubmed/7690693	2017		
30	CHEBI_64355	posaconazole	PR_P08183	p-glycoprotein	is_substrate_of	DIDEO_00000041	dikb	43			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
290	CHEBI_48390	cinacalcet	PR_P10635	cyp2d6	inhibits	RO_0002449	dikb	578			http://www.ncbi.nlm.nih.gov/pubmed/17652181	2017		
31	CHEBI_10119	ziprasidone	PR_P08684	cyp3a4	is_substrate_of	DIDEO_00000041	dikb	236			http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/resource/structuredProductLabelMetadata/8326928a-2cb6-4f7f-9712-03a425a14c37	2017		
32	CHEBI_8028	perphenazine	PR_P10635	cyp2d6	is_substrate_of	DIDEO_00000041	dikb	149			http://www.ncbi.nlm.nih.gov/pubmed/9333110	2017		
33	CHEBI_135949	ambrisentan	PR_P08183	p-glycoprotein	is_substrate_of	DIDEO_00000041	dikb	187			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
34	CHEBI_44032	indinavir	PR_P08684	cyp3a4	inhibits	RO_0002449	dikb	473			http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/resource/structuredProductLabelMetadata/e19405d9-d9a1-4072-5b9e-40cd3ae4bf1f	2017		
35	CHEBI_3732	clarithromycin	PR_P08684	cyp3a4	inhibits	RO_0002449	dikb	622			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
36	CHEBI_9948	verapamil	PR_P08183	p-glycoprotein	inhibits	RO_0002449	dikb	482			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
37	CHEBI_2663	amiodarone	PR_P10635	cyp2d6	inhibits	RO_0002449	dikb	656			http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/resource/structuredProductLabelMetadata/99991CC3-7271-44FC-91C3-3CAB0BBE7645	2017		
335	CHEBI_41423	celecoxib	PR_P10635	cyp2d6	inhibits	RO_0002449	dikb	615			http://www.ncbi.nlm.nih.gov/pubmed/12891223	2017		
38	CHEBI_41774	tamoxifen	PR_P20815	cyp3a5	is_substrate_of	DIDEO_00000041	dikb	44			http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/resource/structuredProductLabelMetadata/407a372d-4448-4d53-afd4-eb0e74bbc336	2017		
39	CHEBI_48390	cinacalcet	PR_P10635	cyp2d6	inhibits	RO_0002449	dikb	577			http://www.ncbi.nlm.nih.gov/pubmed/16680561	2017		
40	CHEBI_80603	R-demethylcitalopram	PR_P10635	cyp2d6	is_substrate_of	DIDEO_00000041	dikb	31			http://www.ncbi.nlm.nih.gov/pubmed/11454728	2017		
41	CHEBI_585948	felodipine	PR_P08684	cyp3a4	inhibits	RO_0002449	dikb	266			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
42	CHEBI_47519	ketoconazole	PR_P08684	cyp3a4	inhibits	RO_0002449	dikb	374			http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?id=1332	2017		
43	CHEBI_52172	nilotinib	PR_P08183	p-glycoprotein	is_substrate_of	DIDEO_00000041	dikb	191			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
44	CHEBI_68478	everolimus	PR_P08183	p-glycoprotein	is_substrate_of	DIDEO_00000041	dikb	127			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
45	CHEBI_6757	S-mephenytoin	PR_P33261	cyp2c19	is_substrate_of	DIDEO_00000041	dikb	86			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
46	CHEBI_101278	diltiazem	PR_P20815	cyp3a5	is_substrate_of	DIDEO_00000041	dikb	59			http://www.ncbi.nlm.nih.gov/pubmed/12124305	2017		
47	CHEBI_47519	ketoconazole	PR_P08684	cyp3a4	inhibits	RO_0002449	dikb	377			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
48	CHEBI_39548	atorvastatin	PR_P08684	cyp3a4	inhibits	RO_0002449	dikb	519			http://www.ncbi.nlm.nih.gov/pubmed/12911366	2017		
49	CHEBI_63608	maraviroc	PR_P08183	p-glycoprotein	is_substrate_of	DIDEO_00000041	dikb	232			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
50	CHEBI_7915	pantoprazole	PR_P08684	cyp3a4	is_substrate_of	DIDEO_00000041	dikb	210			http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/resource/structuredProductLabelMetadata/742ca9f4-9fba-44d4-29a8-1fe3a04f1af6	2017		
51	CHEBI_47519	ketoconazole	PR_P33261	cyp2c19	inhibits	RO_0002449	dikb	425			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
52	CHEBI_38561	fluvastatin	PR_P10632	cyp2c8	is_substrate_of	DIDEO_00000041	dikb	121			http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?id=3237	2017		
53	CHEBI_8768	rabeprazole	PR_P08684	cyp3a4	is_substrate_of	DIDEO_00000041	dikb	30			http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/resource/structuredProductLabelMetadata/5d103551-978f-472a-9c62-51e6e4dea068	2017		
54	CHEBI_9654	trazodone	PR_P08684	cyp3a4	is_substrate_of	DIDEO_00000041	dikb	38			http://dailymed.nlm.nih.gov/dailymed/archives/fdaDrugInfo.cfm?archiveid=4844	2017		
55	CHEBI_6807	methadone	PR_P10635	cyp2d6	inhibits	RO_0002449	dikb	522			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
56	CHEBI_9448	terbinafine	PR_P05177	cyp1a2	inhibits	RO_0002449	dikb	292			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
57	CHEBI_3699	cimetidine	PR_P05177	cyp1a2	inhibits	RO_0002449	dikb	466			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
58	CHEBI_51450	bosentan	PR_Q9Y6L6	oatp1b1	is_substrate_of	DIDEO_00000041	dikb	244			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
59	CHEBI_9342	sulfinpyrazone	PR_P11712	cyp2c9	inhibits	RO_0002449	dikb	294			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
60	CHEBI_46081	fluconazole	PR_P08684	cyp3a4	inhibits	RO_0002449	dikb	490			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
61	CHEBI_7494	nefazodone	PR_P08684	cyp3a4	inhibits	RO_0002449	dikb	626			http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/resource/structuredProductLabelMetadata/b1d149db-ad43-4f3f-aef1-fb0395ba4191	2017		
62	CHEBI_8028	perphenazine	PR_P10635	cyp2d6	is_substrate_of	DIDEO_00000041	dikb	148			http://www.ncbi.nlm.nih.gov/pubmed/11136295	2017		
63	CHEBI_10023	voriconazole	PR_P11712	cyp2c9	inhibits	RO_0002449	dikb	585			http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/resource/structuredProductLabelMetadata/ce3ef5cf-3087-4d92-9d94-9eb8287228db	2017		
64	CHEBI_10023	voriconazole	PR_P08684	cyp3a4	inhibits	RO_0002449	dikb	601			http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/resource/structuredProductLabelMetadata/ce3ef5cf-3087-4d92-9d94-9eb8287228db	2017		
65	CHEBI_28593	quinidine	PR_P08684	cyp3a4	is_substrate_of	DIDEO_00000041	dikb	227			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
66	CHEBI_50659	dronedarone	PR_P08684	cyp3a4	inhibits	RO_0002449	dikb	468			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
67	CHEBI_10119	ziprasidone	PR_P05177	cyp1a2	is_substrate_of	DIDEO_00000041	dikb	156			http://www.ncbi.nlm.nih.gov/pubmed/10771452	2017		
68	CHEBI_6950	mirtazapine	PR_P05177	cyp1a2	is_substrate_of	DIDEO_00000041	dikb	22			http://www.ncbi.nlm.nih.gov/pubmed/10997935	2017		
69	CHEBI_10023	voriconazole	PR_P33261	cyp2c19	inhibits	RO_0002449	dikb	599			http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/resource/structuredProductLabelMetadata/ce3ef5cf-3087-4d92-9d94-9eb8287228db	2017		
70	CHEBI_3090	bicalutamide	PR_P08684	cyp3a4	inhibits	RO_0002449	dikb	461			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
71	CHEBI_7915	pantoprazole	PR_P33261	cyp2c19	is_substrate_of	DIDEO_00000041	dikb	181			http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/resource/structuredProductLabelMetadata/742ca9f4-9fba-44d4-29a8-1fe3a04f1af6	2017		
72	CHEBI_42355	erythromycin	PR_P08684	cyp3a4	inhibits	RO_0002449	dikb	322			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
73	CHEBI_9150	simvastatin	PR_P08684	cyp3a4	is_substrate_of	DIDEO_00000041	dikb	2			http://www.ncbi.nlm.nih.gov/pubmed/9321523	2017		
74	CHEBI_9943	venlafaxine	PR_P10635	cyp2d6	inhibits	RO_0002449	dikb	308			http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/resource/structuredProductLabelMetadata/cf2d9bee-f8e3-477a-e4b4-f0e82657b7d2	2017		
75	CHEBI_7936	paroxetine	PR_P10635	cyp2d6	inhibits	RO_0002449	dikb	611			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
76	CHEBI_9566	thioridazine	PR_P10635	cyp2d6	is_substrate_of	DIDEO_00000041	dikb	242			http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/resource/structuredProductLabelMetadata/56b3f4c2-52af-4947-b225-6808ae9f26f5	2017		
77	CHEBI_5118	fluoxetine	PR_P33261	cyp2c19	inhibits	RO_0002449	dikb	481			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
78	CHEBI_80630	irinotecan	PR_Q9Y6L6	oatp1b1	is_substrate_of	DIDEO_00000041	dikb	27			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
79	CHEBI_10100	zafirlukast	PR_P11712	cyp2c9	inhibits	RO_0002449	dikb	451			http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/resource/structuredProductLabelMetadata/5550433b-8c9c-4378-058f-6bb724c4f18c	2017		
80	PC_213023	dabigatran-etexilate	PR_P08183	p-glycoprotein	is_substrate_of	DIDEO_00000041	dikb	176			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
81	CHEBI_65173	iloperidone	PR_P10635	cyp2d6	is_substrate_of	DIDEO_00000041	dikb	34			http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/resource/structuredProductLabelMetadata/33f60b40-3fca-11de-8f56-0002a5d5c51b	2017		
82	CHEBI_101278	diltiazem	PR_P10635	cyp2d6	inhibits	RO_0002449	dikb	541			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
83	CHEBI_2611	alprazolam	PR_P08684	cyp3a4	is_substrate_of	DIDEO_00000041	dikb	11			http://www.ncbi.nlm.nih.gov/pubmed/10548453	2017		
84	CHEBI_10125	zolpidem	PR_P08684	cyp3a4	is_substrate_of	DIDEO_00000041	dikb	93			http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/resource/structuredProductLabelMetadata/de965605-268a-4479-86f7-84de949cf36f	2017		
85	PC_64718	simvastatin-acid	PR_Q9Y6L6	oatp1b1	is_substrate_of	DIDEO_00000041	dikb	69			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
86	CHEBI_8776	ranitidine	PR_P08684	cyp3a4	inhibits	RO_0002449	dikb	462			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
87	CHEBI_5138	fluvoxamine	PR_P05177	cyp1a2	inhibits	RO_0002449	dikb	565			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
88	CHEBI_31596	febuxostat	PR_P10635	cyp2d6	inhibits	RO_0002449	dikb	574			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
89	CHEBI_8028	perphenazine	PR_P05177	cyp1a2	is_substrate_of	DIDEO_00000041	dikb	136			http://www.ncbi.nlm.nih.gov/pubmed/11136295	2017		
90	CHEBI_44032	indinavir	PR_P08684	cyp3a4	inhibits	RO_0002449	dikb	474			http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/resource/structuredProductLabelMetadata/e19405d9-d9a1-4072-5b9e-40cd3ae4bf1f	2017		
91	CHEBI_47519	ketoconazole	PR_P08183	p-glycoprotein	inhibits	RO_0002449	dikb	367			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
92	CHEBI_41774	tamoxifen	PR_P08684	cyp3a4	is_substrate_of	DIDEO_00000041	dikb	55			http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/resource/structuredProductLabelMetadata/407a372d-4448-4d53-afd4-eb0e74bbc336	2017		
93	CHEBI_36792	R-citalopram	PR_P33261	cyp2c19	is_substrate_of	DIDEO_00000041	dikb	196			http://www.ncbi.nlm.nih.gov/pubmed/11454728	2017		
94	CHEBI_38545	rosuvastatin	PR_Q9Y6L6	oatp1b1	is_substrate_of	DIDEO_00000041	dikb	14			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
95	CHEBI_28593	quinidine	PR_P08684	cyp3a4	inhibits	RO_0002449	dikb	471			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
96	CHEBI_82941	fosamprenavir	PR_P08684	cyp3a4	inhibits	RO_0002449	dikb	422			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
97	CHEBI_5775	hydralazine	PR_P10635	cyp2d6	inhibits	RO_0002449	dikb	566			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
98	CHEBI_28077	rifampin	PR_Q9Y6L6	oatp1b1	is_substrate_of	DIDEO_00000041	dikb	18			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
99	CHEBI_77590	armodafinil	PR_P33261	cyp2c19	inhibits	RO_0002449	dikb	421			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
100	CHEBI_39548	atorvastatin	PR_P08684	cyp3a4	is_substrate_of	DIDEO_00000041	dikb	7			http://www.ncbi.nlm.nih.gov/pubmed/11038166	2017		
101	CHEBI_28593	quinidine	PR_P08183	p-glycoprotein	inhibits	RO_0002449	dikb	334			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
102	CHEBI_36792	R-citalopram	PR_P10635	cyp2d6	is_substrate_of	DIDEO_00000041	dikb	68			http://www.ncbi.nlm.nih.gov/pubmed/11454728	2017		
103	CHEBI_87681	ranolazine	PR_P08684	cyp3a4	inhibits	RO_0002449	dikb	654			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
104	CHEBI_48390	cinacalcet	PR_P05177	cyp1a2	is_substrate_of	DIDEO_00000041	dikb	201			http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/resource/structuredProductLabelMetadata/45028573-13c4-4c8b-ae62-6c75bba97c81	2017		
105	CHEBI_49040	ezetimibe	PR_Q9Y6L6	oatp1b1	is_substrate_of	DIDEO_00000041	dikb	116			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
106	CHEBI_63589	etravirine	PR_P33261	cyp2c19	inhibits	RO_0002449	dikb	356			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
107	CHEBI_80603	S-demethylcitalopram	PR_P10635	cyp2d6	is_substrate_of	DIDEO_00000041	dikb	142			http://www.ncbi.nlm.nih.gov/pubmed/11454728	2017		
108	CHEBI_50275	esomeprazole	PR_P33261	cyp2c19	inhibits	RO_0002449	dikb	254			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
109	CHEBI_5801	hydroxychloroquine	PR_P10635	cyp2d6	inhibits	RO_0002449	dikb	506			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
110	CHEBI_8768	rabeprazole	PR_P33261	cyp2c19	is_substrate_of	DIDEO_00000041	dikb	117			http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/resource/structuredProductLabelMetadata/5d103551-978f-472a-9c62-51e6e4dea068	2017		
111	CHEBI_48390	cinacalcet	PR_P08684	cyp3a4	is_substrate_of	DIDEO_00000041	dikb	36			http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/resource/structuredProductLabelMetadata/45028573-13c4-4c8b-ae62-6c75bba97c81	2017		
185	CHEBI_9943	venlafaxine	PR_P10635	cyp2d6	is_substrate_of	DIDEO_00000041	dikb	42			http://www.ncbi.nlm.nih.gov/pubmed/10192828	2017		
112	CHEBI_53760	eszopiclone	PR_P08684	cyp3a4	is_substrate_of	DIDEO_00000041	dikb	26			http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/page/structuredProductLabelMetadata/fd047b2b-05a6-4d99-95cb-955f14bf329f	2017		
113	PC_12449426	desacetyldiltiazem	PR_P10635	cyp2d6	is_substrate_of	DIDEO_00000041	dikb	118			http://www.ncbi.nlm.nih.gov/pubmed/12235455	2017		
114	CHEBI_87681	ranolazine	PR_P10635	cyp2d6	is_substrate_of	DIDEO_00000041	dikb	62			http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=10bd89e9-2d00-430c-8f55-81a37fed5fab	2017		
115	CHEBI_2955	azithromycin	PR_P08183	p-glycoprotein	inhibits	RO_0002449	dikb	568			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
116	CHEBI_31236	aripiprazole	PR_P10635	cyp2d6	is_substrate_of	DIDEO_00000041	dikb	220			http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/resource/structuredProductLabelMetadata/c040bd1d-45b7-49f2-93ea-aed7220b30ac	2017		
117	CHEBI_6076	itraconazole	PR_P08684	cyp3a4	inhibits	RO_0002449	dikb	370			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
118	CHEBI_63619	propafenone	PR_P05177	cyp1a2	inhibits	RO_0002449	dikb	345			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
119	CHEBI_10100	zafirlukast	PR_P08684	cyp3a4	inhibits	RO_0002449	dikb	436			http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/resource/structuredProductLabelMetadata/5550433b-8c9c-4378-058f-6bb724c4f18c	2017		
120	CHEBI_7494	nefazodone	PR_P08684	cyp3a4	is_substrate_of	DIDEO_00000041	dikb	165			http://www.ncbi.nlm.nih.gov/pubmed/11872324	2017		
121	CHEBI_9123	sertraline	PR_P10635	cyp2d6	inhibits	RO_0002449	dikb	353			http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/resource/structuredProductLabelMetadata/b1de3ed9-1cb8-e419-3f25-5b0aeed5779a	2017		
122	CHEBI_101278	diltiazem	PR_P08183	p-glycoprotein	inhibits	RO_0002449	dikb	495			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
123	CHEBI_2611	alprazolam	PR_P20815	cyp3a5	is_substrate_of	DIDEO_00000041	dikb	12			http://www.ncbi.nlm.nih.gov/pubmed/16765147	2017		
124	CHEBI_2453	acyclovir	PR_P05177	cyp1a2	inhibits	RO_0002449	dikb	315			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
125	CHEBI_48390	cinacalcet	PR_P10635	cyp2d6	is_substrate_of	DIDEO_00000041	dikb	109			http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/resource/structuredProductLabelMetadata/45028573-13c4-4c8b-ae62-6c75bba97c81	2017		
126	CHEBI_135533	talinolol	PR_P08183	p-glycoprotein	is_substrate_of	DIDEO_00000041	dikb	185			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
127	CHEBI_4031	cyclosporine	PR_Q9Y6L6	oatp1b1	inhibits	RO_0002449	dikb	273			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
128	CHEBI_3732	clarithromycin	PR_P08684	cyp3a4	inhibits	RO_0002449	dikb	621			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
129	CHEBI_31236	aripiprazole	PR_P08684	cyp3a4	is_substrate_of	DIDEO_00000041	dikb	49			http://www.ncbi.nlm.nih.gov/pubmed/15770075	2017		
130	CHEBI_8707	quetiapine	PR_P08684	cyp3a4	is_substrate_of	DIDEO_00000041	dikb	100			http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/resource/structuredProductLabelMetadata/473a3ac4-67f4-4782-baa9-7f9bdd8761f4	2017		
131	CHEBI_585948	felodipine	PR_P08183	p-glycoprotein	inhibits	RO_0002449	dikb	514			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
132	CHEBI_8776	ranitidine	PR_P10635	cyp2d6	inhibits	RO_0002449	dikb	598			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
133	CHEBI_5138	fluvoxamine	PR_P33261	cyp2c19	inhibits	RO_0002449	dikb	554			http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/resource/structuredProductLabelMetadata/53664f8d-3a93-9f2b-daee-380707e4062c	2017		
134	CHEBI_37924	atazanavir	PR_P08684	cyp3a4	inhibits	RO_0002449	dikb	333			http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/resource/structuredProductLabelMetadata/165cff62-b284-4a27-a65d-9ec8a5bfcdd8	2017		
135	CHEBI_9123	sertraline	PR_P10635	cyp2d6	inhibits	RO_0002449	dikb	354			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
136	CHEBI_2663	amiodarone	PR_P05177	cyp1a2	inhibits	RO_0002449	dikb	432			http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/resource/structuredProductLabelMetadata/99991CC3-7271-44FC-91C3-3CAB0BBE7645	2017		
137	PC_64718	beta-hydroxy-simvastatin	PR_P08684	cyp3a4	is_substrate_of	DIDEO_00000041	dikb	87			http://www.ncbi.nlm.nih.gov/pubmed/15518608	2017		
138	PC_10044355	voriconazole-N-oxide	PR_P08684	cyp3a4	inhibits	RO_0002449	dikb	456			http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/resource/structuredProductLabelMetadata/ce3ef5cf-3087-4d92-9d94-9eb8287228db	2017		
139	CHEBI_65173	iloperidone	PR_P08684	cyp3a4	is_substrate_of	DIDEO_00000041	dikb	143			http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/resource/structuredProductLabelMetadata/33f60b40-3fca-11de-8f56-0002a5d5c51b	2017		
140	CHEBI_7936	paroxetine	PR_P10635	cyp2d6	inhibits	RO_0002449	dikb	608			http://www.ncbi.nlm.nih.gov/pubmed/12584155	2017		
141	CHEBI_68540	teriflunomide	PR_P11712	cyp2c9	inhibits	RO_0002449	dikb	417			http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/resource/structuredProductLabelMetadata/151ffcf4-e503-4954-af7c-93d0a4f9f80	2017		
142	CHEBI_8028	perphenazine	PR_P05177	cyp1a2	is_substrate_of	DIDEO_00000041	dikb	137			http://www.ncbi.nlm.nih.gov/pubmed/11136295	2017		
143	CHEBI_63619	propafenone	PR_P10635	cyp2d6	inhibits	RO_0002449	dikb	457			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
144	CHEBI_10100	zafirlukast	PR_P11712	cyp2c9	is_substrate_of	DIDEO_00000041	dikb	159			http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/resource/structuredProductLabelMetadata/5550433b-8c9c-4378-058f-6bb724c4f18c	2017		
145	CHEBI_38561	fluvastatin	PR_P11712	cyp2c9	inhibits	RO_0002449	dikb	318			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
146	CHEBI_63637	vemurafenib	PR_P05177	cyp1a2	inhibits	RO_0002449	dikb	337			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
147	CHEBI_63632	topotecan	PR_P08183	p-glycoprotein	is_substrate_of	DIDEO_00000041	dikb	107			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
186	CHEBI_46081	fluconazole	PR_P08684	cyp3a4	inhibits	RO_0002449	dikb	488			http://www.ncbi.nlm.nih.gov/pubmed/8904618	2017		
148	CHEBI_3380	captopril	PR_P08183	p-glycoprotein	inhibits	RO_0002449	dikb	285			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
149	CHEBI_8028	perphenazine	PR_P10635	cyp2d6	is_substrate_of	DIDEO_00000041	dikb	147			http://www.ncbi.nlm.nih.gov/pubmed/11136295	2017		
150	CHEBI_18358	methoxsalen	PR_P05177	cyp1a2	inhibits	RO_0002449	dikb	618			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
151	CHEBI_48416	olmesartan	PR_Q9Y6L6	oatp1b1	is_substrate_of	DIDEO_00000041	dikb	112			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
152	PC_6460146	modafinil-sulfone	PR_P33261	cyp2c19	inhibits	RO_0002449	dikb	383			http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/resource/structuredProductLabelMetadata/e16c26ad-7bc2-d155-3a5d-da83ad6492c8.pdf	2017		
153	CHEBI_9943	venlafaxine	PR_P10635	cyp2d6	is_substrate_of	DIDEO_00000041	dikb	41			http://www.ncbi.nlm.nih.gov/pubmed/10192828	2017		
154	CHEBI_6916	mexiletine	PR_P05177	cyp1a2	inhibits	RO_0002449	dikb	533			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
155	CHEBI_6076	itraconazole	PR_P08183	p-glycoprotein	inhibits	RO_0002449	dikb	549			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
156	CHEBI_3732	clarithromycin	PR_P08684	cyp3a4	is_substrate_of	DIDEO_00000041	dikb	216			http://www.ncbi.nlm.nih.gov/pubmed/12124305	2017		
157	CHEBI_9123	sertraline	PR_P10635	cyp2d6	inhibits	RO_0002449	dikb	352			http://www.ncbi.nlm.nih.gov/pubmed/11910262	2017		
158	CHEBI_52172	nilotinib	PR_P08684	cyp3a4	inhibits	RO_0002449	dikb	637			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
159	CHEBI_45863	paclitaxel	PR_P10632	cyp2c8	is_substrate_of	DIDEO_00000041	dikb	229			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
160	CHEBI_9948	verapamil	PR_P10635	cyp2d6	inhibits	RO_0002449	dikb	526			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
161	CHEBI_6375	lansoprazole	PR_P33261	cyp2c19	is_substrate_of	DIDEO_00000041	dikb	228			http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/resource/structuredProductLabelMetadata/71ba78cb-7e46-43eb-9425-fa130f537f84	2017		
162	CHEBI_68558	ticagrelor	PR_P08183	p-glycoprotein	inhibits	RO_0002449	dikb	551			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
163	CHEBI_100241	ciprofloxacin	PR_P05177	cyp1a2	inhibits	RO_0002449	dikb	344			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
164	CHEBI_5138	fluvoxamine	PR_P10635	cyp2d6	is_substrate_of	DIDEO_00000041	dikb	226			http://www.ncbi.nlm.nih.gov/pubmed/8823236	2017		
165	CHEBI_29688	telithromycin	PR_P10635	cyp2d6	inhibits	RO_0002449	dikb	385			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
166	CHEBI_5138	fluvoxamine	PR_P05177	cyp1a2	inhibits	RO_0002449	dikb	563			http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/resource/structuredProductLabelMetadata/53664f8d-3a93-9f2b-daee-380707e4062c	2017		
167	CHEBI_28077	rifampin	PR_Q9Y6L6	oatp1b1	inhibits	RO_0002449	dikb	289			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
168	CHEBI_65173	iloperidone	PR_P10635	cyp2d6	inhibits	RO_0002449	dikb	342			http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/resource/structuredProductLabelMetadata/33f60b40-3fca-11de-8f56-0002a5d5c51b	2017		
169	CHEBI_39548	atorvastatin	PR_Q9NPD5	oatp1b3	is_substrate_of	DIDEO_00000041	dikb	160			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
170	CHEBI_7735	olanzapine	PR_P10635	cyp2d6	is_substrate_of	DIDEO_00000041	dikb	174			http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/page/structuredProductLabelMetadata/d5051fbc-846b-4946-82df-341fb1216341	2017		
171	CHEBI_2663	amiodarone	PR_P11712	cyp2c9	inhibits	RO_0002449	dikb	351			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
172	CHEBI_40279	allopurinol	PR_P05177	cyp1a2	inhibits	RO_0002449	dikb	605			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
173	CHEBI_5118	fluoxetine	PR_P10635	cyp2d6	is_substrate_of	DIDEO_00000041	dikb	46			http://www.ncbi.nlm.nih.gov/pubmed/8941024	2017		
174	CHEBI_36796	duloxetine	PR_P10635	cyp2d6	inhibits	RO_0002449	dikb	389			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
175	CHEBI_5296	gemfibrozil	PR_P10632	cyp2c8	inhibits	RO_0002449	dikb	508			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
176	CHEBI_7494	nefazodone	PR_P08684	cyp3a4	inhibits	RO_0002449	dikb	628			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
177	CHEBI_4551	digoxin	PR_P08183	p-glycoprotein	is_substrate_of	DIDEO_00000041	dikb	200			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
178	CHEBI_681850	conivaptan	PR_P08183	p-glycoprotein	inhibits	RO_0002449	dikb	394			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
179	CHEBI_5118	fluoxetine	PR_P10635	cyp2d6	is_substrate_of	DIDEO_00000041	dikb	45			http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/resource/structuredProductLabelMetadata/5f356c1b-96bd-4ef1-960c-91cf4905e6b1	2017		
180	CHEBI_31236	aripiprazole	PR_P08684	cyp3a4	is_substrate_of	DIDEO_00000041	dikb	48			http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/resource/structuredProductLabelMetadata/c040bd1d-45b7-49f2-93ea-aed7220b30ac	2017		
181	CHEBI_64318	ergotamine	PR_P08684	cyp3a4	is_substrate_of	DIDEO_00000041	dikb	33			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
182	CHEBI_28593	quinidine	PR_P08183	p-glycoprotein	inhibits	RO_0002449	dikb	335			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
183	CHEBI_87681	ranolazine	PR_P20815	cyp3a5	inhibits	RO_0002449	dikb	652			http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=10bd89e9-2d00-430c-8f55-81a37fed5fab	2017		
184	CHEBI_29688	telithromycin	PR_P08684	cyp3a4	inhibits	RO_0002449	dikb	529			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
187	CHEBI_38545	rosuvastatin	PR_Q9NPD5	oatp1b3	is_substrate_of	DIDEO_00000041	dikb	15			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
188	CHEBI_71272	saxagliptin	PR_P08183	p-glycoprotein	is_substrate_of	DIDEO_00000041	dikb	231			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
189	CHEBI_6950	mirtazapine	PR_P08684	cyp3a4	is_substrate_of	DIDEO_00000041	dikb	57			http://www.ncbi.nlm.nih.gov/pubmed/10997935	2017		
190	CHEBI_7772	omeprazole	PR_P33261	cyp2c19	inhibits	RO_0002449	dikb	401			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
191	CHEBI_2955	azithromycin	PR_P08183	p-glycoprotein	inhibits	RO_0002449	dikb	569			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
192	CHEBI_47519	ketoconazole	PR_P08684	cyp3a4	inhibits	RO_0002449	dikb	375			http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/resource/structuredProductLabelMetadata/8ca815a8-bccb-4ee2-a042-922373329cae	2017		
193	CHEBI_5138	fluvoxamine	PR_P05177	cyp1a2	inhibits	RO_0002449	dikb	564			http://www.ncbi.nlm.nih.gov/pubmed/11719727	2017		
194	CHEBI_38561	fluvastatin	PR_P11712	cyp2c9	is_substrate_of	DIDEO_00000041	dikb	122			http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?id=3237	2017		
195	CHEBI_28593	quinidine	PR_P10635	cyp2d6	inhibits	RO_0002449	dikb	392			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
196	CHEBI_40237	sitagliptin	PR_P08183	p-glycoprotein	is_substrate_of	DIDEO_00000041	dikb	153			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
197	CHEBI_70752	dabigatran	PR_P08183	p-glycoprotein	is_substrate_of	DIDEO_00000041	dikb	138			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
198	CHEBI_10023	voriconazole	PR_P33261	cyp2c19	inhibits	RO_0002449	dikb	600			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
199	CHEBI_6076	itraconazole	PR_P08684	cyp3a4	inhibits	RO_0002449	dikb	368			http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/resource/structuredProductLabelMetadata/a4d555fa-787c-40fb-bb7d-b0d4f7318fd0	2017		
200	CHEBI_9948	verapamil	PR_P08684	cyp3a4	inhibits	RO_0002449	dikb	454			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
201	CHEBI_9948	verapamil	PR_P08183	p-glycoprotein	inhibits	RO_0002449	dikb	483			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
202	CHEBI_8212	pimozide	PR_P08684	cyp3a4	is_substrate_of	DIDEO_00000041	dikb	186			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
203	CHEBI_40303	lovastatin	PR_P08684	cyp3a4	is_substrate_of	DIDEO_00000041	dikb	128			http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/page/structuredProductLabelMetadata/d3620ebe-87e1-4a93-96cc-ff20ddbb30b2	2017		
204	CHEBI_44032	indinavir	PR_P08684	cyp3a4	inhibits	RO_0002449	dikb	475			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
205	CHEBI_29688	telithromycin	PR_P08684	cyp3a4	inhibits	RO_0002449	dikb	528			http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/resource/structuredProductLabelMetadata/4471223e-9023-457e-be2e-8e4e0c2d94d1	2017		
206	CHEBI_5118	fluoxetine	PR_P08684	cyp3a4	inhibits	RO_0002449	dikb	631			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
207	CHEBI_48390	cinacalcet	PR_P10635	cyp2d6	inhibits	RO_0002449	dikb	579			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
208	PC_11369918	N-desalkylquetiapine	PR_P08684	cyp3a4	is_substrate_of	DIDEO_00000041	dikb	126			http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/resource/structuredProductLabelMetadata/473a3ac4-67f4-4782-baa9-7f9bdd8761f4	2017		
209	CHEBI_3699	cimetidine	PR_P08684	cyp3a4	inhibits	RO_0002449	dikb	525			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
210	CHEBI_53760	eszopiclone	PR_P08684	cyp3a4	is_substrate_of	DIDEO_00000041	dikb	25			http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/page/structuredProductLabelMetadata/fd047b2b-05a6-4d99-95cb-955f14bf329f	2017		
211	CHEBI_9448	terbinafine	PR_P10635	cyp2d6	inhibits	RO_0002449	dikb	430			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
212	PC_10114519	dehydro-aripiprazole	PR_P08684	cyp3a4	is_substrate_of	DIDEO_00000041	dikb	134			http://www.ncbi.nlm.nih.gov/pubmed/15770075	2017		
213	CHEBI_3732	clarithromycin	PR_P08684	cyp3a4	inhibits	RO_0002449	dikb	620			http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/resource/structuredProductLabelMetadata/aa44552c-3cfe-4111-8aa5-4251aeed9be9	2017		
214	CHEBI_48390	cinacalcet	PR_P10635	cyp2d6	inhibits	RO_0002449	dikb	576			http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/resource/structuredProductLabelMetadata/45028573-13c4-4c8b-ae62-6c75bba97c81	2017		
215	CHEBI_42355	erythromycin	PR_P08684	cyp3a4	inhibits	RO_0002449	dikb	323			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
216	CHEBI_9948	verapamil	PR_P08684	cyp3a4	inhibits	RO_0002449	dikb	453			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
217	CHEBI_9566	thioridazine	PR_P10635	cyp2d6	is_substrate_of	DIDEO_00000041	dikb	243			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
218	CHEBI_9448	terbinafine	PR_P10635	cyp2d6	inhibits	RO_0002449	dikb	429			http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/resource/structuredProductLabelMetadata/7c6c1494-fb92-4442-bcff-764b77397495	2017		
219	CHEBI_2611	alprazolam	PR_P08684	cyp3a4	is_substrate_of	DIDEO_00000041	dikb	10			http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/page/structuredProductLabelMetadata/b5e516a0-d0f4-4613-ab56-b1bb440fcb78	2017		
220	CHEBI_6950	mirtazapine	PR_P08684	cyp3a4	is_substrate_of	DIDEO_00000041	dikb	56			http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/resource/structuredProductLabelMetadata/31f48378-27db-424f-a4c5-82584a553c35	2017		
221	CHEBI_9588	ticlopidine	PR_P33261	cyp2c19	inhibits	RO_0002449	dikb	480			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
222	CHEBI_3219	bupropion	PR_P20813	cyp2b6	is_substrate_of	DIDEO_00000041	dikb	197			http://www.ncbi.nlm.nih.gov/pubmed/10997944	2017		
223	CHEBI_3699	cimetidine	PR_P10635	cyp2d6	inhibits	RO_0002449	dikb	314			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
224	CHEBI_47519	ketoconazole	PR_P08183	p-glycoprotein	inhibits	RO_0002449	dikb	366			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
225	CHEBI_3766	clozapine	PR_P10635	cyp2d6	is_substrate_of	DIDEO_00000041	dikb	132			http://www.ncbi.nlm.nih.gov/pubmed/11147928	2017		
226	CHEBI_8028	perphenazine	PR_P08684	cyp3a4	is_substrate_of	DIDEO_00000041	dikb	65			http://www.ncbi.nlm.nih.gov/pubmed/11136295	2017		
227	CHEBI_36792	R-citalopram	PR_P08684	cyp3a4	is_substrate_of	DIDEO_00000041	dikb	214			http://www.ncbi.nlm.nih.gov/pubmed/11454728	2017		
228	CHEBI_6950	mirtazapine	PR_P05177	cyp1a2	is_substrate_of	DIDEO_00000041	dikb	21			http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/resource/structuredProductLabelMetadata/31f48378-27db-424f-a4c5-82584a553c35	2017		
229	CHEBI_68621	boceprevir	PR_P08684	cyp3a4	inhibits	RO_0002449	dikb	286			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
230	CHEBI_5296	gemfibrozil	PR_Q9Y6L6	oatp1b1	inhibits	RO_0002449	dikb	518			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
231	CHEBI_83527	desvenlafaxine	PR_P10635	cyp2d6	inhibits	RO_0002449	dikb	636			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
232	CHEBI_37924	atazanavir	PR_P20815	cyp3a5	inhibits	RO_0002449	dikb	332			http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/resource/structuredProductLabelMetadata/165cff62-b284-4a27-a65d-9ec8a5bfcdd8	2017		
233	CHEBI_36796	duloxetine	PR_P10635	cyp2d6	inhibits	RO_0002449	dikb	387			http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/resource/structuredProductLabelMetadata/2f7d4d67-10c1-4bf4-a7f2-c185fbad64ba	2017		
234	CHEBI_8028	perphenazine	PR_P10635	cyp2d6	is_substrate_of	DIDEO_00000041	dikb	150			http://www.ncbi.nlm.nih.gov/pubmed/17429316	2017		
235	CHEBI_2611	alprazolam	PR_P20815	cyp3a5	is_substrate_of	DIDEO_00000041	dikb	13			http://www.ncbi.nlm.nih.gov/pubmed/12124305	2017		
236	CHEBI_3770	cotrimoxazole	PR_P11712	cyp2c9	inhibits	RO_0002449	dikb	253			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
237	CHEBI_85010	eltrombopag	PR_Q9Y6L6	oatp1b1	inhibits	RO_0002449	dikb	384			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
238	CHEBI_39548	atorvastatin	PR_P20815	cyp3a5	is_substrate_of	DIDEO_00000041	dikb	5			http://www.ncbi.nlm.nih.gov/pubmed/11038166	2017		
239	CHEBI_40050	amprenavir	PR_P08684	cyp3a4	inhibits	RO_0002449	dikb	584			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
240	CHEBI_47519	ketoconazole	PR_P08684	cyp3a4	inhibits	RO_0002449	dikb	372			http://www.ncbi.nlm.nih.gov/pubmed/15114429	2017		
241	CHEBI_10023	voriconazole	PR_P33261	cyp2c19	is_substrate_of	DIDEO_00000041	dikb	192			http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/resource/structuredProductLabelMetadata/ce3ef5cf-3087-4d92-9d94-9eb8287228db	2017		
242	CHEBI_5441	glyburide	PR_Q9Y6L6	oatp1b1	is_substrate_of	DIDEO_00000041	dikb	90			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
243	CHEBI_39548	atorvastatin	PR_P20815	cyp3a5	is_substrate_of	DIDEO_00000041	dikb	4			http://www.ncbi.nlm.nih.gov/pubmed/11038166	2017		
244	CHEBI_2569	alfentanil	PR_P08684	cyp3a4	is_substrate_of	DIDEO_00000041	dikb	83			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
245	CHEBI_32246	tolvaptan	PR_P08183	p-glycoprotein	is_substrate_of	DIDEO_00000041	dikb	96			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
246	CHEBI_9943	venlafaxine	PR_P10635	cyp2d6	is_substrate_of	DIDEO_00000041	dikb	40			http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/resource/structuredProductLabelMetadata/cf2d9bee-f8e3-477a-e4b4-f0e82657b7d2	2017		
247	CHEBI_10102	zaleplon	PR_P08684	cyp3a4	is_substrate_of	DIDEO_00000041	dikb	50			http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/resource/structuredProductLabelMetadata/71be4cb7-a42f-43be-9b9b-f090edb2fd21	2017		
248	CHEBI_8707	quetiapine	PR_P08684	cyp3a4	is_substrate_of	DIDEO_00000041	dikb	101			http://www.ncbi.nlm.nih.gov/pubmed/15834460	2017		
249	CHEBI_8499	propranolol	PR_P05177	cyp1a2	inhibits	RO_0002449	dikb	307			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
250	CHEBI_5118	fluoxetine	PR_P10635	cyp2d6	inhibits	RO_0002449	dikb	448			http://www.ncbi.nlm.nih.gov/pubmed/12173784	2017		
251	CHEBI_68595	telaprevir	PR_P08684	cyp3a4	inhibits	RO_0002449	dikb	381			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
252	CHEBI_5138	fluvoxamine	PR_P10635	cyp2d6	is_substrate_of	DIDEO_00000041	dikb	225			http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/resource/structuredProductLabelMetadata/53664f8d-3a93-9f2b-daee-380707e4062c	2017		
253	CHEBI_7936	paroxetine	PR_P10635	cyp2d6	inhibits	RO_0002449	dikb	609			http://www.ncbi.nlm.nih.gov/pubmed/8513845	2017		
254	CHEBI_48416	olmesartan	PR_Q9NPD5	oatp1b3	is_substrate_of	DIDEO_00000041	dikb	113			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
255	CHEBI_87681	ranolazine	PR_P10635	cyp2d6	inhibits	RO_0002449	dikb	269			http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=10bd89e9-2d00-430c-8f55-81a37fed5fab	2017		
256	CHEBI_36796	duloxetine	PR_P05177	cyp1a2	is_substrate_of	DIDEO_00000041	dikb	98			http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/resource/structuredProductLabelMetadata/2f7d4d67-10c1-4bf4-a7f2-c185fbad64ba	2017		
257	CHEBI_65173	iloperidone	PR_P10635	cyp2d6	is_substrate_of	DIDEO_00000041	dikb	35			http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/resource/structuredProductLabelMetadata/33f60b40-3fca-11de-8f56-0002a5d5c51b	2017		
258	CHEBI_42355	erythromycin	PR_P08684	cyp3a4	inhibits	RO_0002449	dikb	321			http://www.ncbi.nlm.nih.gov/pubmed/8720318	2017		
259	CHEBI_6375	lansoprazole	PR_P20815	cyp3a5	is_substrate_of	DIDEO_00000041	dikb	241			http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/resource/structuredProductLabelMetadata/71ba78cb-7e46-43eb-9425-fa130f537f84	2017		
260	CHEBI_42355	erythromycin	PR_P08183	p-glycoprotein	inhibits	RO_0002449	dikb	364			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
261	CHEBI_5138	fluvoxamine	PR_P08684	cyp3a4	inhibits	RO_0002449	dikb	500			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
262	CHEBI_31413	clobazam	PR_P10635	cyp2d6	inhibits	RO_0002449	dikb	378			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
263	CHEBI_3766	clozapine	PR_P10635	cyp2d6	is_substrate_of	DIDEO_00000041	dikb	131			http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/resource/structuredProductLabelMetadata/883b5d43-0339-7dc1-f775-93791fb9b978	2017		
264	CHEBI_3699	cimetidine	PR_P08684	cyp3a4	inhibits	RO_0002449	dikb	524			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
265	CHEBI_6950	mirtazapine	PR_P10635	cyp2d6	is_substrate_of	DIDEO_00000041	dikb	182			http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/resource/structuredProductLabelMetadata/31f48378-27db-424f-a4c5-82584a553c35	2017		
266	CHEBI_41423	celecoxib	PR_P10635	cyp2d6	inhibits	RO_0002449	dikb	614			http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/resource/structuredProductLabelMetadata/8d52185d-421f-4e34-8db7-f7676db2a226	2017		
267	CHEBI_6916	mexiletine	PR_P05177	cyp1a2	inhibits	RO_0002449	dikb	531			http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/resource/structuredProductLabelMetadata/AB73778B-6794-441C-B127-610A6D0733EA	2017		
268	CHEBI_4031	cyclosporine	PR_P08684	cyp3a4	inhibits	RO_0002449	dikb	283			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
269	CHEBI_39548	atorvastatin	PR_P08684	cyp3a4	inhibits	RO_0002449	dikb	520			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
270	CHEBI_3766	clozapine	PR_P08684	cyp3a4	is_substrate_of	DIDEO_00000041	dikb	180			http://www.ncbi.nlm.nih.gov/pubmed/9384460	2017		
271	CHEBI_681850	conivaptan	PR_P08684	cyp3a4	inhibits	RO_0002449	dikb	649			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
272	CHEBI_64355	posaconazole	PR_P08684	cyp3a4	inhibits	RO_0002449	dikb	252			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
273	CHEBI_6950	mirtazapine	PR_P20815	cyp3a5	is_substrate_of	DIDEO_00000041	dikb	58			http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/resource/structuredProductLabelMetadata/31f48378-27db-424f-a4c5-82584a553c35	2017		
274	CHEBI_8768	rabeprazole	PR_P20815	cyp3a5	is_substrate_of	DIDEO_00000041	dikb	28			http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/resource/structuredProductLabelMetadata/5d103551-978f-472a-9c62-51e6e4dea068	2017		
275	CHEBI_46081	fluconazole	PR_P11712	cyp2c9	inhibits	RO_0002449	dikb	540			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
276	CHEBI_3766	clozapine	PR_P08684	cyp3a4	is_substrate_of	DIDEO_00000041	dikb	179			http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/resource/structuredProductLabelMetadata/883b5d43-0339-7dc1-f775-93791fb9b978	2017		
277	CHEBI_3766	clozapine	PR_P05177	cyp1a2	is_substrate_of	DIDEO_00000041	dikb	139			http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/resource/structuredProductLabelMetadata/883b5d43-0339-7dc1-f775-93791fb9b978	2017		
278	CHEBI_6375	lansoprazole	PR_P08684	cyp3a4	is_substrate_of	DIDEO_00000041	dikb	230			http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/resource/structuredProductLabelMetadata/71ba78cb-7e46-43eb-9425-fa130f537f84	2017		
279	CHEBI_10119	ziprasidone	PR_P08684	cyp3a4	is_substrate_of	DIDEO_00000041	dikb	239			http://www.ncbi.nlm.nih.gov/pubmed/10771458	2017		
280	CHEBI_39548	atorvastatin	PR_P08684	cyp3a4	is_substrate_of	DIDEO_00000041	dikb	6			http://www.ncbi.nlm.nih.gov/pubmed/11038166	2017		
281	CHEBI_681850	conivaptan	PR_P08183	p-glycoprotein	inhibits	RO_0002449	dikb	395			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
282	CHEBI_42355	erythromycin	PR_P08183	p-glycoprotein	inhibits	RO_0002449	dikb	365			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
283	CHEBI_8707	quetiapine	PR_P08684	cyp3a4	is_substrate_of	DIDEO_00000041	dikb	102			http://www.ncbi.nlm.nih.gov/pubmed/16390352	2017		
284	CHEBI_5138	fluvoxamine	PR_P33261	cyp2c19	inhibits	RO_0002449	dikb	555			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
285	CHEBI_39548	atorvastatin	PR_P08684	cyp3a4	is_substrate_of	DIDEO_00000041	dikb	8			http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/page/structuredProductLabelMetadata/8a201c80-a51d-4c1c-963b-488c071908c0	2017		
286	CHEBI_101278	diltiazem	PR_P08684	cyp3a4	inhibits	RO_0002449	dikb	419			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
287	CHEBI_10112	zileuton	PR_P05177	cyp1a2	inhibits	RO_0002449	dikb	575			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
288	CHEBI_45783	imatinib	PR_P08684	cyp3a4	inhibits	RO_0002449	dikb	284			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
289	CHEBI_7936	paroxetine	PR_P10635	cyp2d6	is_substrate_of	DIDEO_00000041	dikb	108			http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/resource/structuredProductLabelMetadata/08320ea3-8f93-6f04-5d1c-f69af3eb5a81	2017		
291	PC_10114519	dehydro-aripiprazole	PR_P08684	cyp3a4	is_substrate_of	DIDEO_00000041	dikb	133			http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/resource/structuredProductLabelMetadata/c040bd1d-45b7-49f2-93ea-aed7220b30ac	2017		
292	CHEBI_27882	colchicine	PR_P08183	p-glycoprotein	is_substrate_of	DIDEO_00000041	dikb	173			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
293	CHEBI_3766	clozapine	PR_P05177	cyp1a2	is_substrate_of	DIDEO_00000041	dikb	140			http://www.ncbi.nlm.nih.gov/pubmed/9384460	2017		
294	CHEBI_10023	voriconazole	PR_P08684	cyp3a4	is_substrate_of	DIDEO_00000041	dikb	204			http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/resource/structuredProductLabelMetadata/ce3ef5cf-3087-4d92-9d94-9eb8287228db	2017		
295	CHEBI_3732	clarithromycin	PR_P08183	p-glycoprotein	inhibits	RO_0002449	dikb	399			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
296	CHEBI_7496	nelfinavir	PR_P08684	cyp3a4	inhibits	RO_0002449	dikb	542			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
297	CHEBI_45409	ritonavir	PR_P08684	cyp3a4	inhibits	RO_0002449	dikb	437			http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/resource/structuredProductLabelMetadata/2849298e-de6e-47bb-8194-56e075b33fc3	2017		
298	CHEBI_10033	warfarin	PR_P11712	cyp2c9	is_substrate_of	DIDEO_00000041	dikb	184			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
299	CHEBI_42355	erythromycin	PR_P08684	cyp3a4	inhibits	RO_0002449	dikb	320			http://www.ncbi.nlm.nih.gov/pubmed/9757151	2017		
300	CHEBI_149836	tigecycline	PR_P11712	cyp2c9	inhibits	RO_0002449	dikb	477			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
301	CHEBI_3723	citalopram	PR_P33261	cyp2c19	is_substrate_of	DIDEO_00000041	dikb	23			http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/resource/structuredProductLabelMetadata/62f9e5da-6215-4d6d-8601-ea01ec2655ab	2017		
302	CHEBI_9943	venlafaxine	PR_P08684	cyp3a4	is_substrate_of	DIDEO_00000041	dikb	67			http://www.ncbi.nlm.nih.gov/pubmed/10192828	2017		
303	CHEBI_2955	azithromycin	PR_P08684	cyp3a4	inhibits	RO_0002449	dikb	409			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
304	CHEBI_64310	crizotinib	PR_P08684	cyp3a4	inhibits	RO_0002449	dikb	246			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
305	CHEBI_3732	clarithromycin	PR_P08684	cyp3a4	inhibits	RO_0002449	dikb	619			http://www.ncbi.nlm.nih.gov/pubmed/8880291	2017		
306	CHEBI_87681	ranolazine	PR_P08183	p-glycoprotein	inhibits	RO_0002449	dikb	544			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
307	CHEBI_87681	ranolazine	PR_P08684	cyp3a4	inhibits	RO_0002449	dikb	653			http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=10bd89e9-2d00-430c-8f55-81a37fed5fab	2017		
308	CHEBI_36791	escitalopram	PR_P10635	cyp2d6	is_substrate_of	DIDEO_00000041	dikb	24			http://www.ncbi.nlm.nih.gov/pubmed/11454728	2017		
309	CHEBI_36796	duloxetine	PR_P10635	cyp2d6	is_substrate_of	DIDEO_00000041	dikb	16			http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/resource/structuredProductLabelMetadata/2f7d4d67-10c1-4bf4-a7f2-c185fbad64ba	2017		
310	CHEBI_10100	zafirlukast	PR_P11712	cyp2c9	inhibits	RO_0002449	dikb	450			http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/resource/structuredProductLabelMetadata/5550433b-8c9c-4378-058f-6bb724c4f18c	2017		
311	CHEBI_101278	diltiazem	PR_P08183	p-glycoprotein	inhibits	RO_0002449	dikb	494			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
312	CHEBI_101278	diltiazem	PR_P08684	cyp3a4	inhibits	RO_0002449	dikb	418			http://www.ncbi.nlm.nih.gov/pubmed/9146848	2017		
313	PC_119265	reduced-haloperidol	PR_P08684	cyp3a4	is_substrate_of	DIDEO_00000041	dikb	84			http://www.ncbi.nlm.nih.gov/pubmed/9825830	2017		
314	CHEBI_3219	bupropion	PR_P10635	cyp2d6	inhibits	RO_0002449	dikb	302			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
315	CHEBI_10023	voriconazole	PR_P08684	cyp3a4	inhibits	RO_0002449	dikb	602			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
316	CHEBI_5118	fluoxetine	PR_P10635	cyp2d6	inhibits	RO_0002449	dikb	449			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
317	PC_10044355	voriconazole-N-oxide	PR_P33261	cyp2c19	inhibits	RO_0002449	dikb	597			http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/resource/structuredProductLabelMetadata/ce3ef5cf-3087-4d92-9d94-9eb8287228db	2017		
318	CHEBI_37941	clopidogrel	PR_P20813	cyp2b6	inhibits	RO_0002449	dikb	587			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
319	CHEBI_9927	valsartan	PR_Q9NPD5	oatp1b3	is_substrate_of	DIDEO_00000041	dikb	53			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
320	CHEBI_32020	pitavastatin	PR_Q9Y6L6	oatp1b1	is_substrate_of	DIDEO_00000041	dikb	166			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
321	CHEBI_63637	vemurafenib	PR_P10635	cyp2d6	inhibits	RO_0002449	dikb	458			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
322	CHEBI_2663	amiodarone	PR_P08183	p-glycoprotein	inhibits	RO_0002449	dikb	249			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
323	CHEBI_45783	imatinib	PR_P10635	cyp2d6	inhibits	RO_0002449	dikb	502			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
324	CHEBI_5138	fluvoxamine	PR_P11712	cyp2c9	inhibits	RO_0002449	dikb	512			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
325	CHEBI_49668	gefitinib	PR_P10635	cyp2d6	inhibits	RO_0002449	dikb	559			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
326	PC_14391644	N-demethyldesacetyl-diltiazem	PR_P10635	cyp2d6	is_substrate_of	DIDEO_00000041	dikb	154			http://www.ncbi.nlm.nih.gov/pubmed/12235455	2017		
327	CHEBI_31859	modafinil	PR_P33261	cyp2c19	inhibits	RO_0002449	dikb	261			http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/resource/structuredProductLabelMetadata/e16c26ad-7bc2-d155-3a5d-da83ad6492c8.pdf	2017		
2187	CHEBI_47519	ketoconazole	PR_P10635	CYP2D6	inhibits	RO_0002449	FDA		175		"18372400"	2017		
328	CHEBI_9168	sirolimus	PR_P08684	cyp3a4	is_substrate_of	DIDEO_00000041	dikb	125			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
329	CHEBI_7936	paroxetine	PR_P10635	cyp2d6	inhibits	RO_0002449	dikb	610			http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/resource/structuredProductLabelMetadata/89dd7e24-85fc-4152-89ea-47ec2b48a1ed	2017		
330	CHEBI_8871	risperidone	PR_P08684	cyp3a4	is_substrate_of	DIDEO_00000041	dikb	146			http://www.ncbi.nlm.nih.gov/pubmed/10048600	2017		
331	CHEBI_50659	dronedarone	PR_P08183	p-glycoprotein	inhibits	RO_0002449	dikb	498			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
332	CHEBI_5118	fluoxetine	PR_P10635	cyp2d6	inhibits	RO_0002449	dikb	446			http://www.ncbi.nlm.nih.gov/pubmed/11910262	2017		
333	CHEBI_28077	rifampin	PR_Q9NPD5	oatp1b3	inhibits	RO_0002449	dikb	288			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
334	CHEBI_45409	ritonavir	PR_P10635	cyp2d6	inhibits	RO_0002449	dikb	396			http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/resource/structuredProductLabelMetadata/2849298e-de6e-47bb-8194-56e075b33fc3	2017		
336	CHEBI_47519	ketoconazole	PR_P08684	cyp3a4	inhibits	RO_0002449	dikb	373			http://www.ncbi.nlm.nih.gov/pubmed/14551182	2017		
337	CHEBI_4562	dihydroergotamine	PR_P08684	cyp3a4	is_substrate_of	DIDEO_00000041	dikb	222			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
338	CHEBI_7494	nefazodone	PR_P08684	cyp3a4	inhibits	RO_0002449	dikb	625			http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/resource/structuredProductLabelMetadata/b1d149db-ad43-4f3f-aef1-fb0395ba4191	2017		
339	CHEBI_8028	perphenazine	PR_P08684	cyp3a4	is_substrate_of	DIDEO_00000041	dikb	66			http://www.ncbi.nlm.nih.gov/pubmed/11136295	2017		
340	CHEBI_49603	lapatinib	PR_P08183	p-glycoprotein	is_substrate_of	DIDEO_00000041	dikb	19			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
341	CHEBI_5613	haloperidol	PR_P08684	cyp3a4	is_substrate_of	DIDEO_00000041	dikb	39			http://www.ncbi.nlm.nih.gov/pubmed/9431831	2017		
342	CHEBI_2663	amiodarone	PR_P08684	cyp3a4	inhibits	RO_0002449	dikb	493			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
343	CHEBI_7494	nefazodone	PR_P08684	cyp3a4	inhibits	RO_0002449	dikb	627			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
344	PC_129734485	beta-hydroxy-lovastatin	PR_P08684	cyp3a4	is_substrate_of	DIDEO_00000041	dikb	213			http://www.ncbi.nlm.nih.gov/pubmed/8689812	2017		
345	CHEBI_585948	felodipine	PR_P08183	p-glycoprotein	inhibits	RO_0002449	dikb	515			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
346	CHEBI_8768	rabeprazole	PR_P08684	cyp3a4	is_substrate_of	DIDEO_00000041	dikb	29			http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/resource/structuredProductLabelMetadata/5d103551-978f-472a-9c62-51e6e4dea068	2017		
347	CHEBI_499361	aprepitant	PR_P08684	cyp3a4	inhibits	RO_0002449	dikb	407			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
348	PC_10044355	voriconazole-N-oxide	PR_P11712	cyp2c9	inhibits	RO_0002449	dikb	509			http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/resource/structuredProductLabelMetadata/ce3ef5cf-3087-4d92-9d94-9eb8287228db	2017		
349	CHEBI_36796	duloxetine	PR_P10635	cyp2d6	is_substrate_of	DIDEO_00000041	dikb	17			http://www.ncbi.nlm.nih.gov/pubmed/12621382	2017		
350	CHEBI_3732	clarithromycin	PR_P08183	p-glycoprotein	inhibits	RO_0002449	dikb	400			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
351	CHEBI_2668	amlodipine	PR_P08684	cyp3a4	inhibits	RO_0002449	dikb	257			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
352	CHEBI_87681	ranolazine	PR_P08684	cyp3a4	inhibits	RO_0002449	dikb	655			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
353	CHEBI_41423	celecoxib	PR_P10635	cyp2d6	inhibits	RO_0002449	dikb	616			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
354	CHEBI_29688	telithromycin	PR_P08684	cyp3a4	inhibits	RO_0002449	dikb	527			http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/resource/structuredProductLabelMetadata/4471223e-9023-457e-be2e-8e4e0c2d94d1	2017		
355	CHEBI_5118	fluoxetine	PR_P10635	cyp2d6	inhibits	RO_0002449	dikb	447			http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/resource/structuredProductLabelMetadata/5f356c1b-96bd-4ef1-960c-91cf4905e6b1	2017		
356	CHEBI_36791	escitalopram	PR_P10635	cyp2d6	inhibits	RO_0002449	dikb	402			http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/resource/structuredProductLabelMetadata/13bb8267-1cab-43e5-acae-55a4d957630a	2017		
357	CHEBI_8212	pimozide	PR_P10635	cyp2d6	is_substrate_of	DIDEO_00000041	dikb	61			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
358	CHEBI_27732	caffeine	PR_P05177	cyp1a2	inhibits	RO_0002449	dikb	501			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
360	CHEBI_9150	simvastatin	PR_P08684	cyp3a4	is_substrate_of	DIDEO_00000041	dikb	1			http://www.ncbi.nlm.nih.gov/pubmed/9542477	2017		
361	CHEBI_5138	fluvoxamine	PR_P11712	cyp2c9	inhibits	RO_0002449	dikb	511			http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/resource/structuredProductLabelMetadata/53664f8d-3a93-9f2b-daee-380707e4062c	2017		
362	CHEBI_6950	mirtazapine	PR_P10635	cyp2d6	is_substrate_of	DIDEO_00000041	dikb	183			http://www.ncbi.nlm.nih.gov/pubmed/10997935	2017		
363	CHEBI_87681	ranolazine	PR_P08183	p-glycoprotein	is_substrate_of	DIDEO_00000041	dikb	32			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
364	CHEBI_6909	metronidazole	PR_P11712	cyp2c9	inhibits	RO_0002449	dikb	358			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
365	CHEBI_40303	lovastatin	PR_P08684	cyp3a4	is_substrate_of	DIDEO_00000041	dikb	129			http://www.ncbi.nlm.nih.gov/pubmed/8689812	2017		
366	CHEBI_49603	lapatinib	PR_P08684	cyp3a4	inhibits	RO_0002449	dikb	443			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
367	CHEBI_4031	cyclosporine	PR_P08183	p-glycoprotein	inhibits	RO_0002449	dikb	349			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
368	CHEBI_8028	perphenazine	PR_P33261	cyp2c19	is_substrate_of	DIDEO_00000041	dikb	223			http://www.ncbi.nlm.nih.gov/pubmed/11136295	2017		
369	CHEBI_119915	fentanyl	PR_P08684	cyp3a4	is_substrate_of	DIDEO_00000041	dikb	76			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
370	CHEBI_31348	capecitabine	PR_P11712	cyp2c9	inhibits	RO_0002449	dikb	336			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
371	CHEBI_46081	fluconazole	PR_P08684	cyp3a4	inhibits	RO_0002449	dikb	489			http://www.ncbi.nlm.nih.gov/pubmed/16172184	2017		
372	CHEBI_9123	sertraline	PR_P33261	cyp2c19	is_substrate_of	DIDEO_00000041	dikb	209			http://www.ncbi.nlm.nih.gov/pubmed/11452243	2017		
373	CHEBI_41774	tamoxifen	PR_P11712	cyp2c9	is_substrate_of	DIDEO_00000041	dikb	207			http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/resource/structuredProductLabelMetadata/407a372d-4448-4d53-afd4-eb0e74bbc336	2017		
374	CHEBI_71219	pazopanib	PR_P08684	cyp3a4	inhibits	RO_0002449	dikb	270			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
375	CHEBI_2663	amiodarone	PR_P08183	p-glycoprotein	inhibits	RO_0002449	dikb	250			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
376	CHEBI_87715	prasugrel	PR_P20813	cyp2b6	inhibits	RO_0002449	dikb	424			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
377	CHEBI_45409	ritonavir	PR_P08684	cyp3a4	inhibits	RO_0002449	dikb	438			http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/resource/structuredProductLabelMetadata/2849298e-de6e-47bb-8194-56e075b33fc3	2017		
378	CHEBI_3441	carvedilol	PR_P08183	p-glycoprotein	inhibits	RO_0002449	dikb	248			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
379	CHEBI_5050	fexofenadine	PR_P08183	p-glycoprotein	is_substrate_of	DIDEO_00000041	dikb	219			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
380	CHEBI_3699	cimetidine	PR_P33261	cyp2c19	inhibits	RO_0002449	dikb	595			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
381	CHEBI_41774	tamoxifen	PR_P10635	cyp2d6	is_substrate_of	DIDEO_00000041	dikb	152			http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/resource/structuredProductLabelMetadata/407a372d-4448-4d53-afd4-eb0e74bbc336	2017		
382	CHEBI_36796	duloxetine	PR_P10635	cyp2d6	inhibits	RO_0002449	dikb	388			http://www.ncbi.nlm.nih.gov/pubmed/12621382	2017		
383	CHEBI_6030	isoniazid	PR_P08684	cyp3a4	inhibits	RO_0002449	dikb	281			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
384	CHEBI_9588	ticlopidine	PR_P05177	cyp1a2	inhibits	RO_0002449	dikb	463			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
385	CHEBI_28177	theophylline	PR_P05177	cyp1a2	is_substrate_of	DIDEO_00000041	dikb	111			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
386	CHEBI_100241	ciprofloxacin	PR_P05177	cyp1a2	inhibits	RO_0002449	dikb	343			http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/resource/structuredProductLabelMetadata/c103da18-a822-4944-1bd7-8ecdb5205d69	2017		
387	CHEBI_49603	lapatinib	PR_P08684	cyp3a4	inhibits	RO_0002449	dikb	444			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
388	CHEBI_41423	celecoxib	PR_P11712	cyp2c9	is_substrate_of	DIDEO_00000041	dikb	77			http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/resource/structuredProductLabelMetadata/8d52185d-421f-4e34-8db7-f7676db2a226	2017		
389	CHEBI_36791	escitalopram	PR_P33261	cyp2c19	is_substrate_of	DIDEO_00000041	dikb	145			http://www.ncbi.nlm.nih.gov/pubmed/11454728	2017		
390	CHEBI_3732	clarithromycin	PR_P20815	cyp3a5	inhibits	RO_0002449	dikb	623			http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/resource/structuredProductLabelMetadata/aa44552c-3cfe-4111-8aa5-4251aeed9be9	2017		
391	CHEBI_9150	simvastatin	PR_P08684	cyp3a4	is_substrate_of	DIDEO_00000041	dikb	3			http://www.ncbi.nlm.nih.gov/pubmed/15518608	2017		
392	CHEBI_87681	ranolazine	PR_P08183	p-glycoprotein	inhibits	RO_0002449	dikb	543			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
393	CHEBI_48390	cinacalcet	PR_P08684	cyp3a4	is_substrate_of	DIDEO_00000041	dikb	37			http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/resource/structuredProductLabelMetadata/45028573-13c4-4c8b-ae62-6c75bba97c81	2017		
394	CHEBI_681850	conivaptan	PR_P08684	cyp3a4	inhibits	RO_0002449	dikb	648			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
395	CHEBI_46081	fluconazole	PR_P33261	cyp2c19	inhibits	RO_0002449	dikb	487			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
396	CHEBI_10100	zafirlukast	PR_P11712	cyp2c9	inhibits	RO_0002449	dikb	452			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
397	CHEBI_100241	ciprofloxacin	PR_P08684	cyp3a4	inhibits	RO_0002449	dikb	295			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
398	CHEBI_7936	paroxetine	PR_P10635	cyp2d6	inhibits	RO_0002449	dikb	606			http://www.ncbi.nlm.nih.gov/pubmed/11910262	2017		
399	CHEBI_2663	amiodarone	PR_P11712	cyp2c9	inhibits	RO_0002449	dikb	350			http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/resource/structuredProductLabelMetadata/99991CC3-7271-44FC-91C3-3CAB0BBE7645	2017		
400	CHEBI_2663	amiodarone	PR_P10635	cyp2d6	inhibits	RO_0002449	dikb	657			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
401	CHEBI_2663	amiodarone	PR_P08684	cyp3a4	inhibits	RO_0002449	dikb	491			http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/resource/structuredProductLabelMetadata/99991CC3-7271-44FC-91C3-3CAB0BBE7645	2017		
402	CHEBI_7820	oxandrolone	PR_P11712	cyp2c9	inhibits	RO_0002449	dikb	503			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
403	CHEBI_8871	risperidone	PR_P10635	cyp2d6	is_substrate_of	DIDEO_00000041	dikb	199			http://www.ncbi.nlm.nih.gov/pubmed/10048600	2017		
404	CHEBI_4031	cyclosporine	PR_Q9NPD5	oatp1b3	inhibits	RO_0002449	dikb	274			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
405	PC_129734485	beta-hydroxy-lovastatin	PR_P08684	cyp3a4	is_substrate_of	DIDEO_00000041	dikb	212			http://www.ncbi.nlm.nih.gov/pubmed/9929499	2017		
406	CHEBI_31859	modafinil	PR_P08684	cyp3a4	is_substrate_of	DIDEO_00000041	dikb	74			http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/resource/structuredProductLabelMetadata/e16c26ad-7bc2-d155-3a5d-da83ad6492c8.pdf	2017		
407	CHEBI_135810	atrasentan	PR_Q9Y6L6	oatp1b1	is_substrate_of	DIDEO_00000041	dikb	119			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
408	CHEBI_8104	phenylpropanolamine	PR_P05177	cyp1a2	inhibits	RO_0002449	dikb	327			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
409	CHEBI_49603	lapatinib	PR_P08183	p-glycoprotein	inhibits	RO_0002449	dikb	476			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
410	CHEBI_101278	diltiazem	PR_P08684	cyp3a4	is_substrate_of	DIDEO_00000041	dikb	60			http://www.ncbi.nlm.nih.gov/pubmed/12124305	2017		
411	CHEBI_28593	quinidine	PR_P10635	cyp2d6	inhibits	RO_0002449	dikb	391			http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/resource/structuredProductLabelMetadata/19a30c59-15da-4324-bc08-d09495dc1074	2017		
412	CHEBI_8107	phenytoin	PR_P11712	cyp2c9	is_substrate_of	DIDEO_00000041	dikb	115			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
413	CHEBI_10023	voriconazole	PR_P11712	cyp2c9	is_substrate_of	DIDEO_00000041	dikb	91			http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/resource/structuredProductLabelMetadata/ce3ef5cf-3087-4d92-9d94-9eb8287228db	2017		
414	CHEBI_39548	atorvastatin	PR_Q9Y6L6	oatp1b1	is_substrate_of	DIDEO_00000041	dikb	161			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
415	CHEBI_3219	bupropion	PR_P10635	cyp2d6	inhibits	RO_0002449	dikb	301			http://www.ncbi.nlm.nih.gov/pubmed/15876900	2017		
416	CHEBI_8805	repaglinide	PR_Q9Y6L6	oatp1b1	is_substrate_of	DIDEO_00000041	dikb	221			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
417	CHEBI_3219	bupropion	PR_P10635	cyp2d6	inhibits	RO_0002449	dikb	300			http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/resource/structuredProductLabelMetadata/c2126e2d-3b46-40dd-8168-6d0368e5d233	2017		
418	CHEBI_10023	voriconazole	PR_P11712	cyp2c9	inhibits	RO_0002449	dikb	586			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
419	CHEBI_2663	amiodarone	PR_P08684	cyp3a4	inhibits	RO_0002449	dikb	492			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
420	CHEBI_6076	itraconazole	PR_P08684	cyp3a4	inhibits	RO_0002449	dikb	369			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
421	CHEBI_9588	ticlopidine	PR_P20813	cyp2b6	inhibits	RO_0002449	dikb	262			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
422	CHEBI_71219	pazopanib	PR_P10635	cyp2d6	inhibits	RO_0002449	dikb	416			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
423	CHEBI_10119	ziprasidone	PR_P08684	cyp3a4	is_substrate_of	DIDEO_00000041	dikb	237			http://www.ncbi.nlm.nih.gov/pubmed/10771452	2017		
424	CHEBI_36791	escitalopram	PR_P08684	cyp3a4	is_substrate_of	DIDEO_00000041	dikb	224			http://www.ncbi.nlm.nih.gov/pubmed/11454728	2017		
425	CHEBI_8028	perphenazine	PR_P10635	cyp2d6	is_substrate_of	DIDEO_00000041	dikb	151			http://www.ncbi.nlm.nih.gov/pubmed/8689810	2017		
426	CHEBI_6931	midazolam	PR_P20815	cyp3a5	is_substrate_of	DIDEO_00000041	dikb	103			http://www.ncbi.nlm.nih.gov/pubmed/12124305	2017		
427	CHEBI_3723	citalopram	PR_P08684	cyp3a4	is_substrate_of	DIDEO_00000041	dikb	177			http://www.ncbi.nlm.nih.gov/pubmed/10494454	2017		
428	CHEBI_47519	ketoconazole	PR_P08684	cyp3a4	inhibits	RO_0002449	dikb	376			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
429	CHEBI_100246	norfloxacin	PR_P05177	cyp1a2	inhibits	RO_0002449	dikb	280			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
430	CHEBI_31401	cilostazol	PR_P08684	cyp3a4	inhibits	RO_0002449	dikb	464			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
431	CHEBI_45409	ritonavir	PR_P10635	cyp2d6	inhibits	RO_0002449	dikb	397			http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/resource/structuredProductLabelMetadata/2849298e-de6e-47bb-8194-56e075b33fc3	2017		
432	CHEBI_9927	valsartan	PR_Q9Y6L6	oatp1b1	is_substrate_of	DIDEO_00000041	dikb	54			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
433	CHEBI_10125	zolpidem	PR_P20815	cyp3a5	is_substrate_of	DIDEO_00000041	dikb	92			http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/resource/structuredProductLabelMetadata/de965605-268a-4479-86f7-84de949cf36f	2017		
434	CHEBI_10125	zolpidem	PR_P08684	cyp3a4	is_substrate_of	DIDEO_00000041	dikb	94			http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/resource/structuredProductLabelMetadata/de965605-268a-4479-86f7-84de949cf36f	2017		
435	CHEBI_4659	disulfiram	PR_P05177	cyp1a2	inhibits	RO_0002449	dikb	393			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
436	PC_119265	reduced-haloperidol	PR_P08684	cyp3a4	is_substrate_of	DIDEO_00000041	dikb	85			http://www.ncbi.nlm.nih.gov/pubmed/9825830	2017		
437	CHEBI_10112	zileuton	PR_P08684	cyp3a4	inhibits	RO_0002449	dikb	507			http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf	2017		
2168	CHEBI_63613	nevirapine	PR_Q14242	p-gp	molecularly_interacts_with	RO_0002436	FDA		469		PL	2017		
2172	CHEBI_8426	probenecid	PR_Q8TCC7	OAT3	molecularly_interacts_with	RO_0002436	FDA		385			2017		
2173	CHEBI_3699	cimetidine	PR_P08684	CYP3A4	inhibits	RO_0002449	FDA		65		PL	2017		
2174	CHEBI_47519	ketoconazole	PR_P05177	CYP1A2	inhibits	RO_0002449	FDA		182		PL	2017		
2176	CHEBI_47519	ketoconazole	PR_P33261	CYP2C19	inhibits	RO_0002449	FDA		173		"18372400"	2017		
2177	CHEBI_37924	atazanavir	PR_P10635	CYP2D6	inhibits	RO_0002449	FDA		70		PL	2017		
2179	CHEBI_5138	fluvoxamine	PR_P22310	UGT1A4	inhibits	RO_0002449	FDA		23		PL	2017		
2181	CHEBI_47519	ketoconazole	PR_P10635	CYP2D6	inhibits	RO_0002449	FDA		153		PL	2017		
2183	CHEBI_47519	ketoconazole	PR_Q8TCC7	OAT3	molecularly_interacts_with	RO_0002436	FDA		373		DIDB	2017		
2186	CHEBI_28177	theophylline	PR_P10635	CYP2D6	inhibits	RO_0002449	FDA		319		"12017343"	2017		
2189	CHEBI_4031	cyclosporine	PR_Q9NPD5	OATP1B3	molecularly_interacts_with	RO_0002436	FDA		494		PL	2017		
2192	CHEBI_6717	mefanamic acid	PR_P08183	P-gp	molecularly_interacts_with	RO_0002436	FDA		401		PL	2017		
2193	CHEBI_47519	ketoconazole	PR_P33261	CYP2C19	inhibits	RO_0002449	FDA		29		PL	2017		
2194	SRS_U946SH95EE	milk thistle	PR_P11712	CYP2C9	inhibits	RO_0002449	FDA		186		DIDB	2017		
2195	CHEBI_48923	erythromycin and fluvoxamine	PR_P05177	CYP1A2	inhibits	RO_0002449	FDA		270		PL	2017		
2199	CHEBI_7565	nifedipine	PR_P08684	CYP3A4	inhibits	RO_0002449	FDA		93		PL	2017		
2200	CHEBI_5138	fluvoxamine	PR_P05177	CYP1A2	inhibits	RO_0002449	FDA		22		PL	2017		
2201	CHEBI_47519	ketoconazole	PR_Q9NPD5	OATP1B3	molecularly_interacts_with	RO_0002436	FDA		369		PL	2017		
2202	CHEBI_47519	ketoconazole	PR_P08183	P-gp	molecularly_interacts_with	RO_0002436	FDA		382		DIDB	2017		
2204	CHEBI_6923	miconazole	PR_P08684	CYP3A4	inhibits	RO_0002449	FDA		114		"12527704"	2017		
2205	CHEBI_4031	cyclosporine	PR_Q9Y6L6	OATP1B1	molecularly_interacts_with	RO_0002436	FDA		512		PL	2017		
2206	CHEBI_47519	ketoconazole	PR_P22309	UGT1A1	inhibits	RO_0002449	FDA		27		PL	2017		
2207	CHEBI_7772	omeprazole	PR_P33261	CYP2C19	inhibits	RO_0002449	FDA		1		PL	2017		
2208	CHEBI_47519	ketoconazole	PR_P20813	CYP2B6	inhibits	RO_0002449	FDA		67		PL	2017		
2209	CHEBI_47519	ketoconazole	PR_P08684	CYP3A4	inhibits	RO_0002449	FDA		297		PL	2017		
2210	CHEBI_8985	valspodar	PR_P08684	CYP3A4	inhibits	RO_0002449	FDA		113		PL	2017		
2212	CHEBI_7565	nifedipine	PR_P08183	P-gp	molecularly_interacts_with	RO_0002436	FDA		552		PL	2017		
2213	CHEBI_8985	valspodar	PR_Q9NPD5	OATP1B3	molecularly_interacts_with	RO_0002436	FDA		417		PL	2017		
2216	CHEBI_47519	ketoconazole	PR_Q9UNQ0	BCRP	molecularly_interacts_with	RO_0002436	FDA		902			2017		
2217	CHEBI_47519	ketoconazole	PR_P08183	P-gp	molecularly_interacts_with	RO_0002436	FDA		516		PL	2017		
2219	CHEBI_47519	ketoconazole	PR_Q01740	FMO1	inhibits	RO_0002449	FDA		52		DIDB	2017		
2220	CHEBI_4031	cyclosporine	PR_P08684	CYP3A	inhibits	RO_0002449	FDA		192		PL	2017		
2222	CHEBI_7772	omeprazole	PR_Q07973	CYP24	inhibits	RO_0002449	FDA		221		PL	2017		
2223	CHEBI_45409	ritonavir, in CYP2C19 PMs	PR_P08684	CYP3A4	inhibits	RO_0002449	FDA		342		PL	2017		
2225	CHEBI_5138	fluvoxamine	PR_P08684	CYP3A	inhibits	RO_0002449	FDA		165		Interview form (Japanese)	2017		
2226	CHEBI_47519	ketoconazole	PR_O60656	UGT1A9	inhibits	RO_0002449	FDA		257		PL	2017		
2227	CHEBI_5296	gemfibrozil	PR_P10632	CYP2C8(limitedmetabolism)	inhibits	RO_0002449	FDA		289		PL	2017		
2228	CHEBI_47519	ketoconazole	PR_P08183	P-gp	molecularly_interacts_with	RO_0002436	FDA		915			2017		
2229	CHEBI_4031	cyclosporine	PR_Q9Y6L6	OATP1B1	molecularly_interacts_with	RO_0002436	FDA		493		PL	2017		
2230	CHEBI_6717	mefanamic acid	PR_O60656	UGT1A9	inhibits	RO_0002449	FDA		79		PL	2017		
2231	CHEBI_47519	ketoconazole	PR_P08183	P-gp	molecularly_interacts_with	RO_0002436	FDA		439		PL	2017		
2233	CHEBI_7476	S-naproxen	PR_P11712	CYP2C9	inhibits	RO_0002449	FDA		128		PL	2017		
2235	CHEBI_47519	ketoconazole	PR_P08684	CYP3A4	inhibits	RO_0002449	FDA		107		PL	2017		
2236	CHEBI_6076	itraconazole	PR_Q9NPD5	OATP1B3	molecularly_interacts_with	RO_0002436	FDA		436		PL	2017		
2237	CHEBI_47519	ketoconazole	PR_P04798	CYP1A1	inhibits	RO_0002449	FDA		108		PL	2017		
2238	CHEBI_5118	fluoxetine	PR_P08183	P-gp	molecularly_interacts_with	RO_0002436	FDA		503		PL	2017		
2240	CHEBI_47519	ketoconazole	PR_P33261	CYP2C19	inhibits	RO_0002449	FDA		151		PL	2017		
2242	CHEBI_47519	ketoconazole	PR_Q9UNQ0	BCRP	molecularly_interacts_with	RO_0002436	FDA		375		PL	2017		
2243	CHEBI_47519	ketoconazole	PR_P08684	CYP3A4	inhibits	RO_0002449	FDA		253		PL	2017		
2244	CHEBI_45409	saquinavir and ritonavir	PR_P08183	P-gp	molecularly_interacts_with	RO_0002436	FDA		459		PL	2017		
2247	CHEBI_5138	fluvoxamine	PR_P08684	CYP3A4	inhibits	RO_0002449	FDA		246		PL	2017		
2248	CHEBI_4031	cyclosporine	PR_Q9UNQ0	BCRP	molecularly_interacts_with	RO_0002436	FDA		496		PL	2017		
2249	CHEBI_45409	ritonavir	PR_P08183	P-gp	molecularly_interacts_with	RO_0002436	FDA		395		DIDB	2017		
2251	CHEBI_100241	ciprofloxacin	PR_P08183	P-gp	molecularly_interacts_with	RO_0002436	FDA		362		PL	2017		
2253	CHEBI_47519	ketoconazole	PR_P08684	CYP3A	inhibits	RO_0002449	FDA		159		PL	2017		
2254	CHEBI_45409	ritonavir	PR_P08684	CYP3A	inhibits	RO_0002449	FDA		80		PL	2017		
2258	CHEBI_8426	probenecid	PR_Q86VL8	MATE2K	molecularly_interacts_with	RO_0002436	FDA		434		PL	2017		
2259	CHEBI_8426	probenecid	PR_Q4U2R8	OAT1	molecularly_interacts_with	RO_0002436	FDA		877			2017		
2260	CHEBI_5296	gemfibrozil	PR_P04798	CYP1A1	inhibits	RO_0002449	FDA		237		PL	2017		
2261	CHEBI_47519	ketoconazole	PR_P08183	P-gp	molecularly_interacts_with	RO_0002436	FDA		535		PL	2017		
2263	CHEBI_47519	ketoconazole	PR_P08684	CYP3A4	inhibits	RO_0002449	FDA		39		PL	2017		
2266	CHEBI_8426	probenecid	PR_O15245	OCT1	molecularly_interacts_with	RO_0002436	FDA		861			2017		
2268	CHEBI_47519	ketoconazole	PR_P08684	CYP3A4	inhibits	RO_0002449	FDA		35		PL	2017		
2270	CHEBI_47519	ketoconazole	PR_P08684	CYP3A4	inhibits	RO_0002449	FDA		69		PL	2017		
2271	CHEBI_42355	erythromycin	PR_P08684	CYP3A4	inhibits	RO_0002449	FDA		60		PL	2017		
2272	CHEBI_3699	cimetidine	PR_Q86VL8	MATE2K	molecularly_interacts_with	RO_0002436	FDA		549		PL	2017		
2273	CHEBI_8228	pioglitazone	PR_P06133	UGT2B4	inhibits	RO_0002449	FDA		156		Interview form (Japanese)	2017		
2274	CHEBI_47519	ketoconazole	PR_P08684	CYP3A4	inhibits	RO_0002449	FDA		281		PL	2017		
2275	CHEBI_47519	ketoconazole	PR_P08183	P-gp	molecularly_interacts_with	RO_0002436	FDA		894			2017		
2276	CHEBI_47519	ketoconazole	PR_P08183	P-gp	molecularly_interacts_with	RO_0002436	FDA		376		PL	2017		
2277	CHEBI_7772	omeprazole	PR_Q9UNQ0	BCRP	molecularly_interacts_with	RO_0002436	FDA		500		PL	2017		
2279	CHEBI_45409	BILR 355 and ritonavir	PR_Q9UNQ0	BCRP	molecularly_interacts_with	RO_0002436	FDA		446		PL	2017		
2280	CHEBI_5296	gemfibrozil and itraconazole	PR_P08684	CYP3A4	inhibits	RO_0002449	FDA		260		PL	2017		
2281	CHEBI_68647	regorafenib	PR_Q86VL8	MATE2K	molecularly_interacts_with	RO_0002436	FDA		481		PL	2017		
2285	CHEBI_47519	ketoconazole	PR_Q9NPD5	OATP1B3	molecularly_interacts_with	RO_0002436	FDA		488		PL	2017		
2286	CHEBI_45409	indinavir and ritonavir	PR_Q96FL8	MATE1	molecularly_interacts_with	RO_0002436	FDA		425		PL	2017		
2288	CHEBI_7936	paroxetine	PR_P08684	CYP3A4	inhibits	RO_0002449	FDA		21		PL	2017		
2289	CHEBI_47519	ketoconazole	PR_P00352	ADH/ALDH	inhibits	RO_0002449	FDA		284		PL	2017		
2292	CHEBI_45409	ritonavir	PR_P08684	"3A4"	inhibits	RO_0002449	FDA		66		DIDB	2017		
2293	CHEBI_47519	ketoconazole	PR_P11712	CYP2C9	inhibits	RO_0002449	FDA		17		PL	2017		
2295	PC_71306834	peginterferonalpha-2a	PR_P10635	CYP2D6	inhibits	RO_0002449	FDA		81		DIDB	2017		
2296	CHEBI_100241	ciprofloxacin	PR_P05177	CYP1A2	inhibits	RO_0002449	FDA		254		PL	2017		
2297	CHEBI_4031	cyclosporine	PR_Q9Y6L6	OATP1B1	molecularly_interacts_with	RO_0002436	FDA		428		PL	2017		
2302	CHEBI_5138	fluvoxamine	PR_P08183	P-gp	molecularly_interacts_with	RO_0002436	FDA		450		Interview form (Japanese)	2017		
2304	CHEBI_8426	probenecid	PR_Q96FL8	MATE1	molecularly_interacts_with	RO_0002436	FDA		862			2017		
2306	CHEBI_47519	ketoconazole	PR_P33261	CYP2C19	inhibits	RO_0002449	FDA		16		PL	2017		
2309	CHEBI_8426	probenecid	PR_O15244	OCT2	molecularly_interacts_with	RO_0002436	FDA		556		PL	2017		
2310	CHEBI_4031	cyclosporine	PR_P11712	CYP2C9	inhibits	RO_0002449	FDA		139		PL	2017		
2312	CHEBI_47519	ketoconazole	PR_Q01740	FMO	inhibits	RO_0002449	FDA		32		"16052551"	2017		
2315	CHEBI_47519	ketoconazole	PR_P10635	CYP2D6	inhibits	RO_0002449	FDA		335		PL	2017		
2320	CHEBI_63660	pravastatin	PR_Q8TCC7	OAT3	molecularly_interacts_with	RO_0002436	FDA		904			2017		
2323	CHEBI_47519	ketoconazole	PR_P08684	CYP3A4	inhibits	RO_0002449	FDA		187		PL	2017		
2324	CHEBI_47519	ketoconazole	PR_P08684	CYP3A4	inhibits	RO_0002449	FDA		337		PL	2017		
2327	CHEBI_68647	regorafenib	PR_Q96FL8	MATE1	molecularly_interacts_with	RO_0002436	FDA		480		PL	2017		
2329	CHEBI_6076	itraconazole	PR_P08684	CYP3A4	inhibits	RO_0002449	FDA		144		PL	2017		
2331	CHEBI_6076	itraconazole	PR_Q9NPD5	OATP1B3	molecularly_interacts_with	RO_0002436	FDA		547		PL	2017		
2332	CHEBI_47519	ketoconazole	PR_P08183	P-gp	molecularly_interacts_with	RO_0002436	FDA		405		PL	2017		
2333	CHEBI_7476	S-naproxen	PR_P22309	UGT1A1	inhibits	RO_0002449	FDA		129		PL	2017		
2335	CHEBI_8426	probenecid	PR_Q4U2R8	OAT1	molecularly_interacts_with	RO_0002436	FDA		359		PL	2017		
2338	CHEBI_5778	hydrochlorothiazide	PR_Q9NPD5	OATP1B3	molecularly_interacts_with	RO_0002436	FDA		544		PL	2017		
2341	CHEBI_47519	ketoconazole	PR_P08684	CYP3A4	inhibits	RO_0002449	FDA		256		"10534319"	2017		
2343	CHEBI_7476	S-naproxen	PR_O60656	UGT1A9	inhibits	RO_0002449	FDA		127		PL	2017		
2344	SRS_JQ9EK2H6BG	grapefruit juice	PR_P33261	CYP2C19	inhibits	RO_0002449	FDA		84		PL	2017		
2349	CHEBI_45409	indinavir and ritonavir	PR_Q8TCC7	OAT3	molecularly_interacts_with	RO_0002436	FDA		908			2017		
2351	CHEBI_47519	ketoconazole	PR_P20815	CYP3A5	inhibits	RO_0002449	FDA		280		PL	2017		
2353	CHEBI_46081	fluconazole	PR_P11712	CYP2C9	inhibits	RO_0002449	FDA		215		PL	2017		
2355	CHEBI_47519	ketoconazole	PR_P08183	P-gp	molecularly_interacts_with	RO_0002436	FDA		513		PL	2017		
2357	CHEBI_46081	fluconazole	PR_P08684	CYP3A4	inhibits	RO_0002449	FDA		210		DIDB	2017		
2358	CHEBI_45409	ritonavir	PR_P08183	P-gp	molecularly_interacts_with	RO_0002436	FDA		528		PL	2017		
2360	CHEBI_4031	cyclosporine	PR_P33261	CYP2C19	inhibits	RO_0002449	FDA		11		PL	2017		
2363	CHEBI_47519	ketoconazole	PR_P08183	P-gp	molecularly_interacts_with	RO_0002436	FDA		444		PL	2017		
2364	CHEBI_5296	gemfibrozil	PR_Q8TCC7	OAT3	molecularly_interacts_with	RO_0002436	FDA		864			2017		
2365	CHEBI_45409	indinavir and ritonavir	PR_Q86VL8	MATE2K	molecularly_interacts_with	RO_0002436	FDA		420		PL	2017		
2367	CHEBI_5296	gemfibrozil	PR_Q8TCC7	OAT3	molecularly_interacts_with	RO_0002436	FDA		521		PL	2017		
2368	CHEBI_6923	miconazole	PR_P33261	CYP2C19	inhibits	RO_0002449	FDA		115		"12527704"	2017		
2369	CHEBI_5118	fluoxetine	PR_P10635	CYP2D6	inhibits	RO_0002449	FDA		148		PL	2017		
2370	CHEBI_7772	omeprazole	PR_P08183	P-gp	molecularly_interacts_with	RO_0002436	FDA		498		PL	2017		
2372	CHEBI_47519	ketoconazole	PR_O15245	OCT1	molecularly_interacts_with	RO_0002436	FDA		441		PL	2017		
2373	CHEBI_8426	probenecid	PR_P11712	CYP2C9	inhibits	RO_0002449	FDA		307		"19514967"	2017		
2374	CHEBI_47519	ketoconazole	PR_P08684	CYP3A4	inhibits	RO_0002449	FDA		122		PL	2017		
2376	CHEBI_68595	telaprevir	PR_P08183	P-gp	molecularly_interacts_with	RO_0002436	FDA		526		PL	2017		
2378	CHEBI_4031	cyclosporine	PR_Q9NPD5	OATP1B3	molecularly_interacts_with	RO_0002436	FDA		509		PL	2017		
2379	CHEBI_8426	probenecid	PR_P10635	CYP2D6	inhibits	RO_0002449	FDA		300		PL	2017		
2380	CHEBI_3770	cotrimoxazole	PR_Q8TCC7	OAT3	molecularly_interacts_with	RO_0002436	FDA		464		PL	2017		
2383	CHEBI_7936	paroxetine	PR_P08684	CYP3A4	inhibits	RO_0002449	FDA		218		PL	2017		
2384	CHEBI_37924	atazanavir	PR_P08183	P-gp	molecularly_interacts_with	RO_0002436	FDA		397		PL	2017		
2386	CHEBI_5138	fluvoxamine	PR_P33261	CYP2C19	inhibits	RO_0002449	FDA		164		Interview form (Japanese)	2017		
2388	CHEBI_4031	cyclosporine	PR_P08183	P-gp	molecularly_interacts_with	RO_0002436	FDA		363		PL	2017		
2389	CHEBI_47519	ketoconazole	PR_P10632	CYP2C8	inhibits	RO_0002449	FDA		224		PL	2017		
2392	CHEBI_47519	ketoconazole	PR_Q9UNQ0	BCRP	molecularly_interacts_with	RO_0002436	FDA		525		PL	2017		
2393	CHEBI_4031	cyclosporine	PR_Q9Y6L6	OATP1B1	molecularly_interacts_with	RO_0002436	FDA		898			2017		
2394	CHEBI_119573	delavirdine	PR_P08183	P-gp	molecularly_interacts_with	RO_0002436	FDA		364		PL	2017		
2395	CHEBI_47519	ketoconazole	PR_P51589	CYP2J2	inhibits	RO_0002449	FDA		18		PL	2017		
2396	CHEBI_45409	ritonavir	PR_O15244	OCT2	molecularly_interacts_with	RO_0002436	FDA		455		PL	2017		
2410	CHEBI_45735	troleandomycin	PR_Q9NPD5	OATP1B3	molecularly_interacts_with	RO_0002436	FDA		412		Interview form (Japanese)	2017		
2411	CHEBI_5118	fluoxetine	PR_P10635	CYP2D6	inhibits	RO_0002449	FDA		203		PL	2017		
2412	CHEBI_47519	ketoconazole	PR_P08684	CYP3A4	inhibits	RO_0002449	FDA		51		DIDB	2017		
2413	CHEBI_3770	cotrimoxazole	PR_Q9NPD5	OATP1B3	molecularly_interacts_with	RO_0002436	FDA		463		PL	2017		
2414	CHEBI_63918	artesunate and pyronaridine	PR_P08183	P-gp	molecularly_interacts_with	RO_0002436	FDA		504		PL	2017		
2417	CHEBI_47519	ketoconazole	PR_Q9UNQ0	BCRP	molecularly_interacts_with	RO_0002436	FDA		442		PL	2017		
2418	CHEBI_8985	valspodar	PR_Q9Y6L6	OATP1B1	molecularly_interacts_with	RO_0002436	FDA		416		PL	2017		
2420	CHEBI_47519	ketoconazole	PR_P08183	P-gp	molecularly_interacts_with	RO_0002436	FDA		501		PL	2017		
2421	CHEBI_45409	BILR 355 and ritonavir	PR_O15244	OCT2	molecularly_interacts_with	RO_0002436	FDA		884			2017		
2424	CHEBI_5778	hydrochlorothiazide	PR_P08183	P-gp	molecularly_interacts_with	RO_0002436	FDA		889			2017		
2425	CHEBI_47519	ketoconazole	PR_P51589	CYP2J2	inhibits	RO_0002449	FDA		266		PL	2017		
2428	CHEBI_63613	nevirapine	PR_P33261	CYP2C19	inhibits	RO_0002449	FDA		205		PL	2017		
2430	CHEBI_3770	cotrimoxazole	PR_Q4U2R8	OAT1	molecularly_interacts_with	RO_0002436	FDA		466		PL	2017		
2431	CHEBI_45409	indinavir and ritonavir	PR_P08183	P-gp	molecularly_interacts_with	RO_0002436	FDA		909			2017		
2433	CHEBI_47519	ketoconazole	PR_P33261	CYP2C19	inhibits	RO_0002449	FDA		320		PL	2017		
2434	CHEBI_47519	ketoconazole	PR_P20813	CYP2B6	inhibits	RO_0002449	FDA		227		PL	2017		
2435	CHEBI_3396	levodopa and carbidopa	PR_P54855	UGT2B15	inhibits	RO_0002449	FDA		274		PL	2017		
2436	CHEBI_47519	ketoconazole	PR_P33261	CYP2C19	inhibits	RO_0002449	FDA		336		PL	2017		
2438	CHEBI_68595	telaprevir	PR_P08684	CYP3A4	inhibits	RO_0002449	FDA		288		DIDB	2017		
2439	CHEBI_39867	valproic acid	PR_P08183	P-gp	molecularly_interacts_with	RO_0002436	FDA		456		PL	2017		
2441	CHEBI_4031	cyclosporine	PR_P08684	CYP3A4	inhibits	RO_0002449	FDA		55		PL	2017		
2442	CHEBI_6076	itraconazole	PR_P08183	P-gp	molecularly_interacts_with	RO_0002436	FDA		435		PL	2017		
2443	CHEBI_47519	ketoconazole	PR_P33261	CYP2C19	inhibits	RO_0002449	FDA		168		PL	2017		
2444	CHEBI_47519	ketoconazole	PR_P08684	CYP3A4	inhibits	RO_0002449	FDA		295		PL	2017		
2445	CHEBI_47519	ketoconazole	PR_P08684	CYP3A4	inhibits	RO_0002449	FDA		134		PL	2017		
2446	CHEBI_7565	nifedipine	PR_P10635	CYP2D6	inhibits	RO_0002449	FDA		91		PL	2017		
2447	CHEBI_7772	omeprazole	PR_P22310	UGT1A4	inhibits	RO_0002449	FDA		222		PL	2017		
2450	CHEBI_3699	cimetidine	PR_O15244	OCT2	molecularly_interacts_with	RO_0002436	FDA		550		PL	2017		
2451	CHEBI_47519	ketoconazole	PR_Q9UNQ0	BCRP	molecularly_interacts_with	RO_0002436	FDA		366		PL	2017		
2453	CHEBI_47519	ketoconazole	PR_P08183	P-gp	molecularly_interacts_with	RO_0002436	FDA		895			2017		
2454	CHEBI_5118	fluoxetine	PR_P10635	CYP2D6	inhibits	RO_0002449	FDA		87		PL	2017		
2455	CHEBI_45409	ritonavir, in CYP2C19 PMs	PR_P11712	CYP2C9	inhibits	RO_0002449	FDA		343		PL	2017		
2458	CHEBI_4031	cyclosporine	PR_Q9NPD5	OATP1B3	molecularly_interacts_with	RO_0002436	FDA		429		PL	2017		
2459	CHEBI_47519	ketoconazole	PR_P08183	P-gp	molecularly_interacts_with	RO_0002436	FDA		551		PL	2017		
2460	CHEBI_47519	ketoconazole	PR_P08684	CYP3A4	inhibits	RO_0002449	FDA		311		PL	2017		
2462	CHEBI_47519	ketoconazole	PR_P08684	CYP3A4	inhibits	RO_0002449	FDA		196		PL	2017		
2463	CHEBI_135285	vildagliptin	PR_P08183	P-gp	molecularly_interacts_with	RO_0002436	FDA		485		PL	2017		
2464	PC_119373	elacridar	PR_P08183	P-gp	molecularly_interacts_with	RO_0002436	FDA		538		PL	2017		
2465	CHEBI_47519	ketoconazole	PR_Q9Y6L6	OATP1B1	molecularly_interacts_with	RO_0002436	FDA		368		PL	2017		
2467	CHEBI_47519	ketoconazole	PR_P08684	CYP3A	inhibits	RO_0002449	FDA		36		DIDB	2017		
2469	CHEBI_68595	telaprevir	PR_P08183	P-gp	molecularly_interacts_with	RO_0002436	FDA		517		DIDB	2017		
2472	CHEBI_8426	probenecid	PR_Q8TCC7	OAT3	molecularly_interacts_with	RO_0002436	FDA		872			2017		
2473	CHEBI_42355	erythromycin	PR_P08183	P-gp	molecularly_interacts_with	RO_0002436	FDA		553		DIDB	2017		
2476	CHEBI_63613	nevirapine	PR_P08684	CYP3A	inhibits	RO_0002449	FDA		206		PL	2017		
2477	CHEBI_8499	propranolol	PR_P05177	CYP1A2	inhibits	RO_0002449	FDA		353		DIDB	2017		
2478	CHEBI_47519	ketoconazole	PR_P08183	P-gp	molecularly_interacts_with	RO_0002436	FDA		537		PL	2017		
2479	CHEBI_4031	cyclosporine	PR_Q9UNQ0	BCRP	molecularly_interacts_with	RO_0002436	FDA		508		PL	2017		
2480	CHEBI_47519	ketoconazole	PR_P08684	CYP3A4	inhibits	RO_0002449	FDA		105		PL	2017		
2482	CHEBI_45409	ritonavir	PR_P08183	P-gp	molecularly_interacts_with	RO_0002436	FDA		514		PL	2017		
2483	CHEBI_46081	fluconazole	PR_P33261	CYP2C19	inhibits	RO_0002449	FDA		214		PL	2017		
2484	CHEBI_45409	ritonavir	PR_P08684	CYP3A4	inhibits	RO_0002449	FDA		302		PL	2017		
2485	CHEBI_47519	ketoconazole	PR_P08684	CYP3A4	inhibits	RO_0002449	FDA		279		PL	2017		
2486	CHEBI_8426	probenecid	PR_O15245	OCT1	molecularly_interacts_with	RO_0002436	FDA		432		PL	2017		
2487	CHEBI_5138	fluvoxamine	PR_P10635	"2D6"	inhibits	RO_0002449	FDA		98		PL	2017		
2489	CHEBI_45409	ritonavir	PR_P08684	CYP3A	inhibits	RO_0002449	FDA		102		PL	2017		
2490	CHEBI_45409	BILR 355 and ritonavir	PR_O15245	OCT1	molecularly_interacts_with	RO_0002436	FDA		447		PL	2017		
2491	CHEBI_45409	ritonavir	PR_Q9UNQ0	BCRP	molecularly_interacts_with	RO_0002436	FDA		515		PL	2017		
2492	CHEBI_47519	ketoconazole	PR_P05177	CYP1A2	inhibits	RO_0002449	FDA		61		PL	2017		
2493	CHEBI_45409	ritonavir + ARV	PR_P08183	P-gp	molecularly_interacts_with	RO_0002436	FDA		532		PL	2017		
2497	CHEBI_3732	clarithromycin	PR_P33261	CYP2C19	inhibits	RO_0002449	FDA		219		PL	2017		
2498	CHEBI_47519	ketoconazole	PR_P08684	CYP3A	inhibits	RO_0002449	FDA		37		PL	2017		
2499	CHEBI_47519	ketoconazole	PR_P08684	CYP3A4	inhibits	RO_0002449	FDA		190		"12654667"	2017		
2508	CHEBI_63660	pravastatin	PR_Q4U2R8	OAT1	molecularly_interacts_with	RO_0002436	FDA		475		PL	2017		
2509	CHEBI_7476	S-naproxen	PR_P10632	CYP2C8	inhibits	RO_0002449	FDA		125		PL	2017		
2510	CHEBI_39867	valproic acid	PR_Q9Y6L6	OATP1B1	molecularly_interacts_with	RO_0002436	FDA		457		PL	2017		
2511	CHEBI_5138	fluvoxamine	PR_P08684	"3A4"	inhibits	RO_0002449	FDA		177		Interview form (Japanese)	2017		
2512	CHEBI_47519	ketoconazole	PR_P08684	CYP3A	inhibits	RO_0002449	FDA		72		PL	2017		
2513	CHEBI_5138	fluvoxamine	PR_P05177	CYP1A2	inhibits	RO_0002449	FDA		176		Interview form (Japanese)	2017		
2515	CHEBI_45409	indinavir and ritonavir	PR_Q9NPD5	OATP1B3	molecularly_interacts_with	RO_0002436	FDA		907			2017		
2516	CHEBI_8426	probenecid	PR_Q4U2R8	OAT1	molecularly_interacts_with	RO_0002436	FDA		860			2017		
2518	CHEBI_47519	ketoconazole	PR_P08183	P-gp	molecularly_interacts_with	RO_0002436	FDA		467		PL	2017		
2520	CHEBI_47519	ketoconazole	PR_P10632	CYP2C8	inhibits	RO_0002449	FDA		179		PL	2017		
2521	CHEBI_3770	cotrimoxazole	PR_Q9Y6L6	OATP1B1	molecularly_interacts_with	RO_0002436	FDA		465		PL	2017		
2522	CHEBI_45409	indinavir and ritonavir	PR_P08183	P-gp	molecularly_interacts_with	RO_0002436	FDA		423		PL	2017		
2523	CHEBI_68621	boceprevir	PR_P08684	CYP3A4	inhibits	RO_0002449	FDA		95		PL	2017		
2524	CHEBI_3699	cimetidine	PR_P08183	P-gp	molecularly_interacts_with	RO_0002436	FDA		522		PL	2017		
2525	CHEBI_47519	ketoconazole	PR_Q9NPD5	OATP1B3	molecularly_interacts_with	RO_0002436	FDA		472		NDA 022068	2017		
2528	CHEBI_45409	tipranavir and ritonavir	PR_P08684	CYP3A4	inhibits	RO_0002449	FDA		194		PL	2017		
2529	CHEBI_68647	regorafenib	PR_O15244	OCT2	molecularly_interacts_with	RO_0002436	FDA		482		PL	2017		
2531	CHEBI_47519	ketoconazole	PR_P05177	CYP1A2	inhibits	RO_0002449	FDA		225		PL	2017		
2533	CHEBI_45409	ritonavir	PR_P08183	P-gp	molecularly_interacts_with	RO_0002436	FDA		406		PL	2017		
2534	CHEBI_45409	indinavir and ritonavir	PR_O15245	OCT1	molecularly_interacts_with	RO_0002436	FDA		912			2017		
2535	CHEBI_47519	ketoconazole	PR_P10635	CYP2D6(5-HMT)	inhibits	RO_0002449	FDA		133		PL	2017		
2538	CHEBI_47519	ketoconazole	PR_Q9UNQ0	BCRP	molecularly_interacts_with	RO_0002436	FDA		370		PL	2017		
2540	CHEBI_5118	fluoxetine	PR_P10635	CYP2D6	inhibits	RO_0002449	FDA		264		PL	2017		
2541	CHEBI_8871	risperidone	PR_P10635	CYP2D6	inhibits	RO_0002449	FDA		140		PL	2017		
2542	CHEBI_5138	fluvoxamine	PR_P05177	CYP1A2	inhibits	RO_0002449	FDA		97		PL	2017		
2544	CHEBI_5778	hydrochlorothiazide	PR_P11712	CYP2C9	inhibits	RO_0002449	FDA		327		PL	2017		
2546	CHEBI_4031	cyclosporine	PR_Q8TCC7	OAT3	molecularly_interacts_with	RO_0002436	FDA		495		PL	2017		
2548	CHEBI_28901	busulfan	PR_P20813	CYP2B6	inhibits	RO_0002449	FDA		73		PL	2017		
2550	CHEBI_8426	probenecid	PR_P08183	P-gp	molecularly_interacts_with	RO_0002436	FDA		868			2017		
2551	CHEBI_8426	probenecid	PR_Q8TCC7	OAT3	molecularly_interacts_with	RO_0002436	FDA		866			2017		
2553	CHEBI_135735	delapril	PR_P08684	CYP3A4	inhibits	RO_0002449	FDA		188		Interview form (Japanese)	2017		
2554	CHEBI_28077	rifampin SD	PR_P16662	UGT2B7	inhibits	RO_0002449	FDA		242		PL	2017		
2555	CHEBI_3732	clarithromycin and amoxicillin	PR_Q14242	P-gp(omeprazole)	molecularly_interacts_with	RO_0002436	FDA		355		PL	2017		
2556	CHEBI_28821	piperine	PR_P10632	CYP2C8	inhibits	RO_0002449	FDA		230		PL	2017		
2557	CHEBI_4031	cyclosporine	PR_Q9NPD5	OATP1B3	molecularly_interacts_with	RO_0002436	FDA		388		PL	2017		
2558	CHEBI_46081	fluconazole	PR_P08684	CYP3A4	inhibits	RO_0002449	FDA		216		PL	2017		
2560	CHEBI_6076	itraconazole	PR_P08684	CYP3A4	inhibits	RO_0002449	FDA		344		"19480550"	2017		
2564	CHEBI_68595	telaprevir	PR_P08684	CYP3A	inhibits	RO_0002449	FDA		294		PL	2017		
2565	CHEBI_37924	atazanavir	PR_Q9UNQ0	BCRP	molecularly_interacts_with	RO_0002436	FDA		399		PL	2017		
2567	CHEBI_47519	ketoconazole	PR_P08684	CYP3A4	inhibits	RO_0002449	FDA		207		NDA 022068	2017		
2568	CHEBI_47519	ketoconazole	PR_P08183	P-gp	molecularly_interacts_with	RO_0002436	FDA		531		PL	2017		
2569	CHEBI_47519	ketoconazole	PR_P08183	P-gp	molecularly_interacts_with	RO_0002436	FDA		470		NDA 022068	2017		
2570	CHEBI_5138	fluvoxamine	PR_P05177	CYP1A2	inhibits	RO_0002449	FDA		268		PL	2017		
2571	CHEBI_28901	busulfan	PR_P33261	CYP2C19	inhibits	RO_0002449	FDA		940		PL	2017		
2573	CHEBI_47519	ketoconazole	PR_P33261	CYP2C19	inhibits	RO_0002449	FDA		180		PL	2017		
2574	CHEBI_9588	ticlopidine	PR_P08183	P-gp	molecularly_interacts_with	RO_0002436	FDA		377		PL	2017		
2575	CHEBI_45409	ritonavir	PR_P20815	CYP3A5	inhibits	RO_0002449	FDA		331		"19492868"	2017		
2577	CHEBI_47519	ketoconazole	PR_P08684	CYP3A4	inhibits	RO_0002449	FDA		44		PL	2017		
2579	CHEBI_7936	paroxetine	PR_P10635	CYP2D6	inhibits	RO_0002449	FDA		20		PL	2017		
2580	CHEBI_47519	ketoconazole	PR_P33261	CYP2C19	inhibits	RO_0002449	FDA		40		PL	2017		
2582	CHEBI_63660	pravastatin	PR_Q9Y6L6	OATP1B1	molecularly_interacts_with	RO_0002436	FDA		905			2017		
2583	CHEBI_47519	ketoconazole	PR_P08183	P-gp	molecularly_interacts_with	RO_0002436	FDA		361		PL	2017		
2584	CHEBI_9588	ticlopidine	PR_Q9UNQ0	BCRP	molecularly_interacts_with	RO_0002436	FDA		378		PL	2017		
2587	CHEBI_5296	gemfibrozil	PR_P08684	CYP3A4	inhibits	RO_0002449	FDA		104		PL	2017		
2590	CHEBI_4031	cyclosporine	PR_P10632	CYP2C8	inhibits	RO_0002449	FDA		54		PL	2017		
2591	CHEBI_45409	ritonavir + ARV	PR_Q4U2R8	OAT1	molecularly_interacts_with	RO_0002436	FDA		533		PL	2017		
2593	CHEBI_6076	itraconazole	PR_P08183	P-gp	molecularly_interacts_with	RO_0002436	FDA		468		PL	2017		
2595	CHEBI_6539	lorazepam	PR_P08684	CYP3A4	inhibits	RO_0002449	FDA		204		DIDB	2017		
2596	CHEBI_3732	clarithromycin	PR_P08684	CYP3A4	inhibits	RO_0002449	FDA		220		PL	2017		
2597	CHEBI_47519	ketoconazole	PR_P08684	CYP3A4	inhibits	RO_0002449	FDA		83		PL	2017		
2598	CHEBI_47519	ketoconazole	PR_P08684	CYP3A4	inhibits	RO_0002449	FDA		797			2017		
2599	CHEBI_8382	prednisone	PR_P08684	CYP3A4	inhibits	RO_0002449	FDA		347		PL	2017		
2602	CHEBI_47519	ketoconazole	PR_Q9UNQ0	BCRP	molecularly_interacts_with	RO_0002436	FDA		452		PL	2017		
2603	CHEBI_45409	saquinavir and ritonavir	PR_Q9Y6L6	OATP1B1	molecularly_interacts_with	RO_0002436	FDA		460		PL	2017		
2604	CHEBI_47519	ketoconazole	PR_P11712	CYP2C9	inhibits	RO_0002449	FDA		278		PL	2017		
2605	CHEBI_7772	omeprazole	PR_P33261	CYP2C19	inhibits	RO_0002449	FDA		161		PL	2017		
2606	CHEBI_45409	ritonavir	PR_P11712	CYP2C9	inhibits	RO_0002449	FDA		282		PL	2017		
2607	CHEBI_47519	ketoconazole	PR_P08183	P-gp	molecularly_interacts_with	RO_0002436	FDA		536		PL	2017		
2608	CHEBI_47519	ketoconazole	PR_P04798	CYP1A	inhibits	RO_0002449	FDA		34		"16052551"	2017		
2611	CHEBI_47519	ketoconazole	PR_P05177	CYP1A2	inhibits	RO_0002449	FDA		43		PL	2017		
2613	CHEBI_47519	ketoconazole	PR_P16662	UGT2B7	inhibits	RO_0002449	FDA		285		PL	2017		
2614	CHEBI_45409	BILR 355 and ritonavir	PR_Q96FL8	MATE1	molecularly_interacts_with	RO_0002436	FDA		448		PL	2017		
2615	CHEBI_45409	ritonavir	PR_Q9Y6L6	OATP1B1	molecularly_interacts_with	RO_0002436	FDA		403		PL	2017		
2623	CHEBI_45409	BILR 355 and ritonavir	PR_Q86VL8	MATE2K	molecularly_interacts_with	RO_0002436	FDA		881			2017		
2625	CHEBI_63918	artesunate and pyronaridine	PR_P08684	CYP3A	inhibits	RO_0002449	FDA		265		PL	2017		
2626	CHEBI_7476	S-naproxen	PR_P16662	UGT2B7	inhibits	RO_0002449	FDA		132		PL	2017		
2627	CHEBI_47519	ketoconazole	PR_P10635	CYP2D6	inhibits	RO_0002449	FDA		197		"20110038"	2017		
2628	CHEBI_47519	ketoconazole	PR_P08684	CYP3A4	inhibits	RO_0002449	FDA		9		PL	2017		
2629	CHEBI_47519	ketoconazole	PR_P08684	CYP3A4	inhibits	RO_0002449	FDA		334		PL	2017		
2631	CHEBI_triazolam	triazolam	PR_P08684	CYP3A	inhibits	RO_0002449	FDA		310		PL	2017		
2632	CHEBI_47519	ketoconazole	PR_P08684	CYP3A4	inhibits	RO_0002449	FDA		352		PL	2017		
2633	CHEBI_45409	indinavir and ritonavir	PR_Q86VL8	MATE2K	molecularly_interacts_with	RO_0002436	FDA		911			2017		
2634	CHEBI_47519	ketoconazole	PR_P20815	CYP3A5	inhibits	RO_0002449	FDA		171		"18372400"	2017		
2635	CHEBI_47519	ketoconazole	PR_P08684	CYP3A4	inhibits	RO_0002449	FDA		286		PL	2017		
2636	CHEBI_7936	paroxetine	PR_P10635	CYP2D6	inhibits	RO_0002449	FDA		217		PL	2017		
2638	CHEBI_47519	ketoconazole	PR_P08183	P-gp	molecularly_interacts_with	RO_0002436	FDA		365		PL	2017		
2639	CHEBI_45409	BILR 355 and ritonavir	PR_O15244	OCT2	molecularly_interacts_with	RO_0002436	FDA		449		PL	2017		
2640	CHEBI_8382	prednisone	PR_P11712	CYP2C9	inhibits	RO_0002449	FDA		348		PL	2017		
2641	CHEBI_63660	pravastatin	PR_Q9Y6L6	OATP1B1	molecularly_interacts_with	RO_0002436	FDA		474		PL	2017		
2642	CHEBI_6076	itraconazole	PR_Q9Y6L6	OATP1B1	molecularly_interacts_with	RO_0002436	FDA		546		PL	2017		
2643	CHEBI_4031	cyclosporine	PR_Q9UNQ0	BCRP	molecularly_interacts_with	RO_0002436	FDA		389		PL	2017		
2644	CHEBI_47519	ketoconazole	PR_P08183	P-gp	molecularly_interacts_with	RO_0002436	FDA		505		PL	2017		
2645	CHEBI_5296	gemfibrozil	PR_P08684	CYP3A4	inhibits	RO_0002449	FDA		239		PL	2017		
2646	SRS_U946SH95EE	milk thistle	PR_P08684	CYP3A4	inhibits	RO_0002449	FDA		185		DIDB	2017		
2648	CHEBI_45409	ritonavir	PR_P08684	CYP3A4	inhibits	RO_0002449	FDA		283		PL	2017		
2649	CHEBI_8426	probenecid	PR_Q86VL8	MATE2K	molecularly_interacts_with	RO_0002436	FDA		863			2017		
2650	CHEBI_3732	clarithromycin and amoxicillin	PR_P33261	CYP2C19	inhibits	RO_0002449	FDA		3		PL	2017		
2651	CHEBI_9588	ticlopidine	PR_P20813	CYP2B6	inhibits	RO_0002449	FDA		46		PL	2017		
2652	CHEBI_28077	rifampin SD	PR_P11712	CYP2C9	inhibits	RO_0002449	FDA		243		PL	2017		
2653	CHEBI_45409	ritonavir + ARV	PR_Q8TCC7	OAT3	molecularly_interacts_with	RO_0002436	FDA		878			2017		
2654	CHEBI_4659	disulfiram	PR_P05181	CYP2E1	inhibits	RO_0002449	FDA		58		"7550365"	2017		
2655	CHEBI_47519	ketoconazole	PR_Q9NPD5	OATP1B3	molecularly_interacts_with	RO_0002436	FDA		440		PL	2017		
2656	CHEBI_47519	ketoconazole	PR_P10635	CYP2D6	inhibits	RO_0002449	FDA		195		PL	2017		
2657	CHEBI_8426	probenecid	PR_O15245	OCT1	molecularly_interacts_with	RO_0002436	FDA		555		PL	2017		
2659	CHEBI_3699	cimetidine	PR_O15244	OCT2	molecularly_interacts_with	RO_0002436	FDA		857			2017		
2660	CHEBI_7936	paroxetine	PR_P10635	CYP2D6	inhibits	RO_0002449	FDA		24		PL	2017		
2661	CHEBI_5296	gemfibrozil and itraconazole	PR_P10632	CYP2C8	inhibits	RO_0002449	FDA		259		PL	2017		
2663	CHEBI_3732	clarithromycin	PR_P08183	P-gp	molecularly_interacts_with	RO_0002436	FDA		484		PL	2017		
2665	CHEBI_47519	ketoconazole	PR_Q9Y6L6	OATP1B1	molecularly_interacts_with	RO_0002436	FDA		487		PL	2017		
2667	CHEBI_6076	itraconazole	PR_Q01740	FMO1	inhibits	RO_0002449	FDA		328		PL	2017		
2670	CHEBI_47519	ketoconazole	PR_P08684	CYP3A4	inhibits	RO_0002449	FDA		90		PL	2017		
2671	CHEBI_5296	gemfibrozil	PR_P10632	CYP2C8	inhibits	RO_0002449	FDA		272		PL	2017		
2672	CHEBI_63660	pravastatin	PR_Q8TCC7	OAT3	molecularly_interacts_with	RO_0002436	FDA		477		PL	2017		
2673	CHEBI_6076	itraconazole	PR_Q99518	FMO2	inhibits	RO_0002449	FDA		329		PL	2017		
2674	CHEBI_47519	ketoconazole	PR_P08684	CYP3A	inhibits	RO_0002449	FDA		6		PL	2017		
2675	CHEBI_5138	fluvoxamine	PR_P08684	CYP3A4.	inhibits	RO_0002449	FDA		269		PL	2017		
2676	CHEBI_47519	ketoconazole	PR_P51589	CYP2J2	inhibits	RO_0002449	FDA		99		Interview form (Japanese)	2017		
2677	CHEBI_6076	itraconazole	PR_P08684	CYP3A4	inhibits	RO_0002449	FDA		304		PL	2017		
2678	CHEBI_4031	cyclosporine	PR_P08684	CYP3A4	inhibits	RO_0002449	FDA		12		PL	2017		
2681	CHEBI_45409	saquinavir and ritonavir	PR_Q9Y6L6	OATP1B1	molecularly_interacts_with	RO_0002436	FDA		913			2017		
2683	CHEBI_5296	gemfibrozil	PR_P10632	CYP2C8	inhibits	RO_0002449	FDA		103		PL	2017		
2685	CHEBI_28077	rifampin SD	PR_P08183	P-gp	molecularly_interacts_with	RO_0002436	FDA		489		PL	2017		
2686	CHEBI_47519	ketoconazole	PR_P08684	CYP3A4	inhibits	RO_0002449	FDA		100		Interview form (Japanese)	2017		
2687	CHEBI_8426	probenecid	PR_O60656	UGT1A9	inhibits	RO_0002449	FDA		49		PL	2017		
2689	PC_119373	elacridar	PR_Q86VL8	MATE2K	molecularly_interacts_with	RO_0002436	FDA		540		PL	2017		
2691	CHEBI_45409	BILR 355 and ritonavir	PR_Q96FL8	MATE1	molecularly_interacts_with	RO_0002436	FDA		882			2017		
2695	CHEBI_8426	probenecid	PR_P11712	CYP2C9	inhibits	RO_0002449	FDA		301		PL	2017		
2696	CHEBI_45409	BILR 355 and ritonavir	PR_Q86VL8	MATE2K	molecularly_interacts_with	RO_0002436	FDA		445		PL	2017		
2698	PC_119373	elacridar	PR_Q86VL8	MATE2K	molecularly_interacts_with	RO_0002436	FDA		893			2017		
2699	CHEBI_53289	donepezil	PR_O15244	OCT2	molecularly_interacts_with	RO_0002436	FDA		461		PL	2017		
2700	CHEBI_47519	ketoconazole	PR_P10632	CYP2C8	inhibits	RO_0002449	FDA		166		PL	2017		
2702	CHEBI_45409	indinavir and ritonavir	PR_P08684	CYP3A	inhibits	RO_0002449	FDA		5		DIDB	2017		
2705	CHEBI_4031	cyclosporine	PR_P10632	CYP2C8	inhibits	RO_0002449	FDA		137		PL	2017		
2706	CHEBI_8426	probenecid	PR_P08183	P-gp	molecularly_interacts_with	RO_0002436	FDA		392		PL	2017		
2709	CHEBI_47519	ketoconazole	PR_P08684	CYP3A	inhibits	RO_0002449	FDA		30		PL	2017		
2710	CHEBI_8228	pioglitazone	PR_O60656	UGT1A9	inhibits	RO_0002449	FDA		157		Interview form (Japanese)	2017		
2712	CHEBI_47519	ketoconazole	PR_Q9Y6L6	OATP1B1	molecularly_interacts_with	RO_0002436	FDA		524		PL	2017		
2713	CHEBI_7565	nifedipine	PR_P08684	CYP3A4	inhibits	RO_0002449	FDA		338		PL	2017		
2715	CHEBI_28821	piperine	PR_P10635	CYP2D6	inhibits	RO_0002449	FDA		234		PL	2017		
2716	CHEBI_47519	ketoconazole	PR_P08684	CYP3A4	inhibits	RO_0002449	FDA		226		PL	2017		
2717	CHEBI_8228	pioglitazone	PR_Q9HAW9	UGT1A8	inhibits	RO_0002449	FDA		155		Interview form (Japanese)	2017		
2718	CHEBI_45409	saquinavir and ritonavir	PR_P08183	P-gp	molecularly_interacts_with	RO_0002436	FDA		914			2017		
2719	PC_119373	elacridar	PR_Q96FL8	MATE1	molecularly_interacts_with	RO_0002436	FDA		891			2017		
2720	CHEBI_47519	ketoconazole	PR_P10635	CYP2D6	inhibits	RO_0002449	FDA		89		PL	2017		
2722	CHEBI_28821	piperine	PR_P33261	CYP2C19	inhibits	RO_0002449	FDA		232		PL	2017		
2723	CHEBI_47519	ketoconazole	PR_P08684	CYP3A4	inhibits	RO_0002449	FDA		160		PL	2017		
2724	CHEBI_175901	gemcitabine	PR_P08684	CYP3A4	inhibits	RO_0002449	FDA		315		"16988200"	2017		
2725	CHEBI_28821	piperine	PR_P11712	CYP2C9	inhibits	RO_0002449	FDA		233		PL	2017		
2726	CHEBI_8426	probenecid	PR_Q4U2R8	OAT1	molecularly_interacts_with	RO_0002436	FDA		867			2017		
2727	CHEBI_8426	probenecid	PR_P06133	UGT2B4	inhibits	RO_0002449	FDA		48		PL	2017		
2728	CHEBI_7772	omeprazole	PR_P08684	CYP3A4	inhibits	RO_0002449	FDA		163		PL	2017		
2729	CHEBI_46081	fluconazole	PR_P08183	P-gp	molecularly_interacts_with	RO_0002436	FDA		478		DIDB	2017		
2732	CHEBI_3732	clarithromycin and amoxicillin	PR_P08684	CYP3A4	inhibits	RO_0002449	FDA		4		PL	2017		
2733	CHEBI_47519	ketoconazole	PR_Q9Y6L6	OATP1B1	molecularly_interacts_with	RO_0002436	FDA		471		NDA 022068	2017		
2734	CHEBI_68595	telaprevir	PR_P20815	CYP3A5	inhibits	RO_0002449	FDA		287		DIDB	2017		
2737	CHEBI_4031	cyclosporine	PR_Q9NPD5	OATP1B3	molecularly_interacts_with	RO_0002436	FDA		896			2017		
2738	CHEBI_5138	fluvoxamine	PR_P33261	CYP2C19	inhibits	RO_0002449	FDA		245		PL	2017		
2739	CHEBI_7577	nisoldipine	PR_Q9NPD5	OATP1B3	molecularly_interacts_with	RO_0002436	FDA		530		PL	2017		
2740	CHEBI_5296	gemfibrozil	PR_P08684	CYP3A4	inhibits	RO_0002449	FDA		290		PL	2017		
2741	CHEBI_47519	ketoconazole	PR_P08684	CYP3A4	inhibits	RO_0002449	FDA		198		"20110038"	2017		
2742	CHEBI_45409	ritonavir + ARV	PR_Q4U2R8	OAT1	molecularly_interacts_with	RO_0002436	FDA		880			2017		
2743	CHEBI_5118	fluoxetine	PR_P08684	CYP3A4	inhibits	RO_0002449	FDA		149		PL	2017		
2744	CHEBI_4031	cyclosporine	PR_P08183	P-gp	molecularly_interacts_with	RO_0002436	FDA		427		PL	2017		
2745	CHEBI_8426	probenecid	PR_Q8TCC7	OAT3	molecularly_interacts_with	RO_0002436	FDA		357		PL	2017		
2746	CHEBI_47519	ketoconazole	PR_P08183	P-gp	molecularly_interacts_with	RO_0002436	FDA		408		PL	2017		
2747	CHEBI_47519	ketoconazole	PR_P08684	CYP3A4	inhibits	RO_0002449	FDA		291		PL	2017		
2748	CHEBI_47519	ketoconazole	PR_P05177	CYP1A2	inhibits	RO_0002449	FDA		19		PL	2017		
2749	CHEBI_47519	ketoconazole	PR_P08684	CYP3A4	inhibits	RO_0002449	FDA		293		PL	2017		
2750	CHEBI_47519	ketoconazole	PR_P08183	P-gp	molecularly_interacts_with	RO_0002436	FDA		367		PL	2017		
2751	CHEBI_10033	warfarin	PR_Q9UNQ0	BCRP	molecularly_interacts_with	RO_0002436	FDA		438		"9484872"	2017		
2752	CHEBI_45409	ritonavir	PR_P08684	CYP3A4	inhibits	RO_0002449	FDA		333		"19492868"	2017		
2753	CHEBI_63660	pravastatin	PR_Q9NPD5	OATP1B3	molecularly_interacts_with	RO_0002436	FDA		476		PL	2017		
2754	CHEBI_7476	S-naproxen	PR_P05177	CYP1A2	inhibits	RO_0002449	FDA		131		PL	2017		
2755	CHEBI_8426	probenecid	PR_Q8TCC7	OAT3	molecularly_interacts_with	RO_0002436	FDA		876			2017		
2757	CHEBI_7936	paroxetine	PR_P08183	P-gp	molecularly_interacts_with	RO_0002436	FDA		483		PL	2017		
2759	PC_119373	elacridar	PR_Q9UNQ0	BCRP	molecularly_interacts_with	RO_0002436	FDA		541		PL	2017		
2763	CHEBI_47519	ketoconazole	PR_Q8TCC7	OAT3	molecularly_interacts_with	RO_0002436	FDA		886			2017		
2764	CHEBI_47519	ketoconazole	PR_P78329	CYP4F2	inhibits	RO_0002449	FDA		135		PL	2017		
2766	PC_119373	elacridar	PR_P08183	P-gp	molecularly_interacts_with	RO_0002436	FDA		890			2017		
2769	CHEBI_4031	cyclosporine	PR_P08183	P-gp	molecularly_interacts_with	RO_0002436	FDA		386		PL	2017		
2770	CHEBI_8426	probenecid	PR_Q4U2R8	OAT1	molecularly_interacts_with	RO_0002436	FDA		384			2017		
2775	CHEBI_68595	telaprevir	PR_Q9Y6L6	OATP1B1	molecularly_interacts_with	RO_0002436	FDA		518		DIDB	2017		
2778	CHEBI_47519	ketoconazole	PR_P08684	CYP3A4	inhibits	RO_0002449	FDA		14		PL	2017		
2779	CHEBI_5138	fluvoxamine	PR_P05177	CYP1A2	inhibits	RO_0002449	FDA		317		NDA 020397	2017		
2780	CHEBI_5296	gemfibrozil	PR_P08183	P-gp	molecularly_interacts_with	RO_0002436	FDA		507		PL	2017		
2781	CHEBI_45409	ritonavir, in CYP2C19 PMs	PR_P33261	CYP2C19	inhibits	RO_0002449	FDA		341		PL	2017		
2782	CHEBI_8426	probenecid	PR_Q86VL8	MATE2K	molecularly_interacts_with	RO_0002436	FDA		874			2017		
2784	CHEBI_6076	itraconazole	PR_P08684	CYP3A4	inhibits	RO_0002449	FDA		330		PL	2017		
2788	CHEBI_6923	miconazole	PR_P05177	CYP1A2	inhibits	RO_0002449	FDA		118		"12527704"	2017		
2789	CHEBI_47519	ketoconazole	PR_P10635	CYP2D6	inhibits	RO_0002449	FDA		296		PL	2017		
2790	CHEBI_5296	gemfibrozil and itraconazole	PR_P08183	P-gp	molecularly_interacts_with	RO_0002436	FDA		502		PL	2017		
2793	CHEBI_47519	ketoconazole	PR_P08183	P-gp	molecularly_interacts_with	RO_0002436	FDA		523		PL	2017		
2794	CHEBI_47519	ketoconazole	PR_P08183	P-gp	molecularly_interacts_with	RO_0002436	FDA		400		PL	2017		
2795	CHEBI_5296	gemfibrozil	PR_P10632	CYP2C8	inhibits	RO_0002449	FDA		45		"17199019"	2017		
2797	CHEBI_45409	ritonavir	PR_Q9NPD5	OATP1B3	molecularly_interacts_with	RO_0002436	FDA		454		PL	2017		
2799	CHEBI_42355	erythromycin	PR_P33261	CYP2C19	inhibits	RO_0002449	FDA		59		PL	2017		
2801	CHEBI_8426	probenecid	PR_Q9UNQ0	BCRP	molecularly_interacts_with	RO_0002436	FDA		473		PL	2017		
2803	PC_119373	elacridar	PR_Q96FL8	MATE1	molecularly_interacts_with	RO_0002436	FDA		539		PL	2017		
2804	CHEBI_45409	ritonavir + ARV	PR_Q8TCC7	OAT3	molecularly_interacts_with	RO_0002436	FDA		534		PL	2017		
2805	CHEBI_28077	rifampin SD	PR_P35503	UGT1A3	inhibits	RO_0002449	FDA		241		PL	2017		
2806	CHEBI_5778	hydrochlorothiazide	PR_P08183	P-gp	molecularly_interacts_with	RO_0002436	FDA		542		PL	2017		
2807	CHEBI_3699	cimetidine	PR_P33261	CYP2C19	inhibits	RO_0002449	FDA		64		PL	2017		
2808	CHEBI_8985	valspodar	PR_P08183	P-gp	molecularly_interacts_with	RO_0002436	FDA		415		PL	2017		
2809	CHEBI_8426	probenecid	PR_O15245	OCT1	molecularly_interacts_with	RO_0002436	FDA		875			2017		
2810	CHEBI_47519	ketoconazole	PR_P08183	P-gp	molecularly_interacts_with	RO_0002436	FDA		798			2017		
2814	CHEBI_8426	probenecid	PR_Q4U2R8	OAT1	molecularly_interacts_with	RO_0002436	FDA		431		PL	2017		
2815	CHEBI_6076	itraconazole	PR_P08183	P-gp	molecularly_interacts_with	RO_0002436	FDA		529		PL	2017		
2816	CHEBI_37924	atazanavir	PR_O15244	OCT2	molecularly_interacts_with	RO_0002436	FDA		398		PL	2017		
2818	CHEBI_47519	ketoconazole	PR_P08684	CYP3A	inhibits	RO_0002449	FDA		33		"16052551"	2017		
2822	CHEBI_3770	cotrimoxazole	PR_Q9UNQ0	BCRP	molecularly_interacts_with	RO_0002436	FDA		462		PL	2017		
2823	CHEBI_47519	ketoconazole	PR_P11712	CYP2C9	inhibits	RO_0002449	FDA		41		PL	2017		
2824	CHEBI_47519	ketoconazole	PR_P10635	CYP2D6	inhibits	RO_0002449	FDA		42		PL	2017		
2826	CHEBI_47519	ketoconazole	PR_P08684	CYP3A4	inhibits	RO_0002449	FDA		193		PL	2017		
2827	CHEBI_7772	omeprazole	PR_P22309	UGT1A1	inhibits	RO_0002449	FDA		248		PL	2017		
2828	CHEBI_47519	ketoconazole	PR_P08183	P-gp	molecularly_interacts_with	RO_0002436	FDA		443		PL	2017		
2829	CHEBI_47519	ketoconazole	PR_P10632	CYP2C8	inhibits	RO_0002449	FDA		15		PL	2017		
2831	CHEBI_7772	omeprazole	PR_Q4U2R8	OAT1	molecularly_interacts_with	RO_0002436	FDA		499		PL	2017		
2832	CHEBI_4031	cyclosporine	PR_P08684	CYP3A4	inhibits	RO_0002449	FDA		138		PL	2017		
2834	CHEBI_68595	telaprevir	PR_Q9NPD5	OATP1B3	molecularly_interacts_with	RO_0002436	FDA		519		DIDB	2017		
2836	CHEBI_28177	theophylline	PR_P05177	CYP1A2	inhibits	RO_0002449	FDA		318		"12017343"	2017		
2838	CHEBI_8871	risperidone	PR_P08684	CYP3A4	inhibits	RO_0002449	FDA		141		PL	2017		
2839	CHEBI_8426	probenecid	PR_Q9Y6L6	OATP1B1	molecularly_interacts_with	RO_0002436	FDA		407		Interview form (Japanese)	2017		
2841	CHEBI_47519	ketoconazole	PR_P08684	CYP3A4	inhibits	RO_0002449	FDA		169		PL	2017		
2847	CHEBI_45735	troleandomycin	PR_Q9Y6L6	OATP1B1	molecularly_interacts_with	RO_0002436	FDA		411		Interview form (Japanese)	2017		
2848	CHEBI_47519	ketoconazole	PR_P08684	CYP3A4	inhibits	RO_0002449	FDA		136		PL	2017		
2849	CHEBI_47519	ketoconazole	PR_P20813	CYP2B6	inhibits	RO_0002449	FDA		181		PL	2017		
2851	CHEBI_39867	valproic acid	PR_P08684	CYP3A	inhibits	RO_0002449	FDA		183		PL	2017		
2854	CHEBI_5778	hydrochlorothiazide	PR_P08183	P-gp	molecularly_interacts_with	RO_0002436	FDA		380		PL	2017		
2856	CHEBI_5296	gemfibrozil	PR_P08183	P-gp	molecularly_interacts_with	RO_0002436	FDA		865			2017		
2857	CHEBI_5138	fluvoxamine	PR_P05177	CYP1A2	inhibits	RO_0002449	FDA		47		DIDB	2017		
2858	CHEBI_6076	itraconazole	PR_P08684	CYP3A4	inhibits	RO_0002449	FDA		7		PL	2017		
2859	CHEBI_28901	busulfan	PR_P11712	CYP2C9/18/19	inhibits	RO_0002449	FDA		75		PL	2017		
2860	CHEBI_7565	nifedipine	PR_P33261	CYP2C19	inhibits	RO_0002449	FDA		92		PL	2017		
2862	CHEBI_3962	curcumin	PR_P08183	P-gp	molecularly_interacts_with	RO_0002436	FDA		527			2017		
2863	CHEBI_8426	probenecid		CYP2A19	inhibits	RO_0002449	FDA		298		PL	2017		
2865	CHEBI_499361	aprepitant	PR_P05177	CYP1A2	inhibits	RO_0002449	FDA		211		PL	2017		
2866	CHEBI_28821	piperine	PR_P05177	CYP1A2	inhibits	RO_0002449	FDA		235		PL	2017		
2868	CHEBI_4659	disulfiram	PR_P05177	CYP1A2	inhibits	RO_0002449	FDA		57		"7550365"	2017		
2869	CHEBI_46081	fluconazole	PR_P08183	P-gp	molecularly_interacts_with	RO_0002436	FDA		371		PL	2017		
2871	SRS_U946SH95EE	milk thistle	PR_P08183	P-gp	molecularly_interacts_with	RO_0002436	FDA		458		DIDB	2017		
2872	CHEBI_8426	probenecid	PR_Q4U2R8	OAT1	molecularly_interacts_with	RO_0002436	FDA		554		PL	2017		
2874	CHEBI_47519	ketoconazole	PR_P20815	CYP3A5	inhibits	RO_0002449	FDA		167		PL	2017		
2876	CHEBI_47519	ketoconazole	PR_P10635	CYP2D6	inhibits	RO_0002449	FDA		252		PL	2017		
2878	CHEBI_47519	ketoconazole	PR_P33261	CYP2C19	inhibits	RO_0002449	FDA		68		PL	2017		
2879	CHEBI_7476	S-naproxen	PR_P35503	UGT1A3	inhibits	RO_0002449	FDA		130		PL	2017		
2880	CHEBI_46081	fluconazole	PR_P33261	CYP2C19	inhibits	RO_0002449	FDA		120		PL	2017		
2881	CHEBI_47519	ketoconazole	PR_P08684	CYP3A4	inhibits	RO_0002449	FDA		94		PL	2017		
2885	CHEBI_8499	propranolol	PR_P08183	P-gp	molecularly_interacts_with	RO_0002436	FDA		557		DIDB	2017		
2887	CHEBI_28821	piperine	PR_P11509	CYP2A6	inhibits	RO_0002449	FDA		231		PL	2017		
2888	CHEBI_8228	pioglitazone	PR_P16662	UGT2B7	inhibits	RO_0002449	FDA		158		Interview form (Japanese)	2017		
2889	CHEBI_47519	ketoconazole	PR_P05177	CYP1A2	inhibits	RO_0002449	FDA		228		PL	2017		
2890	CHEBI_45409	ritonavir	PR_P08183	P-gp	molecularly_interacts_with	RO_0002436	FDA		453		PL	2017		
2891	CHEBI_3699	cimetidine	PR_Q86VL8	MATE2K	molecularly_interacts_with	RO_0002436	FDA		859			2017		
2896	CHEBI_47519	ketoconazole	PR_P08684	CYP3A4	inhibits	RO_0002449	FDA		172		"18372400"	2017		
2898	CHEBI_37924	atazanavir	PR_P08684	CYP3A	inhibits	RO_0002449	FDA		71		PL	2017		
2899	CHEBI_7936	paroxetine	PR_P10635	CYP2D6	inhibits	RO_0002449	FDA		308		PL	2017		
2900	CHEBI_47519	ketoconazole	PR_P08183	P-gp	molecularly_interacts_with	RO_0002436	FDA		451		PL	2017		
2901	CHEBI_7772	omeprazole	PR_Q14242	P-gp(citalopram)	molecularly_interacts_with	RO_0002436	FDA		354		PL	2017		
2905	CHEBI_47519	ketoconazole	PR_P10635	CYP2D6	inhibits	RO_0002449	FDA		8		PL	2017		
2906	CHEBI_47519	ketoconazole	PR_P08684	CYP3A4	inhibits	RO_0002449	FDA		244		PL	2017		
2908	CHEBI_47519	ketoconazole	PR_P10635	CYP2D6	inhibits	RO_0002449	FDA		62		PL	2017		
2909	CHEBI_28821	piperine	PR_P05181	CYP2E1	inhibits	RO_0002449	FDA		236		PL	2017		
2911	CHEBI_46081	fluconazole	PR_P11712	CYP2C9	inhibits	RO_0002449	FDA		119		PL	2017		
2912	CHEBI_47519	ketoconazole	PR_P08684	CYP3A	inhibits	RO_0002449	FDA		25		PL	2017		
2916	CHEBI_47519	ketoconazole	PR_P08684	CYP3A4	inhibits	RO_0002449	FDA		321		PL	2017		
2918	CHEBI_8426	probenecid	PR_Q8TCC7	OAT3	molecularly_interacts_with	RO_0002436	FDA		391		PL	2017		
2919	CHEBI_8426	probenecid	PR_Q96FL8	MATE1	molecularly_interacts_with	RO_0002436	FDA		873			2017		
2920	CHEBI_45409	darunavir/ritonavir	PR_P08684	CYP3A	inhibits	RO_0002449	FDA		263		PL	2017		
2923	CHEBI_45409	BILR 355 and ritonavir	PR_Q9UNQ0	BCRP	molecularly_interacts_with	RO_0002436	FDA		883			2017		
2924	CHEBI_8985	valspodar	PR_Q9UNQ0	BCRP	molecularly_interacts_with	RO_0002436	FDA		418		PL	2017		
2925	CHEBI_45409	indinavir and ritonavir	PR_Q9NPD5	OATP1B3	molecularly_interacts_with	RO_0002436	FDA		421		PL	2017		
2926	CHEBI_46081	fluconazole	PR_P10632	CYP2C8	inhibits	RO_0002449	FDA		208		DIDB	2017		
2927	CHEBI_499361	aprepitant	PR_P08684	CYP3A4	inhibits	RO_0002449	FDA		213		PL	2017		
2928	CHEBI_47519	ketoconazole	PR_P08684	CYP3A4	inhibits	RO_0002449	FDA		150		PL	2017		
2929	CHEBI_28077	rifampin SD	PR_Q9UNQ0	BCRP	molecularly_interacts_with	RO_0002436	FDA		492		PL	2017		
2930	CHEBI_8382	prednisone	PR_P05177	CYP1A2	inhibits	RO_0002449	FDA		346		PL	2017		
2931	CHEBI_47519	ketoconazole	PR_P08684	CYP3A4	inhibits	RO_0002449	FDA		258		PL	2017		
2932	CHEBI_47519	ketoconazole	PR_P08684	CYP3A4	inhibits	RO_0002449	FDA		340		PL	2017		
2933	CHEBI_47519	ketoconazole	PR_P08183	P-gp	molecularly_interacts_with	RO_0002436	FDA		419		PL	2017		
2934	CHEBI_47519	ketoconazole	PR_P08684	CYP3A4	inhibits	RO_0002449	FDA		306		PL	2017		
2936	CHEBI_45409	ritonavir	PR_P08183	P-gp	molecularly_interacts_with	RO_0002436	FDA		402		PL	2017		
2937	CHEBI_28077	rifampin SD	PR_P10632	CYP2C8	inhibits	RO_0002449	FDA		240		PL	2017		
2938	CHEBI_45735	troleandomycin	PR_Q9UNQ0	BCRP	molecularly_interacts_with	RO_0002436	FDA		413		Interview form (Japanese)	2017		
2939	CHEBI_4031	cyclosporine	PR_Q9UNQ0	BCRP	molecularly_interacts_with	RO_0002436	FDA		899			2017		
2940	CHEBI_45409	saquinavir and ritonavir	PR_P08684	CYP3A4	inhibits	RO_0002449	FDA		189		PL	2017		
2941	CHEBI_47519	ketoconazole	PR_P08684	CYP3A	inhibits	RO_0002449	FDA		229		PL	2017		
2945	CHEBI_5296	gemfibrozil	PR_P10632	CYP2C8	inhibits	RO_0002449	FDA		238		PL	2017		
2946	CHEBI_45409	BILR 355 and ritonavir	PR_O15245	OCT1	molecularly_interacts_with	RO_0002436	FDA		885			2017		
2947	CHEBI_5296	gemfibrozil	PR_P11712	"2C9"	inhibits	RO_0002449	FDA		271		PL	2017		
2948	CHEBI_45735	troleandomycin	PR_P08684	CYP3A	inhibits	RO_0002449	FDA		109		Interview form (Japanese)	2017		
2949	CHEBI_47519	ketoconazole	PR_P08183	P-gp	molecularly_interacts_with	RO_0002436	FDA		486		PL	2017		
2950	CHEBI_3699	cimetidine	PR_Q96FL8	MATE1	molecularly_interacts_with	RO_0002436	FDA		548		PL	2017		
2951	CHEBI_28077	rifampin (OATP1B1)	PR_Q9Y6L6	OATP1B1	molecularly_interacts_with	RO_0002436	FDA		381		PL	2017		
2952	CHEBI_8426	probenecid	PR_Q4U2R8	OAT1	molecularly_interacts_with	RO_0002436	FDA		871			2017		
2954	CHEBI_6076	itraconazole	PR_P08183	P-gp	molecularly_interacts_with	RO_0002436	FDA		545		PL	2017		
2955	CHEBI_8772	raloxifene	PR_P08684	CYP3A4	inhibits	RO_0002449	FDA		124		PL	2017		
2956	CHEBI_47519	ketoconazole	PR_P05177	CYP1A2	inhibits	RO_0002449	FDA		28		PL	2017		
2958	CHEBI_45409	ritonavir	PR_P11712	CYP2C9	inhibits	RO_0002449	FDA		332		"19492868"	2017		
2960	CHEBI_7772	omeprazole	PR_P08684	CYP3A4	inhibits	RO_0002449	FDA		223		PL	2017		
2962	CHEBI_3699	cimetidine	PR_P11509	CYP2A6	inhibits	RO_0002449	FDA		56		DIDB	2017		
2963	CHEBI_68647	regorafenib	PR_O15245	OCT1	molecularly_interacts_with	RO_0002436	FDA		479		PL	2017		
2964	CHEBI_4031	cyclosporine	PR_P08183	P-gp	molecularly_interacts_with	RO_0002436	FDA		511		PL	2017		
2965	CHEBI_7772	omeprazole	PR_P08684	CYP3A4	inhibits	RO_0002449	FDA		2		PL	2017		
2966	CHEBI_47519	ketoconazole	PR_P08183	P-gp	molecularly_interacts_with	RO_0002436	FDA		901			2017		
2967	CHEBI_42355	erythromycin	PR_P08183	P-gp	molecularly_interacts_with	RO_0002436	FDA		870			2017		
2968	CHEBI_4031	cyclosporine	PR_Q9UNQ0	BCRP	molecularly_interacts_with	RO_0002436	FDA		430		PL	2017		
2969	CHEBI_47519	ketoconazole	PR_Q9UNQ0	BCRP	molecularly_interacts_with	RO_0002436	FDA		409		PL	2017		
2970	CHEBI_45409	indinavir and ritonavir	PR_Q96FL8	MATE1	molecularly_interacts_with	RO_0002436	FDA		910			2017		
2971	CHEBI_4031	cyclosporine	PR_Q8TCC7	OAT3	molecularly_interacts_with	RO_0002436	FDA		510		PL	2017		
2976	CHEBI_6076	itraconazole	PR_Q9UNQ0	BCRP	molecularly_interacts_with	RO_0002436	FDA		437		PL	2017		
2977	CHEBI_47519	ketoconazole	PR_P05177	CYP1A2	inhibits	RO_0002449	FDA		154		PL	2017		
2980	CHEBI_4031	cyclosporine	PR_Q9Y6L6	OATP1B1	molecularly_interacts_with	RO_0002436	FDA		387		PL	2017		
2982	SRS_JQ9EK2H6BG	grapefruit juice	PR_P08684	CYP3A4	inhibits	RO_0002449	FDA		85		PL	2017		
2983	CHEBI_47519	ketoconazole	PR_P22310	UGT1A4	inhibits	RO_0002449	FDA		53		DIDB	2017		
2984	CHEBI_28901	busulfan	PR_P08684	CYP3A4/5	inhibits	RO_0002449	FDA		76		PL	2017		
2985	CHEBI_47519	ketoconazole	PR_Q9UNQ0	BCRP	molecularly_interacts_with	RO_0002436	FDA		916			2017		
2987	CHEBI_7772	omeprazole	PR_P11712	CYP2C9	inhibits	RO_0002449	FDA		162		PL	2017		
2989	CHEBI_46081	fluconazole	PR_P11712	CYP2C9	inhibits	RO_0002449	FDA		31		PL	2017		
2990	CHEBI_47519	ketoconazole	PR_P08183	P-gp	molecularly_interacts_with	RO_0002436	FDA		396		PL	2017		
2991	CHEBI_28077	rifampin SD	PR_Q9NPD5	OATP1B3	molecularly_interacts_with	RO_0002436	FDA		491		PL	2017		
2992	CHEBI_47519	ketoconazole	PR_P08684	CYP3A4	inhibits	RO_0002449	FDA		322		PL	2017		
2993	CHEBI_63660	pravastatin	PR_Q4U2R8	OAT1	molecularly_interacts_with	RO_0002436	FDA		906			2017		
2994	CHEBI_47519	ketoconazole	PR_P05177	CYP1A2	inhibits	RO_0002449	FDA		106		PL	2017		
2996	CHEBI_47519	ketoconazole	PR_P08183	P-gp	molecularly_interacts_with	RO_0002436	FDA		887			2017		
2997	CHEBI_499361	aprepitant	PR_P10635	CYP2D6	inhibits	RO_0002449	FDA		212		PL	2017		
2998	CHEBI_46081	fluconazole	PR_P33261	CYP2C19	inhibits	RO_0002449	FDA		209		DIDB	2017		
3000	CHEBI_4031	cyclosporine	PR_P11712	CYP2C9	inhibits	RO_0002449	FDA		273		PL	2017		
3001	CHEBI_6923	miconazole	PR_P10635	CYP2D6	inhibits	RO_0002449	FDA		117		"12527704"	2017		
3002	CHEBI_8426	probenecid	PR_Q96FL8	MATE1	molecularly_interacts_with	RO_0002436	FDA		433		PL	2017		
3004	CHEBI_45735	troleandomycin	PR_P08183	P-gp	molecularly_interacts_with	RO_0002436	FDA		410		Interview form (Japanese)	2017		
3005	CHEBI_47519	ketoconazole	PR_P08183	P-gp	molecularly_interacts_with	RO_0002436	FDA		426		PL	2017		
3006	CHEBI_5778	hydrochlorothiazide	PR_Q9Y6L6	OATP1B1	molecularly_interacts_with	RO_0002436	FDA		543		PL	2017		
3007	CHEBI_47519	ketoconazole	PR_P08183	P-gp	molecularly_interacts_with	RO_0002436	FDA		900			2017		
3008	CHEBI_3699	cimetidine	PR_Q96FL8	MATE1	molecularly_interacts_with	RO_0002436	FDA		858			2017		
3010	CHEBI_45409	ritonavir + ARV	PR_P08183	P-gp	molecularly_interacts_with	RO_0002436	FDA		879			2017		
3012	CHEBI_3396	levodopa and carbidopa	PR_O60656	UGT1A9	inhibits	RO_0002449	FDA		276		PL	2017		
3013	CHEBI_8426	probenecid	PR_Q4U2R8	OAT1	molecularly_interacts_with	RO_0002436	FDA		390		PL	2017		
3014	CHEBI_63660	pravastatin	PR_Q9NPD5	OATP1B3	molecularly_interacts_with	RO_0002436	FDA		903			2017		
3015	CHEBI_4031	cyclosporine	PR_Q8TCC7	OAT3	molecularly_interacts_with	RO_0002436	FDA		897			2017		
3016	CHEBI_46081	fluconazole	PR_P08684	CYP3A4	inhibits	RO_0002449	FDA		121		PL	2017		
3017	CHEBI_8426	probenecid	PR_Q9UNQ0	BCRP	molecularly_interacts_with	RO_0002436	FDA		393		PL	2017		
3019	CHEBI_47519	ketoconazole	PR_P08183	P-gp	molecularly_interacts_with	RO_0002436	FDA		372		DIDB	2017		
3020	CHEBI_47519	ketoconazole	PR_P08684	CYP3A4	inhibits	RO_0002449	FDA		316		"9021439"	2017		
3021	CHEBI_47519	ketoconazole	PR_P08684	CYP3A4	inhibits	RO_0002449	FDA		267		PL	2017		
3022	PC_119373	elacridar	PR_Q9UNQ0	BCRP	molecularly_interacts_with	RO_0002436	FDA		892			2017		
3023	CHEBI_63631	topiramate	PR_P08183	P-gp	molecularly_interacts_with	RO_0002436	FDA		414		PL	2017		
3026	CHEBI_28077	rifampin SD	PR_Q9Y6L6	OATP1B1	molecularly_interacts_with	RO_0002436	FDA		490		PL	2017		
3027	CHEBI_45409	indinavir and ritonavir	PR_Q8TCC7	OAT3	molecularly_interacts_with	RO_0002436	FDA		422		PL	2017		
3028	CHEBI_47519	ketoconazole	PR_P08183	P-gp	molecularly_interacts_with	RO_0002436	FDA		374		PL	2017		
3030	CHEBI_8426	probenecid	PR_Q86VL8	MATE2K	molecularly_interacts_with	RO_0002436	FDA		356		PL	2017		
3032	CHEBI_47519	ketoconazole	PR_P51589	CYP2J2	inhibits	RO_0002449	FDA		339		PL	2017		
3034	CHEBI_45409	indinavir and ritonavir	PR_O15245	OCT1	molecularly_interacts_with	RO_0002436	FDA		424		PL	2017		
3035	CHEBI_47519	ketoconazole	PR_P11712	CYP2C9	inhibits	RO_0002449	FDA		152		PL	2017		
3038	CHEBI_47519	ketoconazole	PR_Q9UNQ0	BCRP	molecularly_interacts_with	RO_0002436	FDA		506		PL	2017		
3039	PC_71306834	peginterferonalpha-2a	PR_O15245	OCT1	molecularly_interacts_with	RO_0002436	FDA		404		DIDB	2017		
3040	CHEBI_47519	ketoconazole	PR_P05177	CYP1A2	inhibits	RO_0002449	FDA		351		PL	2017		
3041	CHEBI_8426	probenecid	PR_Q9NPD5	OATP1B3	molecularly_interacts_with	RO_0002436	FDA		383		Interview form (Japanese)	2017		
3042	CHEBI_45409	ritonavir	PR_P22309	UGT1A1/3	inhibits	RO_0002449	FDA		101		PL	2017		
3044	CHEBI_8426	probenecid	PR_P08183	P-gp	molecularly_interacts_with	RO_0002436	FDA		379		PL	2017		
